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ABSTRACT OF THE DISSERTATION
Sex Differences in the Role of Cornichon Homolog-3 on Spatial Memory and Synaptic Plasticity
by
Hannah E. Frye
Doctor of Philosophy in Biology and Biomedical Sciences
Neurosciences
Washington University in St. Louis, 2021
Professor Jose A. Morón-Concepción, Ph.D. Chair

Cornichon homolog-3 (CNIH3) is an AMPA receptor (AMPAR) auxiliary protein highly
expressed in the dorsal hippocampus (dHPC), a region where AMPARs are critical for spatial
memory and synaptic plasticity. A 2016 genome-wide association study (GWAS) by Nelson et al.
identified single nucleotide polymorphisms (SNPs) in the gene CNIH3 to be associated with
reduced individual risk for the development of opioid use disorder (OUD) in individuals with prior
opioid exposure. We previously demonstrated a key role for AMPARs in the dHPC in opioidassociated learning and memory, therefore we hypothesized that CNIH3 in the dHPC may mediate
learning and memory processes through AMPAR-mediated mechanisms. To study the role of
CNIH3 on memory and related mechanisms, we bred and characterized three new C57BL/6 mouse
lines: a Cnih3 knockdown (KD), a functional Cnih3 global knockout (KO, Cnih3-/-), and a
humanized transgenic mouse line overexpressing human Cnih3 bearing the SNPs identified in the
Nelson et al., 2016 GWAS. In addition, we also created a viral vector construct to induce localized
overexpression of Cnih3.

x

We utilized these newly generated mouse lines to study the role of Cnih3 in spatial
memory, synaptic plasticity, and AMPAR subunit configuration. In our Cnih3 KD mice, we did
not observe changes due to genotype in spatial memory nor in synaptic protein expression. In mice
overexpressing Cnih3 in the dHPC, we observed significantly improved short-term spatial memory
in a Barnes maze spatial memory task exclusively in female animals, with no observable effect of
dHPC Cnih3 overexpression in males. In Cnih3-/- mice, we observed significantly attenuated shortterm spatial memory only in Cnih3-/- female mice. To investigate how CNIH3 may be affecting
hippocampal function in female animals, we utilized super-resolution SEQUIN imaging to
quantify synaptic loci in the dHPC, biochemical analysis to assess changes in synaptic proteins,
and electrophysiological recordings in slice to measure alterations in synaptic plasticity. In
SEQUIN studies, we observed decreased levels of synaptic structural proteins and reduced
synaptic density in dHPC samples obtained from Cnih3-/- female mice. In biochemical studies, we
detected altered AMPAR subunit composition in synaptosomal samples obtained from the dHPC
of Cnih3-/- female mice. In field recordings of the Schaffer Collateral (SC) circuit in the dHPC, we
observed attenuated maintenance of long-term potentiation in Cnih3-/- female mice. In behavioral
and in biochemical studies of Cnih3-/- mice, we observed the most robust effects of CNIH3 during
the metestrus phase of the female estrous cycle. These studies identify a previously unknown role
for CNIH3, as manipulation of this gene unmasks sexually dimorphic effects in spatial memory
and hippocampal synaptic plasticity.
Due to the role of AMPAR-mediated mechanisms underlying drug-associated learning and
memory, we next investigated how CNIH3 may interact with sex to mediate opioid-associated
behaviors. We revisited the original human genomic data to probe for correlations between CNIH3
SNPs and sex on opioid dependence risk. Separating human participants by sex, we observed that
xi

women with the protective CNIH3 SNPs were less likely than men to develop opioid use disorder
after prior opioid exposure. To assess potential changes in opioid-associated learning and opioid
seeking behavior due to CNIH3, we first tested several paradigms of cue-associated operant opioid
self-administration in mice. Oral fentanyl self-administration resulted in inconsistent and limited
drug consumption during both the light and dark cycles of wild-type mice. In pilot studies testing
intravenous self-administration (IVSA) of fentanyl in male and female wild-type mice, we
successfully trained mice to self-administer fentanyl and induced cue-associated reinstatement
following a period of extinction. Interestingly, female mice took slightly less time to acquire the
IVSA task compared male animals, but additional studies are required to confirm these results.
The next step of these studies will be to test the role of CNIH3 on cue-associated IVSA in male
and female Cnih3-/- mice. In addition, we will also investigate whether humanized transgenic mice
overexpressing the protective human CNIH3 SNPs display attenuation of cue-associated fentanyl
IVSA acquisition and reinstatement.
Taken together, these studies demonstrate a role for CNIH3 in mediating sexually
dimorphic hippocampal mechanisms underlying spatial memory. In addition, preliminary studies
also support an interaction between CNIH3 and sex on opioid use disorder risk. We aim to continue
these studies to further dissect how CNIH3 mediates opioid-associated learning and memory. The
findings presented in this thesis support a role of hippocampal CNIH3 in mediating AMPARdependent memory processes and illustrate the importance of considering sex as a biological factor
in biomedical research.
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Chapter 1: Introduction
This thesis seeks to dissect the link between the AMPA receptor (AMPAR) auxiliary
protein cornichon homolog-3 (CNIH3) and memory processes in the brain, with the long-term goal
of exploring the relationship between memory and drug use disorders. To introduce readers to
some of the topics which shaped this thesis, I have divided this introduction into two main sections.
Section 1 will discuss the biological and behavioral processes which shape memory storage and
retrieval in the brain, with a special focus on how factors such as animal sex and drugs of abuse
interact with memory-associated mechanisms. Section 2 will introduce readers to the function of
CNIH3 in the brain and explore the involvement of CNIH3 in learning, memory, drug use and
psychiatric disorders.
1.1

Memory mechanisms in the brain
The capability of the brain to process, store, and retrieve a memory is perhaps one of the

most fundamental processes underlying cognition. In order for an individual to recall information
regarding survival, relationships, language, preferences, and learned behavior, the brain must
engage complex molecular mechanisms and inter-regional networks. Thousands of researchers
have dedicated their life’s work to understanding the intricate neural machinery which regulates
memory. Modern day researchers of memory stand on the shoulders of many giants whose work
paved the way for our present-day discoveries. However, despite the strong foundation of
knowledge in the study of memory, there remains a vast swathe of unknown components in the
machinery which enables a brain to remember.
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Deficits in memory are characteristic of many debilitating neurological and psychiatric
disorders. While the ability of the brain to extinguish memories which are no longer relevant is an
important process in normal brain function, deficits in the acquisition or retrieval of important
memories can lead to significant dysfunction and reduced quality of life. Memory loss can be the
result of regional brain damage, neurodegenerative disorders such as Alzheimer’s disease and
Parkinson’s disease, prolonged exposure environmental stressors, or exposure to toxins, certain
medications, or drugs of abuse. To ameliorate the effects of memory loss in patients,
neuroscientists must understand how these disorders affect mechanisms in the brain which underlie
memory.
The processes in the brain which underlie memory are vast and incorporate multiple
regions, neuronal subtypes, molecular signaling pathways, and genetic factors. One of the original
prevailing theories of memory is that of the consolidation hypothesis proposed by Müller and
Pilzecker (1), which posits that newly developed memories are easily disrupted shortly after
learning, but can strengthen into long-lasting memories over time. Multiple psychological and
neurobiological studies have built on this early work to demonstrate that traumatic brain injury,
pharmacological agents, electroconvulsive shock, and environmental interruptions can all disrupt
the consolidation of newly formed memories (2, 3). For memories to persist over time, the brain
must interpret the memory as salient for future retrieval. In particular, memories paired with
emotional arousal tend to persist for longer than memories with no emotional context (4),
particularly through the activation of the noradrenergic system in the amygdala (5) (Figure 1). The
basolateral amygdala (BLA) projects to multiple other regions which mediate specific forms of
memory, such as spatial memory in the dorsal hippocampus and cue-associated memory in the
caudate nucleus (6). Long-term consolidation of memories results in time-dependent diffusion of
2

memory processing across the brain,
involving additional areas such as the
neocortex and circuitry between the
hippocampus and associated cortical
regions (7).
1.1.1

Hippocampal

mechanisms

underlying memory
One of the classically studied
Figure 1. Summary of systems underlying memory
consolidation. Acquisition of a learned experience engages multiple
brain regions to begin the process of memory consolidation.
Memories accompanied by emotional arousal engage noradrenergic
systems in the basolateral amygdala, which interact with memory
systems to strengthen consolidation of the memory over time. Image
adapted from McGaugh et al., 2018. (3)

regions of the brain in the field of
memory, especially episodic and
spatial memory, is the hippocampus.
Lesions in the hippocampus lead to

memory loss in human and animal studies (8, 9), with these deficits particularly pronounced in
spatial memory (9). One of the leading theories of hippocampal function is that it generates
cognitive maps of an organism’s environments and consolidates these spatial and temporal
memories for future retrieval (10, 11). These cognitive maps incorporate important episodic
contexts, enabling an organism to make logical predictions about what will occur in this
environment in the future (ex: “apples were in the produce area at the front of the store last week,
therefore when I go to the store for apples tomorrow I should go to produce section in the front of
the store”) (12). Place cells in the hippocampus are also highly adaptable, able to create multiple
cognitive maps of the same environment depending on the relevant episodic contexts and goals
within the environment (13).
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As scientific investigation of this region advanced over time,
scientists have been able to dissect distinct subregions and circuits
within the hippocampus which mediate memory. The rodent
hippocampus is frequently divided into dorsal and ventral
subregions, which are homologous in function and orientation with
the septal and temporal portions of the human hippocampus (As this
dissertation primarily explores hippocampal function in rodent
models, I will describe these subregions as dorsal and ventral) (14).
While these areas are highly interconnected, they are reported to
mediate distinct functions within the brain. The two regions have
distinct cellular organization (15), send and receive projections from
differing brain regions (16), display differences in synaptic plasticity
(17) and gene expression profiles (18), and mediate distinct
behaviors (19). In particular, the dorsal hippocampus is
predominantly associated with spatial learning and memory (19, 20)
whereas the ventral hippocampus primarily mediates emotional
regulation and memory (21-23).
In addition to hippocampal polarization along the dorsalventral axis, the hippocampus is also organized by distinct layers:
Figure 2: The Mouse
Hippocampus (A – D) NeuN
stained
coronal
sections
outlining the hippocampus
along the rostral – caudal axis,
with CA1, CA2, CA3, and DG
regions labeled. Adapted from
Witter, 2012. (24)

the dentate gyrus (DG), CA1, CA2, and CA3 (Figure 2) (24). Each
layer has unique cellular organization with projection pathways
between layers as well as with other brain regions. Pyramidal
neurons in the CA1 and CA3 have been implicated as key regions
4

mediating temporal and spatial memory (25). Projections from the CA3 to the CA1 form the
Schaffer Collateral, which is frequently utilized in cellular recordings as a model synaptic pathway
for the study of synaptic plasticity in the hippocampus (24). Granule neurons in the DG largely
project to the CA3, giving rise to the high density of unmyelinated axons, termed “mossy fibers”.
These projections have been shown to mediate pattern separation of information received from
areas such as the entorhinal cortex before being passed to the CA3 and then to the remainder of
the hippocampus for memory encoding and retrieval (26). Interestingly, the granule neurons in
the DG undergo neurogenesis even into adulthood, which is thought to play a critical role in the
lifelong cognitive plasticity required for spatial pattern separation (27). Overall, the hippocampus
is comprised of multiple interconnected subregions which play key roles in mediating hippocampal
function and memory.
1.1.2 Cellular and molecular mechanisms underlying memory
The link between learning and synaptic plasticity has been extensively explored in the field
of neuroscience. As early as 1894, Santiago Ramon y Cajal hypothesized that “The ability of
neurons to grow in an adult and their power to create new connections can explain learning” (28).
In the mid-20th century, Donald Hebb theorized that when an axon consistently and repeatedly
excites another neuron, the synapse between them is strengthened over time to improve firing
efficiency. This led to the common colloquialism to describe Hebbian plasticity as “cells that fire
together, wire together” (29). With the advancement of electrophysiological recording techniques,
it was soon discovered that hippocampal synaptic potentiation possessed plasticity which could
provide a functional model for long-term memory storage. High frequency stimulation of synaptic
projections produces an initial potentiation of synaptic transmission, followed by prolonged
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maintenance of this potentiation (30). Long-term potentiation (LTP) and long-term depression
(LTD) are theorized to be key cellular processes underlying learning and memory (31).
LTP and LTD involve a precise sequence of molecular activity which involve multiple
actors on the pre- and postsynaptic sites. For the purposes of this thesis, I will primarily focus on
the process of LTP, with particular emphasis on the hippocampal region (although LTP/LTD occur
in multiple regions throughout the brain). Upon stimulation of the presynaptic neuron during LTP
induction, synaptic vesicle exocytosis occurs at the presynaptic site and neurotransmitter is
released into the synapse where it diffuses towards the postsynaptic terminal (32). One of the most
common excitatory neurotransmitters in the brain is glutamate, which binds to ionotropic
glutamatergic AMPA, NMDA, and kainate receptors (AMPARs, NMDARs, KARs, respectively)
and to metabotropic glutamate receptors (mGluRs). AMPARs and NMDARs both are key
contributors to the induction and maintenance of LTP (33).
AMPARs are one of the most ubiquitously expressed glutamatergic receptors in the brain
and drive fast excitatory signaling. AMPARs are composed of two heteromeric or homomeric
dimerized subunits (four total subunits), GluA1-4, which form an ion channel pore (33). GluA2containing AMPARs are permeable to Na+ ions (and to K+ efflux), but GluA2-lacking AMPARs
are permeable to both Na+ and to Ca2+ ions. Thus, GluA2-containing AMPARs are often termed
as “calcium-impermeable” AMPARs (34). In a basal state, most AMPARs at the synapse are
GluA2-containing with minimal influx of Ca2+ ions (35). AMPAR activity is also regulated by a
diverse range of AMPAR auxiliary proteins which act to traffic the receptor to and from the
membrane and to modulate receptor activity (36), more information on these AMPAR auxiliary
proteins can be found in section 1.2 of this chapter.
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NMDARs are another class of ionotropic glutamate receptor which plays a key role in LTP
and are also permeable to both Na+ and to Ca2+ ions. At resting membrane potential, the ion channel
pore of the NMDAR is blocked by a magnesium ion that is not expelled unless depolarization
occurs. While AMPARs have much faster kinetics, NMDARs activate much slower upon
glutamate binding and remain open for significantly longer than AMPARs. NMDARs require both
postsynaptic depolarization and binding to glutamate for the ion channel pore to be open, therefore
they can only be functional when both pre- and postsynaptic neurons are activated (33, 37).
LTP is classically induced by high-frequency tetanic stimulation of an axonal pathway
(such as the Schaffer collaterals projecting from the CA3 to the CA1 regions of the hippocampus)
(38). This induction stimulus triggers a large release of glutamate from the pre-synaptic terminal,
which binds to and activates the GluA2-containing AMPARs at the post-synaptic membrane,
causing an influx of Na+ ions and a strong depolarization of the post-synaptic membrane.
Depolarization leads to the expulsion of the magnesium ion from the NMDAR ion channel and
permit the influx of Ca2+ ions into the post-synaptic neuron (37, 39). This acute potentiation of the
postsynaptic neuron triggers the exocytosis and lateral diffusion of additional AMPARs to the
post-synaptic membrane (40). In particular, an important component of the early phase of LTP is
thought to be mediated by a replacement of calcium-impermeable GluA2-containing AMPARs
with calcium-permeable GluA2-lacking AMPARs (41, 42). This stabilizes calcium influx into the
cell to facilitate the establishment of LTP expression. However, there is some controversy in the
field regarding the role of calcium-permeable AMPARs during LTP (35). The insertion of GluA2lacking AMPARs at the membrane is only transient, as they are subsequently replaced by enhanced
recruitment of GluA2-containing AMPARs to the membrane to maintain LTP expression (40, 4244). In addition to changes in AMPAR subunit composition at the membrane, AMPARs also
7

undergo post-translational modifications such as phosphorylation and palmitoylation to signal to
auxiliary proteins whether the receptor is to be targeted for membrane insertion or removal (41).
These tags are important signals for AMPAR auxiliary proteins to assist in regulating receptor
trafficking, stability at the membrane, and signaling to recognize the targeted location of the
receptors during synaptic plasticity (45-47).
Following LTP induction and the establishment of stable LTP expression, the synapse
makes several long-lasting changes to promote long-term maintenance of LTP. In order to
accommodate the increased insertion of AMPARs at the membrane, the scaffolding matrix of the
post-synaptic density (PSD) becomes enlarged following LTP (48, 49). Post-synaptic dendritic
spines increase in size, which is also associated with increased structural stability of the synapse
(50-53). In addition to increased size, in order to promote LTP maintenance the cell also increases
the density of synaptic spines along the dendritic shaft (54). For these structural changes to occur,
LTP-induced signaling cascades within the cell upregulate protein synthesis through elevated
transcription of mRNA in the nucleus or in local dendrites and increased somatic translation (55).
Overall, these structural changes at the synapse promote LTP through increased efficiency of
circuit firing, promoting both stability and plasticity for the storage and retrieval of memory
engrams.
Learning and memory are mediated by a complex interworking of both cellular and
molecular components. Taken together, these processes serve as the foundation underlying how
memories are acquired, stored, and retrieved.
1.1.3 The study of learning and memory in rodent models
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Psychological studies of memory behavior, macroscale functional imaging studies of brain
activity, population-wide genomic data collection, carefully controlled pharmacological and
clinical studies, or post-mortem tissue analysis can all be used to enhance our understanding of
memory in human subjects. However, for clear ethical reasons, it is difficult to dissect the precise
circuitry and mechanisms underlying memory through the sole use of human trials. On the opposite
end of the spectrum, analysis of in vitro cellular models can provide useful mechanistic data of
simple cellular systems but cannot be tested for higher level cognitive functions nor can these
models adequately represent the complex circuitry and diverse cellular components of brain
systems. Animal models are therefore essential for the field of neuroscience for both behavioral
analysis and for basic studies of neural circuitry and neurobiology.
The humane and ethical use of animal subjects is of the utmost importance for scientific
progress. Not only is it the moral responsibility of a scientist to ensure that her wards are kept
healthy and comfortable, but prioritizing animal well-being is also a matter of scientific rigor. To
ensure scientific integrity and ethical practices, all studies presented in this thesis using animal
subjects were carefully reviewed and approved by the Washington University Institutional Animal
Care and Use Committee. All animal colonies were housed in university-maintained or approved
laboratory satellite facilities with daily inspections of animal health and well-being. Specific
details regarding animal care are provided in each chapter.
One caveat of all scientific study using animal models is the translation of findings in
animal models to human behaviors or biology. In particular, it is a topic of much debate among
animal behaviorists regarding the extent to which we can anthropomorphize animal behavior. As
we cannot ask a mouse whether it is in pain or how much pleasure it receives from a reward or
whether it is feeling depressed, scientists have developed a multitude of tests in an attempt to
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characterize observable behaviors associated with these conditions. In the study of memory, it can
be especially challenging due to the inherent limitations in using animals with significantly limited
memory capacity compared to more intelligent species and humans. However, many scientists
have found rodents to possess adequate cognitive capacity for simple memory tasks while also
providing the benefits of established inbred lines, ease of animal care, and accessibility for many
research laboratories. In this thesis I will specifically focus on memory testing paradigms
commonly used in rodents, but variations of these tasks have been adapted for more intelligent
species such as non-human primates and for simpler organisms such as the fruit fly or zebrafish.
The utilization of the maze as a test of memory is perhaps one of the most iconic behavioral
paradigms in animal testing. The ability of an animal to use spatial cues and environmental stimuli
to navigate through a maze can answer key questions regarding learning and memory. One
common test of spatial memory is the radial-arm maze (RAM), where animals are trained to search
for appetitive cues located in radial arms extending from the center of the maze (56). This is similar
to T and Y mazes which also involve reference and/or spatial memory (depending on experimental
design) for the location of appetitive rewards (57). However, one issue with many of these tests is
the reliance on food rewards, and therefore on pre-test food restriction, for task completion.
Multiple factors may affect the reliability of these tests as truly assessing spatial memory, such as
whether the experimental factor being tested affects animal weight or food palatability, or whether
the animal would choose to rely on their keen sense of smell to locate the food reward. Therefore,
a widely used test of spatial memory is the Morris water maze (MWM), developed by Richard
Morris (58). In this test, animals are placed in a circular pool surrounded by external spatial cues
surrounding the pool. Animals are trained to use these spatial cues to navigate the pool to locate a
platform shallowly submerged below the opaque water. Over repeated trials, animals are able to
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quickly locate the platform. However, there are several disadvantages to the MWM. The test
requires a large, dedicated space which can house the pool, the water temperature must be tightly
controlled to reduce animal stress, animals will frequently swim on the perimeter instead of
exploring the center of the maze, and studies have found that while rats are adept swimmers, a
significant portion of inbred mouse strains will instead opt to float motionless or tread water until
experimenter rescue (59).
Similar to the MWM, the Barnes maze was developed by Carol Barnes in 1979 and reduces
the impact of several of the issues presented by the MWM in mice (60). Instead of a pool with a
hidden platform, the Barnes maze consists of an elevated circular table with equidistant falsebottom holes surrounding the perimeter. One hole leads a hidden escape box which allows the
animal to escape the exposed surface of the table. Surrounding the table are clearly visible and
distinct cues. With repeated trials, animals learn to use the external spatial cues to commit fewer
errors and reduce the latency to the location of the escape chamber. In all of these mazes, animals
can be tested in a probe trial shortly after training days as a test of short-term memory, or they can
be tested in a probe trial after a longer period of time as a test of long-term memory. The Barnes
maze offers several key advantages over other maze-based memory tasks. Animals are intrinsically
motivated to find the target box without the requirement of appetitive rewards or added stressors,
confounds such as scent cues or swimming behavior are minimized, and the equipment is readily
accessible for many laboratories. Therefore, in this study we opted to apply the Barnes Maze task
in our study of spatial memory.
In addition to spatial memory, several memory tasks have been developed to measure
discriminative and working memory. Object recognition memory (ORM) involves the introduction
of two objects to the animal and the time the animal spends investigating each object is recorded.
11

Following this introductory session, one of the objects is replaced by a new object, the animal is
reintroduced to the context, and once again the interaction time with each object is recorded.
Animals which recognize that one of the objects changed prefer to spend more time investigating
the novel object (61, 62). A variation of this task is the object location memory task (OLM), where
the location of one of the objects is changed in the apparatus. Similarly, the animal will
demonstrate a preference for the object with the new location (62, 63). These tests have also been
expanded to test for object pattern separation (OPS) memory (64). Additional tests which have
also been used in rodent models have been tests of delay memory, where an animal is rewarded
for identifying where a light was once located or the order of a pattern of lights as a test of working
memory (65).
One cannot discuss learning and memory paradigms without reviewing Pavlovian
conditioning (also referred to as classical conditioning). Originally described by Ivan Pavlov in
late 19th to early 20th centuries, classical conditioning involves training the subject to pair an
unconditioned stimulus (US) which elicits a measurable unconditioned response (UR) with a
conditioned stimulus (CS). With repeated pairing of the US and the CS, the subject will soon
respond to the CS alone, termed the conditioned response (CR). In the famous original study by
Pavlov, the dogs were presented with food (US) accompanied by the sound of the bell (CS). The
presentation of the food caused the dogs to salivate (UR). With repeated pairing of the US and CS,
the dogs began to salivate (CR) to the sound of the CS even in the absence of the US (66). This
principle underlies multiple behavioral paradigms and has been adapted into various forms of
behavioral testing. Fear-conditioning is frequently used in rodent studies of memory, where an
auditory or visual CS is paired with a fear or anxiety-provoking US such as a loud noise or an
electrical foot shock. The animal will quickly associate the US with the CS, and the animal will
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freeze upon presentation of the CS alone (67). In addition to memory paradigms using an aversive
US, variants of classical conditioning paradigms also investigate how animals learn to associate a
rewarding US with an CS. Conditioned place preference (CPP) and context dependentsensitization (CDS) train mice to associate a distinct environment (such as a striped box) as the CS
along with a reinforcing US such as a drug, food, or rewarding social interaction. The animal is
then placed back in the reward-associated context and their behavior is observed. In CDS, the
observer records a measurable CR behavior upon reintroduction to the CS context, such as
hyperlocomotion in the case of stimulant drugs (68, 69). In CPP, the animal is allowed to choose
to spend time in a reward-associated context or in a non-reward-associated context; most animals
will choose to spend the majority of time in the reward-associated context (70). However, CPP
also contains the aspect of animal choice, which has led some researchers to argue that it is instead
a variant of operant conditioning instead of true classical conditioning (71).
Operant conditioning also involves the use of CS cues associated with a rewarding or
punishing US. However, the key difference is that the animal must make a voluntary action to
obtain a reward or avoid a punishment. In the classic studies conducted by B.F. Skinner in the
1930’s, animals were trained in an operant conditioning chamber (called a “Skinner Box”) to press
a lever or button to administer a reward or avoid a punishment (72). Modern versions of these
boxes are still in use for variations of operant conditioning experiments. One especially common
test is that of cue-associated self-administration for food, drugs, or other rewarding stimuli.
Experimenters can modify the schedules of reward delivery to measure if the animal is willing to
increase effort for the reward. A fixed ratio (FR) can be utilized where a set number of responses
are necessary for reward delivery (such as FR1, FR2, FR5, etc.). A progressive ratio (PR) requires
an increased number of responses with each consecutive reward delivery and tests the motivation
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of an animal to obtain the reward. A period of extinction can be used where both the reward and
the cue are absent regardless of animal responding to lever pressing. Over time the animal learns
that pressing of the lever no longer results in reward. Following extinction, the CS is reintroduced
in the absence of the reward as a test of reinstatement and seeking of the reward (73). There are
multiple variations of this highly adaptable protocol depending on the animal model and on the
questions to be addressed by the experiment.
Animal models can provide informative data regarding how learning and memory is
mediated behaviorally and mechanistically. However, scientists must carefully design their
behavioral experiments to minimize potential confounds from extraneous variables and to ensure
animal well-being during their experiments.
1.1.4 Sex as a biological variable in the study of memory
Multiple biological factors affect how memory is processed in the brain during both healthy
and dysfunctional states. One such variable to consider in study designs of memory processes is
the inclusion of sex as a biological variable (SABV). The National Institutes of Health (NIH)
required the inclusion of women in clinical research in the 1993 NIH Revitalization Act (74).
However, it was not necessary for SABV to be reported in basic and preclinical research studies
funded by NIH until 2015 (75). The inclusion of female specimens in basic research studies was
especially dismal in neuroscience, with one study observing that the exclusive use of male subjects
in neuroscientific studies was nearly six times that of studies which included females (76). Since
the NIH mandate for the inclusion of SABV in basic research, a 2020 meta-analysis evaluating the
inclusion of SABV in published studies across 700 journals from nine biomedical research
disciplines found that reporting of specimen sex increased from 28% in 2009 to 49% of studies in
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2019 (77). These statistics are encouraging evidence that researchers are considering how
biological variables such as sex can potentially impact their experiments, but they also demonstrate
that there is still a long road ahead towards wider representation of half of the animal and human
population in biological research. While many studies have reported no differences due to sex in
their findings , this shift in the consideration of SABV in basic research has led to multiple studies
which identify previously unexplored instances of sexual dimorphism in biological and behavioral
findings.
In the field of memory, differences, or lack there-of, in behavior and biology due to animal
sex have yielded a rich body of literature investigating how hormones, genes, and environment
can differentially affect memory processes. However, it is important to note that the observance of
sex differences in rodent behavior can be highly dependent upon animal species, age, strain, stress,
and memory task (78, 79). Due to the variability inherent to individual study designs, researchers
have reported a wide range of sex differences in rodent memory tasks. These include an overall
superior spatial memory in male rats (80), sex differences in search strategies but not end-of-task
performance (81), sex differences in spatial memory retention but not short-term memory
consolidation (82), or no overall observable sex differences (83, 84). In addition, multiple studies
have also found that sex differences may only become unmasked upon pharmacological,
developmental, or genetic manipulation (85, 86). Therefore, while SABV has been repeatedly
shown to affect memory processes in the brain, the specific mechanisms or necessary co-variates
to explain these dimorphisms have yet to be fully elucidated.
One key concern regarding the inclusion of SABV in rodent studies is potential variability
in behavior and cellular function due to the rodent estrous cycle (87). While this was routinely
utilized as a convenient justification for the exclusion of female specimens, researchers rarely
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considered the natural hormonal fluctuations of male animals as a confounding variable in study
designs. Group-housed male mice will form a social hierarchy within their cages, and the dominant
male develops elevated levels of testosterone compared to his cage-mates (88). Despite this
finding, few researchers test for circulating testosterone variability in male subjects to control for
hormonal confounds. In addition, a 2014 meta-analysis of rodent studies incorporating data from
both sexes found that inclusion of females in experimental designs did not increase data variability
(89). However, when initially approaching studies with both male and female animals, it can still
be useful to monitor female estrous cycling as circulating hormonal levels can lead to interesting
discoveries which may otherwise go undetected. In the study of memory, this may be of particular
importance as multiple studies indicate that estrous cycling and sex hormones such as 17β-estradiol
and progesterone play key roles in hippocampal molecular signaling, synaptic structure, neuronal
excitability, and synaptic plasticity (78, 90-95). Multiple studies observed changes in
glutamatergic activity in the hippocampus during the estrous cycle and in the presence of 17βestradiol. 17β-estradiol has been shown to mediate LTP and dendritic spine density in the
hippocampus of female rodents through NMDAR-dependent mechanisms (96-98). In addition,
estrous cycling and 17β-estradiol modulate diffusion of AMPARs to the surface of the synaptic
membrane in female mice (99-101), alter AMPAR subunit stoichiometry (99), and increase the
expression of AMPAR subunits and associated scaffolding protein PSD-95 (102). However, prior
studies investigating the role of the estrous cycle on memory have been mixed with some studies
reporting contributing effects of the estrous cycle (103-105) and others little to no effect of natural
estrous cycling on memory (106). More research is necessary to dissect how hormonal fluctuations
mediate sex differences in learning and memory processes in the brain.
1.1.5 Memory and opioid use disorders
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As would be expected with the model of memory consolidation described earlier in this
chapter (Figure 1), rewarding stimuli or drugs which activate reward systems in the brain can form
powerful, long-lasting memories. From an evolutionary perspective, one can see the advantage of
retaining memories associated with natural rewards such as the location of nutritious food, the
names and faces of those in one’s social network, or how to best woo a potential mate. However,
the introduction of highly rewarding and addictive drugs commandeers the processes in the brain
linking reward and memory. Exposure to drugs of abuse leads to the formation of potent drugassociated memories that can persist over long periods of time, promoting maladaptive drug-taking
behavior and progression to disordered drug use. Due to the longevity of drug-associated
memories, triggering the retrieval of these memories induces intense drug craving which can lead
to relapse even after prolonged periods of drug abstinence. However, extended use of cognitionaltering drugs of abuse have been shown to negatively impact normal memory and hippocampal
function (107, 108). One hypothesis for this potential confound is that repeated drug use leads to
a cycle of forming strong drug-associated maladaptive memories paired with increased cognitive
inflexibility and overall learning deficits, culminating in the strengthened maintenance of drugassociated memories at the expense of adaptive brain function (108). For the scope of this thesis,
I will focus on how opioids affect hippocampal function, although other classes of drugs of abuse
function through both similar and distinct mechanisms.
Opioid use and opioid overdose deaths rapidly in the United States from 1999 to 2018. In
the 1990’s, prescription opioids were gaining in popularity due to the philosophy of treating patient
pain as the “fifth vital sign” (109, 110). In 2010 a second wave of the opioid epidemic began with
a rise in heroin deaths, presumably due to increased numbers of patients moving to the heroin after
their prescription opioids became more difficult and expensive to obtain (111). Between 2013 –
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2018 the number of deaths due to highly potent synthetic opioids such as fentanyl rose sharply as
illicit production of these compounds increased (112). Despite promising decreases in opioid
deaths over the last few years, the COVID-19 pandemic has reversed many of these gains in
combatting the opioid epidemic in the United States (113). The need to combat opioid addiction
remains a key priority for scientists, clinicians, judiciary professionals, and policymakers.
Consistent pairing of opioids with a specific CS cue or a unique can lead to the development
of strong associations of the rewarding properties of the drug with the CS. Animals trained to
associate an external context with an opioid will choose to spend more time in the drug-paired
context than in an environment with no drug association (70). When a discrete cue, such as a light,
is paired with drug availability in a self-administration paradigm, even after weeks of extinction
from the drug and the cue, a reintroduction of the cue alone or with a far lower drug dose will
trigger reinstatement of drug seeking (114, 115). Multiple studies link hippocampal processes with
both of these behaviors. Chronic administration of opioids reduces LTP in the hippocampus (116),
inhibits adult neurogenesis in the dentate gyrus (117), and alters synaptic proteins which mediate
hippocampal synaptic plasticity (118-120). When opioid administration is paired with a specific
context, this further reduces hippocampal LTP and leads to an increase in GluA2-lacking
AMPARs at the synapse, potentially resulting in a saturation of excitatory signaling (69, 121).
Pairing of a context with opioid administration also decreases the density of thin, highly plastic
dendritic spines in the hippocampus (122). This impairment in LTP continues into extinction, but
upon drug-primed reinstatement to the opioid-associated context, hippocampal LTP is
significantly enhanced (121). Taken together, these data indicate an important role of hippocampal
signaling in mediating the expression, extinction, and reinstatement of opioid-associated memory
and synaptic plasticity.
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1.2

Introduction to cornichon homolog-3 (CNIH3)
Cornichon homolog-3 (CNIH3) is an AMPAR auxiliary protein in the brain which was

recently identified as a promising candidate for the study of memory and OUD. Single-nucleotide
polymorphisms (SNPS) in CNIH3 were found to be associated with reduced risk of developing
opioid dependence in human subjects with a history of prior opioid use (123). Originally identified
in invertebrate organisms to modulate epidermal growth factor (EGF) signaling pathways (124,
125), the cornichon homolog (CNIH) proteins in mammals have been shown to act as AMPAR
auxiliary proteins, particularly in the hippocampus (126). However, the role of CNIHs on animal
behavior and the link between CNIH3 and OUD was unclear. In order to ascertain how CNIH3
affects AMPAR-dependent processes in the brain which may underlie opioid-associated behavior,
we sought to dissect how modulation of the Cnih3 gene in a mouse model affects animal behavior
and neuronal function.
1.2.1 The cornichon homolog family
Cornichon (cni) was first characterized in Drosophila melanogaster to interact with EGF
receptor signaling pathways to establish dorsal-ventral and anterior-posterior polarity (124, 125,
127). Cni acts as a cargo exporter of Gurken, a TGFα growth factor, from the endoplasmic
reticulum (ER) (128). The growth-factor trafficking function of cornichon-like proteins play a key
role in ensuring embryonic cranial nerve development (129).
Cornichon proteins are highly conserved across species, from invertebrates to vertebrates
(130, 131). In vertebrate systems, four cornichon homologs have been identified (CNIH1-4) and
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two of these homologs further evolved to mediate key components of glutamatergic signaling in
the brain (132). CNIH2 and CNIH3 co-assemble with AMPARs in the brain to increase AMPAR
surface expression and enhance AMPAR signaling (126). Interestingly, CNIH2/3 expression peaks
in the neonatal brain, but the level of CNIH proteins bound to AMPARs remains steady. This
indicates a shift in function of CNIH proteins from growth factor traffickers to AMPAR auxiliary
proteins during development (133).
CNIH2/3 serve as AMPAR chaperones from the endoplasmic reticulum and Golgi to the
synapse (134-137). In addition, CNIHs also act as AMPAR auxiliary proteins that enhance
receptor sensitivity (138, 139), improve ion channel permeability (138, 140), regulate receptor
gating (141-143), slow decay of AMPAR excitatory post-synaptic currents (EPSCs) (144), and
slow receptor deactivation (133, 140, 145, 146). CNIH2/3 bind AMPAR subunits through a unique
extracellular loop which interacts with the transmembrane and ligand-binding domain of AMPAR
subunits; this loop is not present in CNIH1 or CNIH4 (143, 146, 147).
While CNIH2/3 act in similar functions, key differences exist between the two homologs.
CNIH2 interacts primarily with the GluA1 subunit (141, 145), while CNIH3 appears to interact
with both GluA1 and GluA2 subunits (146, 148). CNIH2 is expressed at a higher level in the brain
than CNIH3 (18), therefore most studies have either investigated CNIH2 alone or the cumulative
effects of both CNIH2/3 in neural systems (145); significantly less is known about CNIH3-specific
effects on cellular and behavioral function.
In addition to CNIH2/3, additional AMPAR auxiliary proteins such as transmembrane
AMPAR regulatory proteins (TARPs) (126, 148-150), CKAMPs (151), and GSG1L (152, 153)
are also important components of AMPAR machinery in the brain. CNIH2 forms synergistic
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complexes with AMPARs and the TARP γ-8 to modulate AMPAR pharmacology and
desensitization (141, 154). This leads to regionally specific differences in CNIH function in across
the brain, as a CNIH proteins do not effectively modulate AMPAR function in cerebellar granule
neurons where γ-8 is absent (142, 154). In addition to AMPAR auxiliary proteins, AMPARs also
depend on a matrix of disk-large membrane-associated guanylate kinase (DLG-MAGUK)
scaffolding proteins to anchor receptors at the PSD, such as PSD-95 and SAP102. While CNIH
proteins do not contain a PDZ-binding site for direct interaction with the scaffolding matrix, recent
studies have demonstrated that regulation of SAP102 on AMPAR synaptic transmission depends
on the coexpression of CNIH2 (155). Overall, CNIH proteins are part of a complex matrix of
proteins which regulate AMPAR trafficking and function.
Multiple studies have characterized these families of AMPAR interacting proteins to
investigate their molecular interactions, cellular function, and importance for a wide range of
behaviors and psychiatric disorders (36, 149, 156, 157). For example, the TARP stargazin
regulates motor activity and epilepsy (158), pain sensitization (159), and memory (160). In
addition, AMPARs and their auxiliary proteins have been implicated in drug-associated contextual
memory (69, 161), opioid-induced hyperalgesia (162), social behaviors (163), and stress-induced
impairment of learning and memory (164). In C. elegans, cni mutants demonstrated excessive
hyper-reversal behavior, indicating changes in glutamatergic signaling (134), but the effect of
CNIHs on behavioral phenotypes in vertebrates have not yet been investigated. However, several
studies in human subjects have suggested a role of CNIH genetic variants in mediating AMPARdependent processes in the mammalian brain.
1.2.2 Genetic variants in cornichon homologs identified in cognitive, psychiatric, and drug use
disorders
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Despite extensive studies investigating the roles of AMPARs and their auxiliary partners
in mediating adaptive behaviors and brain disorders, CNIH proteins have not yet been
characterized for their role in cognitive function. However, a small number of studies point to a
potential role of CNIHs in mediating mammalian cognition.
A 2012 study of postmortem human tissue identified an upregulation of CNIH1, CNIH2,
and CNIH3 in the dorsolateral prefrontal cortex of patients diagnosed with schizophrenia (165).
No changes were observed in the cortical Cnih expression of rats treated with the antipsychotic
medication haloperidol decanoate, therefore the researchers suggested that this change in
expression was not due to antipsychotic treatment. As the dysregulation of glutamatergic signaling
is commonly observed in schizophrenia, it was hypothesized that this effect may be driven by
CNIH-mediated changes in AMPAR trafficking (165).
A case-report study observed a deletion of CNIH2 in a patient with dysmorphic features
and intellectual disability (166). Additional genes affected by the 1 Mb de novo deletion in the
patient included Cofilin-1 (CFL1) and neuronal PAS domain-containing protein 4 (NPAS4). The
authors hypothesized that the deletions of these genes may be responsible for the cognitive and
developmental phenotype observed in the patient (166).
In a 2016 genome-wide association study (GWAS) of opioid-exposed individuals, singlenucleotide polymorphisms (SNPs) in CNIH3 were associated with reduced risk for opioid
dependence in individuals with prior history of opioid use (123). The GWAS compared
Comorbidity and Trauma Study (CATS) data obtained from opioid-dependent subjects who were
daily injectors to opioid-exposed subjects who did not use opioids daily. The findings of this study
were confirmed by a meta-analysis of data obtained from the CATS, Yale-Penn genetic studies of
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Table 1: Association of CNIH3 SNPs with opioid dependence endpoint (ODE) vs. opioid use with impeded progression
(OUIP) in CATS, Yale-Penn and SAGE data, and in meta-analysis. From Nelson et al., 2016 (123).

opioid, cocaine and alcohol dependence, and Study of Addiction: Genetics and Environment
(SAGE) datasets. Five CNIH3 SNPs were identified with genome-wide significance, but the A
allele of rs10799590 was observed to have the strongest protective effect (P = 4.30E-9; odds ratio
(OR) 0.64 (95% confidence interval (CI): 0.55 – 0.74)) against progression to OUD (Table 1). The
observed SNPs were predominantly intronic, suggesting that they may affect gene expression and
transcription factor binding affinity. In a computational analysis of haplotype-based genetic
mapping for interstrain differences between common laboratory inbred mouse strains, researchers
identified a significant correlation between altered naloxone-induced morphine withdrawal in mice
containing haplotype blocks for Cnih3 and AMPAR-associated genes. Interestingly, no correlation
between withdrawal-associated behavior and haplotypes in Cnih2 were observed across mouse
strains. This study provided the first link between CNIH3 and OUD. The researchers hypothesized
that changes in CNIH3 expression modulate glutamatergic signaling pathways which mediate
opioid-associated learning and memory (123).
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1.3

Conclusions
Memory is regulated by a highly interconnected web of circuitry in the brain, and one

particular region of interest for the study of memory is the hippocampus. Within the hippocampus,
glutamatergic transmission tightly coordinates LTP to modulate synaptic plasticity, one of the key
functional mechanisms thought to underlie memory consolidation. In order to study these neural
mechanisms underlying memory and learning, rodent models are commonly used for both
behavioral and biological studies. However, a key consideration in the study of memory is how
biological variables such as animal sex and hormonal fluctuations can potentially impact the
molecular and cellular signaling mechanisms of interest.
The processes in the brain which mediate learning and memory share significant overlap
with neural mechanisms that underlie the development of drug use disorders. Repeated pairing of
drug availability with cues or contexts leads to the formation of memories which are long-lasting
and potent even after extended periods of drug extinction. Opioid-associated memories can be
particularly strong, leading to significant dysregulation of hippocampal plasticity and
glutamatergic signaling mechanisms. As more research is starting to demonstrate a link between
AMPAR-mediated signaling and drug-associated memory, it is key that scientists improve our
understanding of how these factors intersect to influence addiction.
CNIH3, an AMPAR auxiliary protein which is highly expressed in the hippocampus, has
been correlated with reducing individual OUD risk in human patients with prior opioid exposure.
However, the role of CNIH3 in the hippocampus and on hippocampal mechanisms has not yet
been fully characterized. Therefore, the work presented in this thesis seeks to test the hypothesis
that CNIH3 regulates AMPAR-dependent memory through maintenance of AMPAR subunits at
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the post-synaptic density, which thereby mediates synapse density and plasticity in the
hippocampus. The long-term goal of this work is to expand these findings to future studies
investigating how CNIH3 mediates opioid-associated learning and reinstatement.
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Chapter 2: Generation and
characterization of mouse models to
modulate Cnih3 expression
This chapter contains unpublished data and data included in following manuscript (currently
under revision for publication):

Frye HF, Izumi Y, Harris AN, Williams SB, Trousdale CR, Sun M-Y, Sauerbeck AD, Kummer
TT, Mennerick SJ, Zorumski CF, Nelson EC, Dougherty JDD, Moron JA. Sex Differences in the
Role of Cornichon Homolog-3 on Spatial Memory and Synaptic Plasticity. Biological
Psychiatry. Under revision.

Preprint: Frye HF, Williams SB, Trousdale CR, Nelson EC, Dougherty JD, Moron JA.
Cornichon Homolog-3 (CNIH3) Modulates Spatial Memory in Female Mice. bioRxiv
724104. doi: https://doi.org/10.1101/724104
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2.1

Abstract
The first step to investigate the role of CNIH3 in the brain was to develop mouse models

which express a range of a Cnih3 expression. The first chapter in this thesis describes the work
performed in the Moron-Concepcion laboratory and by collaborators in the Dougherty laboratory
to generate Cnih3 mouse models for the work described in this thesis and for future projects. For
this project we generated and/or characterized three categories of C57BL/6 mouse colonies: a
Cnih3 knockdown, a Cnih3 knockout, and humanized transgenic mice bearing the entire human
CNIH3 gene containing the SNPs previously identified in the Nelson et al., 2016 GWAS (See
Chapter 1: Introduction, Section 1.2.2) (123). We also generated an AAV5-CAMKII-mycCNIH3GFP viral vector to induce localized viral overexpression of CNIH3. The work described in this
chapter demonstrates the foundation for the work presented in the later chapters of this thesis.

2.2

Introduction
In order to study the role of CNIH3 in mediating memory and hippocampal function, we

needed to generate the model systems required for our research. CNIH protein function and
expression are highly conserved across mammalian species, therefore we chose to use established
inbred mouse models to manipulate Cnih3 expression. Prior studies investigating the role of CNIH
proteins commonly studied only Cnih2 knockout (KO) or Cnih2/3 double KO mice, with CNIH3
activity inferred by analyzing differences between these two models (145). One prior study did
use a Cnih3 KO mouse model, but these mice were not studied beyond measurements of AMPAR
and NMDAR dependent evoked excitatory post-synaptic currents (EPSCs) (145). This is only a
single approach to investigating the effects of Cnih3 KO, making it an incomplete investigation of
how CNIH3 specifically may influence AMPAR activity. For the purposes of this thesis, a Cnih2/3
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KO mouse model would not allow us to specifically dissect the role of CNIH3 apart from CNIH2.
To begin breeding a colony a Cnih3 KO mice, we obtained heterozygous Cnih3tm1a(KOMP)Wtsi mice
from the Knockout Mouse Project (167), which contained a polyadenylation (pA) site following
Cnih3 exon 3 to attenuate transcription. However, during genetic validation of the
Cnih3tm1a(KOMP)Wtsi mouse line, we observed a functional knockdown (KD) in gene expression
instead of true KO. Several preliminary experiments were conducted in Cnih3 KD animals to
assess whether a decrease in Cnih3 expression affected hippocampal AMPAR subunit
composition, structural protein density, synaptic spine morphology, and spatial memory.
Additional crossings with Actin-FLPe and -Cre transgenic mouse lines were required to obtain a
full Cnih3 KO (Cnih3-/-) mouse. Experiments utilizing the Cnih3-/- mice are detailed in Chapter 3
of this thesis.
The SNPs in CNIH3 associated with protection against the development of OUD were
predominantly located in the intronic regions of the gene (123), suggesting that these SNPs resulted
in altered expression levels of CNIH3. However, this has not yet been confirmed in the human
data. Therefore, we were interested not only in conducting experiments using Cnih3 KO mouse
models, but also in modulating Cnih3 expression. To overexpress wild-type (WT) Cnih3, we
developed and validated a Cnih3 viral vector. An additional advantage with this viral
overexpression model was the ability to locally induce overexpression in a desired region. This
enabled us to specifically target the dorsal hippocampus to overexpress Cnih3 in this region for
experiments testing spatial memory.
Finally, to study how the SNPs on interest in human CNIH3 affect opioid response and
cue-associated drug self-administration, we collaborated with the laboratories of Dr. Joseph
Dougherty and Dr. Elliot Nelson to generate a line of humanized transgenic mice containing the
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entire protective haplotype of human CNIH3. While we initially were also interested in comparing
mice bearing the protective-associated haplotype to a second line of mice bearing a risk-associated
haplotype, we were only able to successfully obtain the protective haplotype line. These
humanized mice will be utilized in future experiments studying the role of CNIH3 in opioidassociated learning and memory; included in this chapter is a brief description of how they were
generated.
Overall, we successfully generated and validated several models of Cnih3 expression for
the experiments presented in this thesis.

2.3

Materials and Methods

Animals
All animal procedures were approved by the Institutional Animal Care and Use Committee
at Washington University in St. Louis. Adult (8 – 16 weeks) male and female C57BL/6 wild-type
(WT, Cnih3+/+), Cnih3tm1a(KOMP)Wtsi, and Cnih3 knockout (KO, Cnih3-/-) mice were kept in climatecontrolled facilities with a 12-hour light/dark cycle and ad libitum access to food and water.
Toe or tail snips were obtained at P7-10 for genotyping either in the lab or through
TransNetYX genotyping services. Mice were identified by either a toe snip numbering system or
by insertion of numbered metal ear tags.
Primer sequences
All primers used for polymerase chain reaction (PCR) and real-time quantitative PCR (RTqPCR) were obtained from Integrated DNA Technologies. Primers used by Transnetyx genotyping
services were designed in coordination with company representatives.
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Primer sequences are as follows for animal genotyping (developed in coordination with
Transnetyx genotyping services): WT Cnih3: 5’-TCAGTTTTCATTTATACCACATGTGCCT3’ (forward), 5’-GGGAGAAGGTGAGCTCAGACT-3’ (reverse). KOMP mutant Cnih3: 5’GCATTCTAGTTGTGGTTTGTCCAAA-3’ (forward), 5’-GGGCGCGCCGTTTAA-3’ (reverse).
Global

Cnih3

KO:

5’-GGCGCATAACGATACCACGATAT-3’

(forward),

5’-

TGATGGCGAGCTCAGACC-3’ (reverse).
Primer sequences used for PCR genotyping and RT-qPCR: Cnih3 exon 4: 5’TGGTGCTGCCCGAGTACTC-3’
(reverse).

Cnih2:

(forward),

5’-GGAACATTGAGTCCCAGGGTG-3’

5’-ATATTCCATCCACGGCCTCTTC-3’

TCCAGAGGTGGTAGAAGAGGAG-3’
TCCAGTGTGAACTGGGGAGG-3’

(reverse).

(forward),

5’-

Cnih3

(forward),
exon

5:

5’5’-

GGCACAGTGGCAGAATACAT-3’

(reverse). Cnih3 exon 1-2 (early gene): 5’-TCGCTATCTGGCACATAATCGC-3’ (forward), 5’GGACCCCTCTGACCTTTCTC-3’ (reverse). LacZ: 5’-CCGCCGTTTGTTCCCACGGA-3’
(forward),

5’-CCATCACCGCGAGGCGGTTT-3’

(reverse).

Neomycin:

5’-

GGTGGAGAGGCTATTCGGC-3’ (forward), 5’-GAACACGGCGGCATCAG-3’ (reverse).
Viral

Cnih3

gene

variant

2:

5’-GCGCTGCGCTCATCTTTTTC-3’

(forward),

5’-

CTTGAAATCCGTTCTTAGCTCGT-3’ (reverse).
Genotyping PCR
For animal genotyping in the laboratory, samples were lysed overnight in tissue lysis buffer
at 55 ºC (10mM Tris-HCl, 1 mM EDTA, 2 µL/mL proteinase K [New England BioLabs], pH 8.0).
Samples were then boiled at 99 ºC to halt the lysis reaction. 1 – 2 µL of lysed tissue samples were
loaded into 200 µL PCR tubes with 19 µL of PCR master mix (Per tube: 2X Quick-Load Taq
Mastermix [New England BioLabs] diluted to 1X with Milli-Q double distilled H2O, 500 nM
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forward and reverse DNA primers) and then placed in a thermal cycler (Bio-Rad) to facilitate PCR
(for Cnih3 genotyping: samples heated to 94 ºC for 5 min; 32 cycles of: 30 s 94 ºC, 30 s 56 ºC, 60
s 72 ºC; followed by 5 min 72 ºC before cooling samples to 4 ºC for storage and analysis). Every
primer reaction sample set also included negative and positive controls. Following PCR, samples
were separated by electrophoresis in a 2% agarose gel with ethidium bromide and imaged under
UV light on a Kodak Image Station.
RT-qPCR
Fresh dorsal hippocampi (dHPC) tissue samples were rapidly dissected on ice and frozen
for RT-qPCR analysis. RNA was extracted with RNeasy Mini Kit (QIAGEN) and assessed with
a Nanodrop Spectrophotometer (Thermo Fisher Scientific). cDNA was synthesized from 500 ng
RNA using iScript Reverse Transcriptase Supermix (Bio-Rad). qPCR utilized 500 nM of each
primer and PowerUp SYBR Green Master Mix (QIAGEN), in an Applied Biosystems Quant
Studio 6 PCR system (Thermo Fisher Scientific). In mouse line and viral overexpression validation
experiments, Ct scores were normalized to β-actin and to WT or YFP injected controls using delta
delta Ct analysis (ddCt).
Post-synaptic density fractionation
Hippocampi were collected from both hemispheres and pooled by individual animal.
Whole-cell homogenate and post-synaptic density (PSD) fractions were obtained as previously
described (69, 168, 169). Dissected fresh hippocampi were homogenized in 0.32 M sucrose
solution with 0.1 mM CaCl2 in the presence of protease and phosphatase inhibitor cocktails
(Sigma-Aldrich). An aliquot of the homogenized tissue was saved for whole-cell homogenate
samples. Homogenized tissue for fractionation was brought up to 1.25M sucrose in 0.1 mM CaCl2
and overlaid with 1M sucrose in 0.1 mM CaCl2. Samples were centrifuged at 100,000 x g for 3 hr
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at 4ºC. The synaptosomal layer at the interface between the sucrose gradients was removed and
solubilized in 20 mM Tris-HCl pH 6.0 buffer with 1% Triton X-100 and 0.1 mM CaCl2 for 20 min
at 4ºC with gentle rocking. Samples were centrifuged at 40,000 x g for 30 min at 4ºC and the pellet
containing the synaptic junction fraction was resuspended in 20 mM Tris-HCl pH 8.0 with 1%
Triton X-100 and 0.1 mM 0.1 mM CaCl2 for 20 min at 4ºC with gentle rocking. The PSD fraction
was pelleted at 40,000 x g for 30 min at 4 ºC and the supernatant containing the presynaptic fraction
was removed. The pellet was resuspended in 1% SDS with vigorous mixing and kept at -80ºC until
ready for western blot analysis. PSD fractionation isolates synaptic proteins in the PSD as
confirmed through immunoblot staining for PSD-95.
Western blotting
Protein concentrations of whole-cell homogenate and PSD fractionated samples were
measured by a bicinchoninic acid (BCA) protein assay (Pierce). 15 µg of sample was loaded per
well and separated on a 10% SDS-polyacrylamide gel and transferred to PVDF membranes.
Membranes were stained for total protein using the Revert 700 Total Protein Stain and Wash
Solution Kit (LI-COR Biosciences) to ensure equal loading and blot transfer across all samples,
then blocked in 5% bovine serum albumin (BSA) in Tris-buffered saline with 0.1% Tween-20.
Membranes were incubated in antibodies targeting PSD-95 (1:1,000, Cell Signaling Technologies
#3409), GluA1 (1:1,000, Abcam ab174785), GluA2 (1:500, Millipore Sigma MABN1189), or βactin (1:2,000, Millipore Sigma MAB1501) overnight at 4 ºC. Membranes were probed with
IRDye 680RD donkey anti-mouse (1:5,000, LI-COR Biosciences #926-68072), or IRDye 800CW
donkey anti-rabbit (1:5,000, LI-COR Biosciences #925-32213) and imaged using the Odyssey
infrared fluorescent imaging system (LI-COR Biosciences). Signal linearity of each antibody was
tested in control tissue to test for signal detection and to prevent signal saturation. Actin
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housekeeping proteins (HKPs) did not vary across experimental groups. Quantification was
performed with Image Studio software (LI-COR Biosciences) by comparing band intensities to
HKP control bands or to quantitative total protein stain controls within each lane to control for
potential variation in loading and transfer. Results are represented as a percentage of the average
intensity of WT controls.
Dendritic spine morphology
Dendritic spine morphology was assessed as previously described (122). 0.5 μL of AAV5CAMKII-eYFP (8.6x1011 particles per mL, Virus Vector Core, The University of North Carolina
at Chapel Hill) YFP virus was slowly infused bilaterally into the dorsal hippocampus (A/P: -1.8
mm, Lat: ±1.4 mm, D/V: -1.8 mm). Three weeks after completion of this procedure, mice were
transcardially perfused with 4% PFA and brains were sectioned at 100 µm for
immunohistochemical amplification for YFP (chicken anti-GFP and anti-chicken AlexaFluor
488). Sections were mounted and cover-slipped for confocal imaging (Leica) of apical dendritic
segments in the dorsal hippocampus (dHPC) using a 63 x oil immersion objective (N.A. = 1.4).
Images were deconvoluted using Huygens deconvolution software (Scientific Volume Imaging)
and dendritic spines were quantified using NeuronStudio software (Mount Sinai, New York, NY)
(170). 3 – 6 dendritic segments approximately 30 µm in length were analyzed per animal.
Experimenters were blinded to sample genotype throughout imaging and analysis and image
analysis was cross-checked by two experimenters.
Barnes maze spatial memory task
To assess changes in spatial learning and memory, we performed a Barnes maze spatial
learning task as previously described (122). Mice were handled by the experimenter for three days
prior to the experiment to minimize handling stress. We used a Barnes maze apparatus which was
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91 cm circular platform surround by twenty-equidistant 5 cm holes. One hole led to a dark escape
box in which the mouse could hide (referred to as the target hole). All other holes led to false
bottoms. Spatial cues in the form of large shapes (triangle, square, hexagon, and cross) surrounded
the apparatus to allow for spatial navigation. Any-Maze tracking software (Stoelting) was used for
video recording and animal tracking. During habituation to the apparatus, the mouse was gently
placed in the center of the maze and allowed to explore the maze for 180 s in two consecutive
trials. Upon entering the target hole, the experimenter covered the entrance and the animal
remained in the target box for 1 min. If the animal did not enter the target hole in the 180 s period,
the animal was gently guided to the hole. During training days 1-4, three 180 s trials were
conducted for each animal in 15 min intervals. The table was thoroughly cleaned between each
trial with 70% ethanol and the top table was rotated to minimize olfactory cues leading to the target
hole. The latency to the first entry in the target hole (primary latency), the number of errors made
prior to target hole entry (primary errors), and the primary path efficiency (actual distance traveled
to target hole divided by the shortest distance to target hole from starting location) were recorded.
On Days 5 and 12, a 90 s probe trial was conducted where the escape box was replaced with a false
bottom to prevent entry.
Generation of a Cnih3 expressing virus
A viral vector was constructed using mus musculus mRNA sequence of Cnih3, variant 2,
PCR’d from clone BC115640. This transcriptional variant was chosen based on expression level
in the brain and hippocampus, as notated on the UCSC Genome browser (171). Using PCR
stitching and inFusion cloning into pENTR3x plasmid, the Cnih3 transcript was N-terminal Myctagged and a t2A sequence followed by a GFP sequence was added at the C-terminus, and the
entire construct was confirmed by Sanger sequencing. The construct was then swapped into
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pAAV-EL1a using Gateway cloning. Upon confirmation of cloning for this vector, the EF1A
promoter was replaced by a CamKIIa promoter via classical digestion enzyme cloning. The
resulting plasmid, once fully sequence verified using GENEWIZ, was packaged into an AAV5
viral vector at the Hope Center Viral Core at Washington University in St. Louis.
Viral intracranial injection surgeries for Cnih3 overexpression
WT mice were anesthetized with 1-3% isofluorane and head-fixed in a stereotaxic
apparatus (Stoelting). 0.5 μL of AAV5-CAMKII-myc-CNIH3-t2a-GFP virus (1.7x1013 particles
per mL) or 0.5 μL of AAV5-CAMKII-eYFP (8.6x1011 particles per mL, Virus Vector Core, The
University of North Carolina at Chapel Hill) YFP control virus was slowly infused bilaterally into
the dorsal hippocampus (A/P: -1.8 mm, Lat: ±1.4 mm, D/V: -1.8 mm). Three weeks after
completion of this procedure, hippocampi were extracted for RT-qPCR or mice were transcardially
perfused with 4% PFA and brains were sectioned for immunohistochemical verification of viral
placement.
Immunohistochemistry for validation of viral expression
40 µm free-floating brain slices from viral Cnih3 overexpressing mice were stained with
rabbit anti-myc primary antibody (1:1000, Cell Signaling Technology, #2272) and goat anti-rabbit
594 Alexa Fluor secondary antibody (Life Technologies, #A11037). Slices were mounted and
imaged via confocal microscopy (Leica) to visualize expression of the myc-tag adjacent to Cnih3
within the viral construct.
Statistics and analysis
Results are presented as the mean ± SEM. For statistical analysis, datasets were analyzed
using GraphPad Prism 9 software. Dataset normality was determined by the Shapiro-Wilk test.
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Datasets which passed normality were analyzed by unpaired two-tailed t tests (two groups) or by
one-way ANOVA (three or more groups) followed by post hoc Sidak’s multiple comparisons test.
Datasets which failed normality were analyzed by a two-tailed Mann-Whitney U test (two groups)
or by a Kruskal-Wallis test (three or more groups) followed by post hoc Dunn’s multiple
comparisons test. Datasets comparing two factors (such as sex and genotype, or estrous cycle and
genotype) were compared using a two-way ANOVA followed by post hoc Sidak’s multiple
comparisons test. Outliers were determined within each dataset using a Grubbs’ Outlier test.
Datasets were considered statistically significant with p < 0.05.

2.4

Results

Characterization of Cnih3tm1a(KOMP)Wtsi mice
To further explore the role of CNIH3 in spatial memory and underlying memory
mechanisms, heterozygous Cnih3tm1a(KOMP)Wtsi C57BL/6 mice were obtained from the Knockout
Mouse Project (167) and bred with WT C57BL/6J mice to generate WT and heterozygous (HET)
offspring. The resulting HET offspring were crossed to generate three genotypes: WT, HET, and
homozygous (HOM) Cnih3tm1a(KOMP)Wtsi offspring. The Cnih3tm1a(KOMP)Wtsi allele contains a
polyadenylation (pA) site following exon 3 to attenuate transcription (Figure 1A). However, RTqPCR analysis of mRNA synthesized cDNA in the hippocampus (HPC) found only a 60%
reduction in exon 4 of Cnih3 in Cnih3tm1a(KOMP)Wtsi HET and HOM animals compared to WT
littermates (One-way ANOVA, F(2,14) = 20.40, p < 0.0001, post-hoc Sidak’s multiple comparisons
test, p = 0.0001 and 0.0003 respectively), resulting in a Cnih3 knockdown (KD) instead of a full
KO animal (Figure 1B). As CNIH2 is a functionally similar homolog of CNIH3, we also conducted
RT-qPCR to measure Cnih2 expression to determine if Cnih3 KD induced compensatory
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expression of Cnih2. We observed no
change

in

Cnih2

expression

in

Cnih3tm1a(KOMP)Wtsi HET or HOM animals
compared to WT controls (F(2,13) = 2.041,
p = 0.1695) (Figure 1C). Male and female
mice did not show differences in gene
expression and were therefore combined
for analysis.
While Cnih3 expression was only
reduced by 60% in the Cnih3tm1a(KOMP)Wtsi
mice compared to WT littermates, we
conducted several experiments utilizing
Cnih3tm1a(KOMP)Wtsi mice to investigate
whether a reduction in Cnih3 expression
affected AMPAR-mediated processes in
the HPC and spatial memory behavior. For

Figure 1: Characterization of Cnih3 knockdown (KD)
mice. (A) Cnih3tm1a(KOMP)Wtsi mice obtained from the
Knockout Mouse Project (KOMP). The Cnih3tm1a(KOMP)Wtsi
gene contained a polyadenylation (pA) site after exon 3 to
halt mRNA transcription. The pA site as well as lacZ and
neo cassettes and a splice acceptor (SA) site were contained
within two FRT sites. Exon 4 was surrounded by two loxP
sites. Cnih3tm1a(KOMP)Wtsi mice were bred to create a colony of
WT, heterozygote (KOMP(+/-)), and homozygote (KOMP(/-)) Cnih3tm1a(KOMP)Wtsi mice. RT-qPCR analysis was
conducted to measure mRNA expression for Cnih3 and
Cnih2 compared to WT controls. (B) RT-qPCR results for
WT (n = 7), KOMP(+/-) (n = 6), and KOMP(-/-) (n = 4) mice
for expression of Cnih3 and Cnih2 mRNA. Relative mRNA
expression presented using ddCt analysis. Ct values were
normalized to β-actin loading controls and then to the
average of β-actin-normalized WT values. Relative mRNA
expression presented as relative fold change calculated by 2(ddCt)
. Datasets underwent one-way ANOVA for genotype
and post-hoc Sidak’s multiple comparison test, * denotes
significance compared to WT (ns p > 0.05, *** p < 0.001).

clarity, Cnih3tm1a(KOMP)Wtsi genotypes will be referred to as Cnih3 WT, KD(HET), and KD(HOM)
mice. First we assessed whether Cnih3 KD led to changes in AMPAR subunit composition at the
PSD of the HPC. We observed no changes in GluA1 or in GluA2 subunit levels at the PSD in any
genotypes of either sex (One-way ANOVA within sex, p > 0.05 for each) (Figure 2A – B).
However, we did observe a decrease in PSD-95 at the PSD in female Cnih3 KD(HOM) samples
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Figure 2: PSD-95 is reduced in the PSD of Cnih3 KD female mice. The post-synaptic density was isolated from
hippocampi of n = 7-10 male and female mice by subcellular fractionation. Western blots were normalized to βActin and are shown as the percentage of the WT average. PSD samples are probed for AMPA receptors (A)
GluA1 and (B) GluA2, and the excitatory synaptic scaffolding protein (C) PSD-95. Representative blots are shown
for both sexes. Statistical significance due to genotype was assessed within each sex by one-way ANOVA (ns p >
0.05, * p < 0.05).

compared to WT females (One-way ANOVA, F(2, 21) = 3.452, p = 0.0506; Post-hoc Sidak’s multiple
comparisons test to female WT samples, p = 0.0406). (Figure 2C).
As PSD-95 is a key structural scaffolding protein at excitatory synapses, we also conducted
preliminary studies to see if decreased levels of PSD-95 at the PSD in female Cnih3 KD(HOM).
Utilizing a previously validated protocol to quantify dendritic spines in the dorsal hippocampus
(dHPC), we examined the density of total spines and of spine subtypes along dendritic shaft
subtypes: thin, mushroom, and stubby spines. After examining images from Cnih3 WT, KD(HET),
and KD(HOM) male and female animals, pilot study data suggested that there may be changes in
dendritic spine density and morphology due to Cnih3 KD (Figure 3). However, due to low sample
size and difficulty obtaining the necessary resolution for confident spine classification in these
experiments, additional study would be required to dissect how Cnih3 expression affects dendritic
spine morphology. If these experiments were to be reassessed in the future, I recommend the
utilization of a tissue clearing protocol to improve spine visualization through the thick slices
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Figure 3: Pilot study on the structural morphological effects of a Cnih3 KD on hippocampal dendritic spines.
(A) Male and female mice aged 6-8 weeks were injected with AAV5-CAMKII-eYFP virus in the dorsal
hippocampus: A/P -1.7 mm, M/L ±1.0 mm, D/V -1.4 mm. (B) Representation of image processing from the raw
confocal image, deconvolution using Huygens Scientific Volume Imaging software, to spine quantification and
identification using NeuronStudio software. (C and D) Pilot study findings represented as animal averages
(average of 4 – 7 images/animal) on total, thin, mushroom, and stubby spine densities between genotypes and
separated by sex.

required for analysis across the length of the dendritic shaft. In addition, special care should be
taken to utilize a high-resolution microscope with superior lens capabilities or a super-resolution
laser scanning microscope (such as what is described in the super-resolution SEQUIN experiments
presented in Chapter 3 of this thesis).
In addition to biochemical and morphological analysis, we also conducted a small study of
the effect of Cnih3 KD on performance in the Barnes maze spatial memory task (Figure 4A). We
did not observe any changes in the short-term probe trial of the Barnes maze due to sex or genotype
(Two-way ANOVA, p > 0.05 for sex and genotype) (Figure 4B). In the long-term probe trial, we
observed a potential increase in the number of primary errors committed by Cnih3 KD(HOM)
females (Two-way ANOVA, Sex: F(1, 27) = 0.2857, p = 0.5973; Genotype: F(2, 27) = 2.226, p =
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0.1274; Interaction: F(2,
27)

= 5.223, p = 0.0121.

Post-hoc

Sidak’s

multiple

comparison

test by genotype, p =
0.0115 between female
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mice)
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additional
would

be
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result as the sample
sizes were small in this
preliminary study. Data

Figure 4: Cnih3 KD affected spatial memory only in female mice in a pilot
study of the Barnes maze spatial memory task. (A) In the Barnes maze, male
and female mice (n = 3 – 7/group) were trained to use spatial cues to locate a hidden
escape box in the spatial memory Barnes Maze task. Mice were habituated to the
apparatus on Day 0 and trained over the course of 4 days, 3 trials/day. (B) On Day
5, a short-term memory probe trial was conducted and the number of errors prior
to location of the target was recorded. (C) On Day 12, a long-term memory probe
trial was conducted and the number of errors prior to location of the target was
recorded. Statistical significance due to sex and genotype was assessed by twoway ANOVA followed by Sidak’s multiple comparisons test within groups. (ns p
> 0.05, * p < 0.05).

presented in Chapter 3 of this thesis explores the role of Cnih3 on spatial memory in greater depth
and I would refer readers to those experiments.
Generation and characterization of Cnih3-/- mice
As the Cnih3tm1a(KOMP)Wtsi mice only produced a 60% knockdown of Cnih3 mRNA, we
conducted additional breeding to eliminate exon 4 from the Cnih3tm1a(KOMP)Wtsi gene (Figure 5A):
Cnih3tm1a(KOMP)Wtsi homozygote males were bred with Actin-FLPe females to excise the Splice
Acceptor (SA) and pA sites, and the lacZ and neomycin (neo) cassettes contained within the FRT
sites (generation F1). An important note, mice in generation F1 can be utilized in future studies as
a conditional KO for localized KO of Cnih3 by intracranial injection of cre recombinase. To
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generate a global Cni3h KO, male F1 mice
were bred with Actin-Cre females to excise
exon 4 contained with the loxP sites
(generation F2). F2 mice were backcrossed
to wildtype C57/BL6J mice to remove Cre
and Flpe alleles.

Removal of exon 4

resulted in a frameshift mutation across
exons 5 and 6, encoding for a truncation of
CNIH3 translation that would be predicted
to undergo nonsense-mediated decay.
Indeed, RT-qPCR analysis found decreased
Cnih3

expression

between

genotypes

(F(2,22) = 264.1, p < 0.0001). Cnih3+/- mice
expressed ~50% of Cnih3 exon 4 compared
to WT animals and Cnih3-/- had a total
elimination of Cnih3 exon 4 expression (p
< 0.0001 each genotype) (Figure 5B).
Cnih2 expression remained unchanged in
Cnih3+/- and Cnih3-/- mice compared to WT

Figure 5: Generation and validation of Cnih3 KO mice
(A) Breeding scheme for Cnih3 KO mice from
Cnih3tm1a(KOMP)Wtsi mice. Cnih3tm1a(KOMP)Wtsi male mice (F0)
were bred with Actin-FLPe females to excise cassettes
between the FRT sites. Male F1 mice were bred with ActinCre females to excise exon 4 contained within the loxP sites.
Mice in generation F2 are Cnih3+/-, which were bred to
create a colony of Cnih3+/+, Cnih3+/-, and Cnih3-/- animals.
(B) RT-qPCR results for Cnih3 and Cnih2 mRNA
expression in Cnih3+/+ (n = 10), Cnih3+/- (n = 10), and Cnih3/(n = 5) mice. Relative mRNA expression presented using
ddCt analysis as previously described. (ns p > 0.05, **** p
< 0.0001).

mice (F(2,22) = 1.097, p = 0.3513) (Figure
5B). No differences were observed in gene expression between male and female mice of any
genotype therefore they were combined for RT-qPCR analysis. Experiments utilizing the Cnih3-/mice are discussed in Chapter 3.
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Overview of humanized CNIH3 transgenic mice
To develop a mouse model for the study of association between human CNIH3 SNPs
identified and altered risk of opioid dependence (123), we participated in a multi-laboratory
collaboration to generate lines of humanized transgenic mice containing either CNIH3 protective
or risk-associated haplotypes. To achieve this aim, we identified the CNIH3 SNP with the strongest
genome-wide significance on opioid dependence risk: rs10799590, with the A allele predictive of
the protective effects, and the G allele associated with higher risk (123). Despite initial challenges
to generate bacterial artificial chromosomes (BACs) from human samples bearing the correct
haplotypes, we were ultimately able to successfully isolate BACs of each desired haplotype from
established BAC libraries. In order to facilitate targeted insertion of the human BACS into mouse
oocytes, we utilized a unique strategy for the knock-in of large genomic regions as proposed in
Yoshimi et al., 2016 (172). Through the conjunction of the CRISPR-Cas9 system with long single
stranded oligonucleotides (sODNS) as proposed by Yoshimi et al. to guide the insertion of the
targeted regions, leading to the generation of several promising colony founders. Potential
humanized lines were backcrossed onto a C57BL/6J background in preparation for future studies.
We
expression

recently

confirmed

of

humanized

the

CNIH3 protective haplotype in the
mouse Cnih3 locus (Figure 6),
indicating successful generation of
humanized
mouse

CNIH3

lines.

transgenic

These

mice

overexpress human CNIH3 mRNA,

Figure 6: Confirmation of human CNIH3 mRNA overexpression
in CNIH3 transgenic mice. (A) RT-qPCR using junction-spanning
primers specific for human CNIH3 (hCnih3) exons 1-2, 3-4, and 56; and mouse Cnih3 (mCnih3) (A & expanded in B) to assess
expression of human CNIH3 mRNA in humanized transgenic mice
(Cnih3+) compared to human and WT mouse samples. Data
collected & analyzed by Alexis Harris in the lab of Joe Dougherty,
Ph.D., presented here with permission.

42

which is absent in WT
littermates. Unfortunately,
upon

validation

of

the

potential humanized line
founders

obtained

from

BAC integration we found
that we did not obtain a
correctly integrated line of
humanized

CNIH3

transgenic mice bearing the
risk-associated
However,

haplotype.
we

are

encouraged that we can
utilize

humanized

Figure 7: Generation and validation of Cnih3 overexpression viral vector
(A) AAV5-CAMKII-mycCNIH3-t2a-GFP or AAV5-CAMKII-eYFP viruses
were injected bilaterally into the dorsal hippocampus of WT male and female
mice to overexpress Cnih3 (-1.8 mm A/P, ±1.4 mm M/L, -1.8 mm D/V). (B)
RT-qPCR results of the dorsal hippocampus for Cnih3 and Cnih2 mRNA 3
weeks following viral injection of YFP (n = 7) and Cnih3 overexpression (n
= 5) viruses. Datasets underwent a two-tailed unpaired t test between YFP and
Cnih3 virus injected animals (ns p > 0.05, **** p < 0.0001). (C)
Immunohistochemical representative image of a brain injected with AAV5CAMKII-myc-CNIH3-t2a-GFP. Brain slices were probed for the myc-tag
adjacent to Cnih3 in the viral construct.

transgenic mice for future experiments which not only endogenously overexpress CNIH3, but also
bear a CNIH3 SNP associated with reduced risk of opioid dependence in humans.
Generation and characterization of AAV5-CAMKII-mycCNIH3-GFP
To investigate the effect of overexpressing Cnih3 in the dHPC on spatial memory, we
generated an AAV5-CAMKII-mycCNIH3-t2a-GFP virus to overexpress Cnih3 in excitatory
neurons. 0.5 µL of AAV5-CAMKII-myc-CNIH3-t2a-GFP or an AAV5-CAMKII-eYFP YFP
control virus were bilaterally injected into the dorsal hippocampus of WT animals (Figure 7A). To
verify overexpression of Cnih3, we utilized RT-qPCR to measure mRNA expression of Cnih3 and
Cnih2 (Figure 7B). The dHPC of mice injected with the Cnih3 overexpression virus expressed
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~200X more Cnih3 mRNA than YFP-injected controls (Two-tailed unpaired t test, p < 0.0001).
We observed a slight decrease in Cnih2 expression in the dHPC of Cnih3 overexpressing animals
compared to YFP-injected controls, but this change in Cnih2 expression did not reach significance
(p = 0.0593). To verify the location of viral expression, brain slices were imaged for identification
of the myc-tag on CNIH3 in the AAV5-CAMKII-myc-NIH3-GFP construct or for YFP in the
AAV5-CAMKII-eYFP controls to validate viral expression in the hippocampus and to monitor the
viral spread from the site of injection (Figure 7C). Experiments utilizing WT mice overexpressing
Cnih3 are described in Chapter 3.

2.5

Discussion
In order to conduct studies dissecting the role of Cnih3 on spatial memory and hippocampal

synaptic function, we generated and validated several mouse lines with unique Cnih3 expression
profiles. We successfully generated and validated two lines of Cnih3 KD and KO C57BL/6 mouse
lines, which can also be bred to create a Cnih3 conditional cre-induced knockout line for future
studies. In addition, we also completed the generation of a new line of humanized CNIH3
transgenic mice bearing the A allele protective haplotype of the CNIH3 SNP rs10799590 identified
in the prior human GWAS of human subjects with a history of opioid misuse. Finally, we generated
and validated an AAV5-CAMKII-mycCNIH3-t2a-GFP viral vector to induce targeted WT Cnih3
overexpression. With this diverse spectrum of Cnih3 expression, we can utilize these mouse
models to assess the function of Cnih3 on memory and opioid-associated behaviors.
In addition to the development of these unique models, we also conducted several pilot
studies in Cnih3 KD animals to begin our investigation into CNIH3-mediated processes. In
biochemical studies of PSD fractionated hippocampal brain tissue samples, we did not observe
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any changes in AMPAR GluA1 or GluA2 subunits in the hippocampal PSD of Cnih3 KD animals.
This suggests that a reduction in Cnih3 is not sufficient to lead to disruptions in AMPAR
localization or subunit configuration at the PSD. However, we did observe a decrease in PSD-95
expression at the hippocampal PSD in homozygous Cnih3 KD female mice, but not in males. As
PSD-95 is a key scaffolding protein in the PSD matrix, we conducted a pilot study to assess
postsynaptic dendritic spine morphology in dHPC brain slices from Cnih3 KD mice. Additional
experiments are required to draw sound conclusions from these studies, but our initial findings
suggested that changes may occur in spine density and morphology in Cnih3 KD mice. Finally, in
a small study of spatial memory, we observed deficits in long-term spatial memory in Cnih3 KD
female mice. Taken together, these experiments suggested that Cnih3 may affect postsynaptic
organization of hippocampal neurons in a sex-dependent manner to mediate spatial memory. To
expand on these preliminary findings, we conducted additional studies using our Cnih3
overexpression and Cnih3 KO mouse models to investigate the interaction between CNIH3 and
sex-specific changes in spatial memory and hippocampal synaptic plasticity.
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3.1

Abstract

Background
Cornichon homolog-3 (CNIH3) is an AMPA receptor (AMPAR) auxiliary protein highly
expressed in the dorsal hippocampus (dHPC), a region that plays a critical role in spatial memory
and synaptic plasticity. However, effects of CNIH3 on AMPAR-dependent synaptic function and
behavior have not been investigated.
Methods
We assessed a gain-of-function model of Cnih3 overexpression in the dHPC and
generated and characterized a line of Cnih3-/- C57BL/6 mice. We assessed spatial memory
through behavioral assays, protein levels of AMPAR subunits and synaptic proteins by
immunoblotting, and long-term potentiation (LTP) in electrophysiological recordings. We also
utilized a super-resolution imaging workflow, SEQUIN, for analysis of nanoscale synaptic
connectivity in dHPC.
Results
Overexpression of Cnih3 in dHPC improved short-term spatial memory in female mice,
but not in male mice. Cnih3-/- female mice exhibited weakened short-term spatial memory,
reduced dHPC synapse density, enhanced expression of calcium-impermeable AMPAR (GluA2containing) subunits in synaptosomes, and attenuated LTP maintenance compared to Cnih3+/+
controls; Cnih3-/- males were unaffected. Further investigation revealed that deficiencies in
spatial memory and changes in AMPAR composition and synaptic plasticity were most
pronounced during the metestrus phase of the estrous cycle in female Cnih3-/- mice.
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Conclusion
This study identified a novel effect of sex and estrous on CNIH3’s role in spatial memory
and synaptic plasticity. Manipulation of CNIH3 unmasked sexually dimorphic effects on spatial
memory, synaptic function, AMPAR composition, and hippocampal plasticity. These findings
reinforce the importance of considering sex as a biological variable in studies of memory and
hippocampal synaptic function.

3.2

Introduction
The

α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic

acid

glutamate

receptor

(AMPAR) is widely expressed in the central nervous system and is an essential component of
glutamatergic signaling as well as mechanisms underlying synaptic plasticity and memory (173).
AMPARs are highly regulated by auxiliary proteins that regulate trafficking, subunit composition,
glutamate sensitivity, synaptic location, and membrane stabilization (36, 148, 149, 173).
Cornichon homolog-3 (CNIH3) is one such auxiliary protein previously studied for its role in
mediating AMPAR function in the brain (126, 140, 145-147). However, little is known about how
it impacts mammalian behavior.
The CNIH proteins CNIH2 and CNIH3 serve as AMPAR chaperones from the
endoplasmic reticulum and Golgi to the synapse (134-136). In addition, CNIHs also act as
AMPAR auxiliary proteins that enhance glutamate sensitivity (138), improve ion channel
permeability (138, 140), regulate receptor gating (141-143), slow decay of AMPAR excitatory
post-synaptic currents (EPSCs) (144), and slow receptor deactivation (133, 140, 145, 146).
However, as CNIH2 is expressed at a higher level in the brain than CNIH3 (18), most studies have
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either investigated CNIH2 alone or the cumulative effects of both CNIH2/3 in neural systems;
significantly less is known about CNIH3-specific effects on cellular and behavioral function. In
addition, prior studies of CNIH2/3 function utilized male rodents or combined data from males
and females without reporting potential effects of sex, an important limitation to consider given
previously identified sex differences in glutamatergic signaling (174) and the imperative of
considering sex as a biological variable (SABV) at all stages of biomedical research (175).
In addition to CNIH2/3, additional AMPAR auxiliary proteins such as transmembrane
AMPAR regulatory proteins (TARPs) (126, 148-150), CKAMPs (151), and GSG1L (152, 153)
are also important components of AMPAR machinery in the brain. Multiple studies have
characterized these families of AMPAR interacting proteins to investigate their molecular
interactions, cellular function, and importance for a wide range of behaviors and psychiatric
disorders (36, 149, 156, 157). For example, the TARP stargazin regulates motor activity and
epilepsy (158), pain sensitization (159), and memory (160). In addition, AMPARs and their
auxiliary proteins have been implicated in drug-associated contextual memory (69, 161), opioidinduced hyperalgesia (162), social behaviors (163), and stress-induced impairment of learning and
memory (164). Despite the established links between several classes of AMPAR auxiliary proteins
and behavior, only a small number of studies have explored the role of CNIH proteins in
mammalian behavior. A post-mortem study of human brain tissue identified correlations between
abnormal brain expression of CNIH1, CNIH2, and CNIH3 and schizophrenia (165). A case-report
study found a deletion of CNIH2 in a patient with dysmorphic features and intellectual disability
(166). Finally, in a genome-wide association study (GWAS) of human patients, we previously
identified single-nucleotide polymorphisms (SNPs) in CNIH3 that were associated with reduced
risk for opioid dependence in individuals with prior history of opioid use (123). However, no
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studies have addressed how CNIH-dependent mechanisms may contribute to these disorders. As
we have previously reported on the role of AMPARs and the dorsal hippocampus (dHPC) on
learning and memory in mice (69, 118, 120-122, 176), we examined the potential link between the
AMPAR auxiliary protein CNIH3 and hippocampal synaptic plasticity and memory.
For this study, we hypothesized that CNIH3 could play key roles in spatial memory,
synaptic connectivity, and synaptic plasticity. Across modalities ranging from biochemical,
physiological, structural, and behavioral studies, our results uncovered marked effects of both sex
and estrous cycling on CNIH3-dependent spatial memory, synaptic connectivity, AMPAR subunit
composition, and plasticity in the dHPC. To our knowledge, no prior studies report sex effects for
any of the CNIH proteins. This study builds on previous literature that describes CNIH3 as a key
contributor to the maintenance of AMPAR signaling and function, and identifies a new role
involving estrous phase-specific sex differences in spatial memory and synaptic plasticity.

3.3

Materials and Methods

Animals
Procedures were approved by the Institutional Animal Care and Use Committee at
Washington University in St. Louis. Adult (8 – 16 weeks) male and female C57BL/6 wild-type
(WT, Cnih3+/+), Cnih3tm1a(KOMP)Wtsi, and Cnih3 knockout (KO, Cnih3-/-) mice were kept in climatecontrolled facilities with a 12-hour light/dark cycle and ad libitum access to food and water.
β-galactosidase staining
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To visualize the anatomical expression of the Cnih3tm1a(KOMP)Wtsi gene in the brain, we
stained the brains of homozygous mutant mice using a β-galactosidase staining assay (177, 178)
to identify expression of the lacZ cassette contained within the Cnih3tm1a(KOMP)Wtsi gene. Mice were
transcardially perfused with ice-cold 4% paraformaldehyde (PFA) in phosphate-buffered saline
(PBS) while deeply anesthetized with isofluorane. The whole brain was extracted and post-fixed
overnight in 4% PFA before the brains were transferred for equilibration in 30% sucrose in PBS.
Equilibrated brains were flash-frozen and the entire brain was sectioned into 40 µm slices using a
cryostat. Floating slices were washed 3x15 minutes with rinse buffer (0.1M PB, 2 mM MgCl2,
0.1% Triton X-100, 0.01% Deoxycholic Acid, and 1.25 mM EGTA, pH 7.4) and then placed in
X-gal staining solution (1 mg/mL X-gal and 0.4 mg/mL Nitrotetrazolium blue in rinse buffer) for
18 hours overnight at 37⁰C. Following overnight incubation, brain slices were rinsed 3x15 minutes
in rinse buffer, mounted onto slides, dehydrated in successive washes of ethanol (50, 75, 95, 100,
and 100%), cleared in three changes of xylene, and cover-slipped using Cytoseal XYL mounting
media (Richard-Allen). Slides were imaged on a Zeiss Axio Scan Z1 Brightfield slide scanner
microscope (Carl Zeiss Microscopy).
Viral intracranial injection surgeries for Cnih3 overexpression
WT mice were anesthetized with 1-3% isofluorane and head-fixed in a stereotaxic
apparatus (Stoelting). 0.5 μL of AAV5-CAMKII-myc-CNIH3-t2a-GFP virus (1.7x1013 particles
per mL) or 0.5 μL of AAV5-CAMKII-eYFP (8.6x1011 particles per mL, Virus Vector Core, The
University of North Carolina at Chapel Hill) YFP control virus was slowly infused bilaterally into
the dorsal hippocampus (A/P: -1.8 mm, Lat: ±1.4 mm, D/V: -1.8 mm). Three weeks after
completion of these procedures, mice underwent training in the Barnes maze or hippocampi were
extracted for real-time quantitative PCR (RT-qPCR). Following testing in the Barnes maze, mice
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were transcardially perfused with 4% PFA and brains were sectioned for immunohistochemical
verification of viral placement.
Real-time quantitative PCR
Fresh dHPCs were rapidly dissected on ice and frozen for RT-qPCR analysis. RNA was
extracted with RNeasy Mini Kit (QIAGEN) and assessed with a Nanodrop Spectrophotometer
(Thermo Fisher Scientific). cDNA was synthesized from 500 ng RNA using iScript Reverse
Transcriptase Supermix (Bio-Rad). qPCR utilized 500 nM of each primer and PowerUp SYBR
Green Master Mix (QIAGEN), in an Applied Biosystems Quant Studio 6 PCR system (Thermo
Fisher Scientific). In mouse line and viral overexpression validation experiments, Ct scores were
normalized to β-actin and to WT or YFP injected controls using delta delta Ct analysis (ddCt). In
experiments monitoring gene expression in the estrous cycle, Ct scores were normalized to control
gene Rpl19, which has a high degree of stability in the rodent brain during estrous cycling (179),
and to WT males. Primer sequences are included in the supplemental methods.
Barnes maze spatial memory task
To assess changes in spatial learning and memory, we performed a Barnes maze spatial
learning task as previously described (122). Mice were handled by the experimenter for three days
prior to the experiment to minimize handling stress. We used a Barnes maze apparatus which was
91 cm circular platform surround by twenty-equidistant 5 cm holes. One hole led to a dark escape
box in which the mouse could hide (referred to as the target hole). All other holes led to false
bottoms. Spatial cues in the form of large shapes (triangle, square, hexagon, and cross) surrounded
the apparatus to allow for spatial navigation. Any-Maze tracking software (Stoelting) was used for
video recording and animal tracking. During habituation to the apparatus, the mouse was gently
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placed in the center of the maze and allowed to explore the maze for 180 s in two consecutive
trials. Upon entering the target hole, the experimenter covered the entrance and the animal
remained in the target box for 1 min. If the animal did not enter the target hole in the 180 s period,
the animal was gently guided to the hole. During training days 1-4, three 180 s trials were
conducted for each animal in 15 min intervals. The table was thoroughly cleaned between each
trial with 70% ethanol and the top table was rotated to minimize olfactory cues leading to the target
hole. The latency to the first entry in the target hole (primary latency), the number of errors made
prior to target hole entry (primary errors), and the primary path efficiency (actual distance traveled
to target hole divided by the shortest distance to target hole from starting location) were recorded.
On Days 5 and 12, a 90 s probe trial was conducted where the escape box was replaced with a false
bottom to prevent entry.
Estrous cycle monitoring
The estrous cycle was monitored daily by vaginal lavage of sterile saline during behavioral
testing and prior to electrophysiological and relevant RT-qPCR analysis. Samples were allowed to
dry on glass slides, rinsed with water, and stained with giemsa stain (Ricca Chemical) to improve
contrast and differentiate between cell types. Vaginal cell cytological analysis was used to identify
estrous cycle stage. Estrus (E) was characterized by the presence of cornified epithelial cells,
metestrus (M) by a mix of leukocytes and both nucleated and cornified epithelial cells, diestrus
(D) by leukocytes, and proestrus (P) by nucleated epithelial cells (Figure S1) (180).
Western blotting
Dorsal hippocampi were collected from both hemispheres and pooled by individual animal.
Whole-cell homogenate and synaptosomal fractions were obtained as previously described (69,
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168, 169). Protein concentrations were measured by a bicinchoninic acid (BCA) protein assay
(Pierce). 15 µg of sample was loaded per well and separated on a 10% SDS-polyacrylamide gel
and transferred to PVDF membranes. Membranes were stained for total protein using the Revert
700 Total Protein Stain and Wash Solution Kit (LI-COR Biosciences) to ensure equal loading and
blot transfer across all samples, then blocked in 5% bovine serum albumin (BSA) in Tris-buffered
saline with 0.1% Tween-20. Membranes were incubated in antibodies targeting PSD-95 (1:1,000,
Cell Signaling Technologies #3409), Synapsin-1/2 (1:1,000 Synaptic Systems #106 004), GluA1
(1:1,000, Abcam ab174785), P-GluA1 Ser(845) (1:1,000, Cell Signaling Technologies #8084),
GluA2 (1:500, Millipore Sigma MABN1189), P-GluA2 Tyr(876) (1:250, Cell Signaling
Technologies #4027), β-III-tubulin (1:10,000, Millipore Sigma AB15708), or β-actin (1:2,000,
Millipore Sigma MAB1501) overnight at 4 ºC. Membranes were probed with IRDye 680RD
donkey anti-guinea pig (1:5,000, LI-COR Biosciences #926-68077), IRDye 680RD donkey antimouse (1:5,000, LI-COR Biosciences #926-68072), or IRDye 800CW donkey anti-rabbit (1:5,000,
LI-COR Biosciences #925-32213) and imaged using the Odyssey infrared fluorescent imaging
system (LI-COR Biosciences). Signal linearity of each antibody was tested in control tissue to test
for signal detection and to prevent signal saturation. Actin and tubulin housekeeping proteins
(HKPs) did not vary across experimental groups. Quantification was performed with Image Studio
software (LI-COR Biosciences) by comparing band intensities to HKP control bands within each
lane to control for potential variation in loading and transfer. Results are represented as a
percentage of the average intensity of within-sex WT controls.
Synapse quantification with SEQUIN multiscale imaging
Synaptic density analysis was conducted utilizing a newly developed method to efficiently
and accurately quantify synaptic loci: SEQUIN (Synaptic Evaluation and QUantification by
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Imaging of Nanostructure). A detailed description and validation of this method can be found in
the technique’s original manuscripts by Sauerbeck et al., 2020 (181) and Reitz et al., 2021 (182);
a visual flow chart of this technique can be found in Supplemental Figure 7. Animals were
transcardially perfused with 4% PFA in PBS and brains were extracted. Following overnight postfixation in 4% PFA, brains were cryoprotected with 30% sucrose in PBS. Brains were sectioned
by cryostat to a thickness of 15 µm (Leica CM1520), transferred directly onto charged glass slides,
and allowed to dry at room temperature. Slides were stored at -20 ºC prior to staining. Slices were
rinsed 3X in PBS, blocked with 4% BSA, and immunolabeled with guinea pig anti-Synapsin-1/2
(1:500, Synaptic Systems #106 004) and goat anti-PSD95 (1:200, Abcam ab12093) primary
antibodies in antibody solution (4% BSA and 0.3% Triton X-100 in PBS) overnight. For secondary
antibody staining, slices were rinsed with PBS, stained with donkey anti-goat 594 Alexa Fluor
secondary antibody (1:200, Life Technologies #A-11058) in antibody solution, rinsed with PBS,
and then stained with goat anti-guinea pig 488 Alexa Fluor secondary antibody (1:200, Life
Technologies #A-11073) with 10% normal goat serum in antibody solution. Slices were allowed
to dry and were cover-slipped with MWL 4-88 mounting media with antifade 300 (Citifluor
#MWL4-88-25 and #AF300-10, 9:1 ratio) and 1.5h cover glass (Carl Zeiss Microscopy #4740309000-000). Slides cured at room temperature for 72 h prior to imaging. Images were obtained with
a Zeiss LSM 880 Airyscan Microscope (Carl Zeiss Microscopy) (5-7 images/animal), synaptic
puncta were identified using Imaris 3D visualization software (Bitplane), and individual spots and
synaptic loci were quantified using custom nearest neighbor analysis (Matlab, Mathworks; code
available on GitHub: https://github.com/KummerLab/SEQUIN) (181, 182). For quantification of
synaptic loci we generated a frequency distribution of nearest neighbor pairs for the top 20%
intensity of pre- and post- synaptic puncta, followed by subtraction of the number of pairings
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expected from an equally dense random distribution of pairings (based on reflected postsynaptic
data as previously described) (181, 182). The total number of nearest neighbor pairs separated by
<400 nm were used to calculate synaptic loci density (181, 183).
Field excitatory postsynaptic potentials (fEPSPs) and long-term potentiation (LTP)
Female Cnih3+/+ and Cnih3-/- mice aged 6-8 weeks were monitored daily for estrous
cycling, and mice in the metestrus stage were selected for LTP experiments using previously
described methods (184). Mice were anesthetized with isoflurane and decapitated. The brain was
immediately extracted and the hippocampus dissected. The dorsal half was cut into 400 μm slices
using a rotary tissue slicer in cold artificial cerebral spinal fluid (ACSF) containing (mM): 124
NaCl, 5 KCl, 2 MgSO4, 2 CaCl2, 1.25 NaH2PO4, 22 NaHCO3, and 10 glucose, bubbled with 95%
O2-5% CO2 at 4–6 °C. Slices were incubated in gassed ACSF for at least 1 h at 30°C to recover
from slicing. At the time of experiments, slices were transferred to a submersion-recording
chamber kept at 30 °C with continuous perfusion of ACSF at 2 ml/min. For standard LTP
experiments, ACSF contained 2 mM CaCl2 and 2 mM MgSO4. fEPSPs were evoked through a
bipolar stimulating electrode in the Schaffer Collateral (SC) pathway with 0.1 ms constant current
pulses. A SC input-output (IO) curve was obtained to determine half-maximal intensity. pClamp
software (pClamp) was used to monitor experimental responses. At 60s intervals, single stimuli
were applied to the SC pathway at half-maximal intensity for 10 minutes to establish a stable
baseline. SC LTP was induced by a single 100 Hz x 1 s high-frequency stimulus (HFS), and 60
min following the induction of LTP, IO curves were repeated and half-maximal intensities were
compared to baseline.
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We also examined the effects of a more intense electrical stimulation paradigm that
enhanced NMDAR activation beyond traditional HFS. For these experiments, ACSF in the
recording chamber contained 2.5 mM CaCl2 and 1.3 mM MgSO4 to enhance Ca2+ ion influx via
NMDARs. In addition, we used a θ-burst stimulation (TBS) paradigm (six trains of six 250 Hz
bursts of six pulses, 200 ms between bursts, 20s between trains), which promotes activation of
NMDARs at synapses more efficiently than the single HFS paradigm (185-187).
Statistics and analysis
Results are presented as the mean ± SEM. For statistical analysis, datasets were analyzed
using GraphPad Prism 9 software. Dataset normality was determined by the Shapiro-Wilk test.
Datasets which passed normality were analyzed by unpaired two-tailed t tests (two groups) or by
one-way ANOVA (three or more groups) followed by post hoc Sidak’s multiple comparisons test.
Datasets which failed normality were analyzed by a two-tailed Mann-Whitney U test (two groups)
or by a Kruskal-Wallis test (three or more groups) followed by post hoc Dunn’s multiple
comparisons test. Datasets comparing two factors (such as sex and genotype, or estrous cycle and
genotype) were compared using a two-way ANOVA followed by post hoc Sidak’s multiple
comparisons test. Outliers were determined within each dataset using a Grubbs’ Outlier test. In
behavioral experiments where multiple parameters were assessed within an experiment, an animal
was only excluded from the analysis if it contained two or more statistical outliers across analyzed
parameters. Datasets were considered statistically significant with p < 0.05.

3.4

Results

Cnih3 is highly expressed in the hippocampus
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To

identify

anatomical

expression of Cnih3 in the brain,
we used a β-galactosidase staining
assay to visualize the lacZ cassette
contained

within

Cnih3tm1a(KOMP)Wtsi

the

gene

of

Cnih3tm1a(KOMP)Wtsi mice obtained
from the Knockout Mouse Project
(167)

(Figure

1A).

No

lacZ

staining was observed in WT lacZbrains, demonstrating that this
staining assay specifically targeted
expression of the lacZ gene (Figure
1B). In lacZ+ brains, there was no
apparent

difference

in

Cnih3

expression due to sex (Figures 1C
– D). Cnih3 expression was highest
in the prefrontal cortex (PFC),
hypothalamus, cortical regions,
amygdala,

and

(Figure

1E,

hippocampus
illustrations

reproduced with permission from

Figure 1: Cnih3 highly expressed in the CA1 and dentate gyrus
regions of the hippocampus. (A) Using the lacZ cassette contained
within the Cnih3tm1a(KOMP)Wtsi gene, a β-galactosidase staining assay
was used to qualitatively identify Cnih3 expression throughout the
brain. (B – D) Representative slices from (B) lacZ- and from lacZ+
(C) male and (D) female brain slices are shown next to (E)
corresponding illustrations (Adapted from Franklin & Paxinos, 2007
(185)). (E) A higher magnification image of a lacZ+ dHPC showed
strong lacZ expression in the CA1 and dentate gyrus regions of the
dHPC.

The Mouse Brain in Stereotaxic Coordinates by Keith B.J. Franklin and George Paxinos (188)).
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Within the hippocampus, Cnih3 expression was especially pronounced within the Dentate Gyrus
(DG) and CA1 (Figure 1F). These results concurred with previous studies which also reported
strong expression of Cnih3 expression in the hippocampus (18, 141, 145).
Validation of a new Cnih3 viral overexpression construct
To investigate the effect of overexpressing Cnih3 in the dHPC on spatial memory, we
generated an AAV5-CAMKII-myc-CNIH3-t2a-GFP virus to overexpress Cnih3 in excitatory
neurons. 0.5 µL of AAV5-CAMKII-myc-CNIH3-t2a-GFP or an AAV5-CAMKII-eYFP YFP
control virus were bilaterally injected into the dorsal hippocampus of WT animals (Figure 2A). To
verify overexpression of Cnih3, we utilized RT-qPCR to measure mRNA expression of Cnih3 and
Cnih2 (Figure 2B). The dHPC of mice injected with the Cnih3 overexpression virus expressed
~200X more Cnih3 mRNA than YFP-injected controls (Two-tailed unpaired t test, p < 0.0001).
We observed a slight decrease in Cnih2 expression in the dHPC of Cnih3 overexpressing animals
compared to YFP-injected controls, but this change in Cnih2 expression did not reach significance
(p = 0.0593). To verify the location of viral expression, brain slices were imaged for identification
of the myc-tag on CNIH3 in the AAV5-CAMKII-myc-CNIH3-GFP construct or for YFP in the
AAV5-CAMKII-eYFP controls to validate viral expression in the hippocampus and to monitor the
viral spread from the site of injection (Figure 2C).
Spatial memory is improved in female mice overexpressing Cnih3 in the dHPC
AMPAR activity in the dHPC plays a critical role in spatial memory (46, 189), and
numerous AMPAR auxiliary proteins facilitate these AMPAR-dependent mechanisms (47, 190,
191). To assess whether hippocampal CNIH3 can modulate spatial memory, we induced viral
overexpression of Cnih3 in the dHPC of male and female mice and tested animals in a Barnes
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Figure 2: Cnih3 overexpression in the dorsal hippocampus improved short-term memory in female mice.
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Figure 2: Cnih3 overexpression in the dorsal hippocampus improved short-term memory in female mice.
(A) AAV5-CAMKII-myc-CNIH3-t2a-GFP or AAV5-CAMKII-eYFP viruses were injected bilaterally into the
dorsal hippocampus of WT male and female mice to overexpress Cnih3 (-1.8 mm A/P, ±1.4 mm M/L, -1.8 mm
D/V). (B) RT-qPCR results of the dorsal hippocampus for Cnih3 and Cnih2 mRNA 3 weeks following viral
injection of YFP (n = 7) and Cnih3 overexpression (n = 5) viruses. Datasets underwent a two-tailed unpaired t test
between YFP and Cnih3 virus injected animals (ns p > 0.05, **** p < 0.0001). (C) Immunohistochemical
representative image of a brain injected with AAV5-CAMKII-myc-CNIH3-t2a-GFP. Brain slices were probed for
the myc-tag adjacent to Cnih3 in the viral construct. (D) Timeline for injection of virus and Barnes Maze testing.
(E) Injection placements for AAV5-CAMKII-myc-CNIH3-t2a-GFP and YFP AAV5-CAMKII-eYFP viruses of
animals tested in the Barnes Maze. (F – H) Barnes Maze results of male and female mice injected with either YFP
(male: n = 9; female: n = 8) or Cnih3 overexpression (male: n = 10; female: n = 10) virus during the short-term
probe trial represented by (F) primary errors before location of the target hole, (G) primary latency to entry into
the target hole, and (H) path efficiency to the target hole. (I – K) Barnes Maze results from the long-term probe
for (I) primary errors, (J) primary latency, and (K) path efficiency. Datasets underwent two-way ANOVA for
genotype and sex or estrous cycle stage and post-hoc Sidak’s test (ns p > 0.05, * p < 0.05).

maze spatial memory task. Following testing, animals were perfused and brain slices were probed
for viral expression (Figure 2D – E). One YFP-injected female mouse was removed from analysis
due to failure of viral expression and one Cnih3 overexpressing female mouse was excluded due
to outlier values across all measured parameters as determined by a Grubbs’ outlier test. Animal
performance over the training trials is shown in Figure S2.
During the short-term probe trial, analyses of the data from mice overexpressing Cnih3 in
the dHPC demonstrated a strong effect of sex on the number of primary errors committed prior to
location of the target and the primary latency to locate the target (2-way ANOVA, Primary errors:
F(1, 33) = 4.362, p = 0.0445; Primary latency: F(1, 33) = 4.429, p = 0.0430; Path efficiency: F(1, 33)
= 1.908, p = 0.1765), a significant effect of genotype on primary errors (Primary errors: F(1, 33) =
5.071, p = 0.0311; Primary latency: F(1, 33) = 4.429, p = 0.1497; Path efficiency: F(1, 33) = 3.536,
p = 0.0689), and a significant interaction between sex and genotype on the primary latency and
path efficiency (Primary errors: F(1, 33) = 3.848, p = 0.0583; Primary latency: F(1, 33) = 4.783, p
= 0.0359; Path efficiency: F(1, 33) = 7.438, p = 0.0101). Female mice overexpressing Cnih3 in the
dHPC committed fewer primary errors (post-hoc Sidak’s multiple comparisons test, p = 0.0121),
had a shorter latency to reach the target (p = 0.0310), and took more direct routes to the target (p
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= 0.0059) compared to YFP-injected females (Figure 2F - H). As the path efficiency dataset for
female mice overexpressing Cnih3 in the dHPC did not pass the Shapiro-Wilk normality test, path
efficiency was also assessed by a nonparametric Kruskal-Wallis test which identified substantial
differences between groups (H(3) = 11.52, p = 0.0092). A nonparametric post-hoc Dunn’s
multiple comparisons test confirmed that female mice overexpressing Cnih3 in the dHPC located
the target with greater path efficiency than female controls (p = 0.0204).
In male mice overexpressing Cnih3 in the dHPC, there were no differences in the number
of primary errors (post-hoc Sidak’s multiple comparisons test, p = 0.9731), the primary latency (p
= 0.8497), nor the path efficiency (p = 0.7947) compared to male mice expressing the YFP virus
in the hippocampus (Figure 2F - H). We did not observe any differences between YFP-injected
male and female mice in the number of primary errors made (p > 0.9999), primary latency (p >
0.9999), nor path efficiency (p = 0.9356) (Figure 2F - H).
During the long-term probe trial, performance in the Barnes maze was not affected by sex
(Primary errors: F(1, 31) = 0.5714, p = 0.6817; Primary latency: F(1, 31) = 0.4544, p = 0.5053; Path
efficiency: F(1, 31) = 2.674, p = 0.1121), virus expressed (Primary errors: F(1, 31) = 0.5714, p =
0.6817; Primary latency: F(1, 31) = 0.4966, p = 0.4863; Path efficiency: F(1, 31) = 0.2696, p =
0.6073), nor by an interaction between sex and virus (Primary errors: F(1, 31) = 0.5714, p = 0.6817;
Primary latency: F(1, 31) = 4.18x10-5, p = 0.9949; Path efficiency: F(1, 31) = 0.4638, p = 0.5009)
(Figure 2 I – K).
In addition to testing both male and female mice in the Barnes maze, we also monitored
natural estrous cycling in female animals during training and testing in Barnes maze. No
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differences were observed due to estrous cycling
across females in either the short-term or longterm probes when Cnih3 was overexpressed in
the dHPC (Figure S3).
These experiments demonstrated that
targeted overexpression of Cnih3 in the dHPC
improved short-term spatial memory in the
Barnes maze task in female mice, while no effect
of Cnih3 overexpression was observed in males.
However, this experiment does not address
whether CNIH3 is an underlying component of
spatial memory retrieval in females.
Generation and validation of a Cnih3 knockout
(KO) mouse line
To further explore the role of CNIH3 in
spatial

memory

and

underlying

memory

mechanisms, we generated a mouse line with a
KO

of

functional

CNIH3.

Heterozygous

Figure 3: Generation and characterization of Cnih3 knockout (KO) mice. (A) Cnih3tm1a(KOMP)Wtsi mice
obtained from the Knockout Mouse Project (KOMP). The Cnih3tm1a(KOMP)Wtsi gene contained a polyadenylation
(pA) site after exon 3 to halt mRNA transcription. The pA site as well as lacZ and neo cassettes and a splice
acceptor (SA) site were contained within two FRT sites. Exon 4 was surrounded by two loxP sites.
Cnih3tm1a(KOMP)Wtsi mice were bred to create a colony of WT, heterozygote (KOMP(+/-)), and homozygote
(KOMP(-/-)) Cnih3tm1a(KOMP)Wtsi mice. RT-qPCR analysis was conducted to measure mRNA expression for Cnih3
and Cnih2 compared to WT controls. (B) RT-qPCR results for WT (n = 7), KOMP(+/-) (n = 6), and KOMP(-/-)
(n = 4) mice for expression of Cnih3 and Cnih2 mRNA. Relative mRNA expression presented using ddCt analysis.
Ct values were normalized to β-actin loading controls and then to the average of β-actin-normalized WT values.
Relative mRNA expression presented as relative fold change calculated by 2 -(ddCt). (Continued on next page)
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(Figure 3 cont.) Datasets underwent one-way ANOVA for genotype and post-hoc Sidak’s multiple comparison
test, * denotes significance compared to WT (ns p > 0.05, *** p < 0.001). (C) Breeding scheme for Cnih3 KO
mice from Cnih3tm1a(KOMP)Wtsi mice. Cnih3tm1a(KOMP)Wtsi male mice (F0) were bred with Actin-FLPe females to excise
cassettes between the FRT sites. Male F1 mice were bred with Actin-Cre females to excise exon 4 contained within
the loxP sites. Mice in generation F2 are Cnih3+/-, which were bred to create a colony of Cnih3+/+, Cnih3+/-, and
Cnih3-/- animals. (D) RT-qPCR results for Cnih3 and Cnih2 mRNA expression in Cnih3+/+ (n = 10), Cnih3+/- (n =
10), and Cnih3-/- (n = 5) mice. Relative mRNA expression presented using ddCt analysis as previously described.
(ns p > 0.05, **** p < 0.0001).

Cnih3tm1a(KOMP)Wtsi mice, obtained from the Knockout Mouse Project (167), were bred to create
WT, heterozygous (HET), and homozygous (HOM) Cnih3tm1a(KOMP)Wtsi offspring. The
Cnih3tm1a(KOMP)Wtsi allele contained a polyadenylation (pA) site following exon 3 to attenuate
transcription (Figure 3A). However, RT-qPCR analysis of mRNA synthesized cDNA found only
a 60% reduction in exon 4 of Cnih3 in Cnih3tm1a(KOMP)Wtsi HET and HOM animals compared to
WT

littermates (One-way ANOVA, F(2,14) = 20.40, p < 0.0001, post-hoc Sidak’s multiple

comparisons test, p = 0.0001 and 0.0003 respectively), resulting in a Cnih3 knockdown instead of
a full KO animal (Figure 3B). As CNIH2 is a functionally similar homolog of CNIH3, we also
conducted RT-qPCR to measure Cnih2 expression to determine if Cnih3 knockdown induced
compensatory expression of Cnih2. We observed no change in Cnih2 expression in
Cnih3tm1a(KOMP)Wtsi HET or HOM animals compared to WT controls (F(2,13) = 2.041, p = 0.1695)
(Figure 3B). Male and female mice did not show differences in gene expression and were therefore
combined for analysis.
To create full Cnih3 KO animals, we conducted additional breeding to eliminate exon 4
from the Cnih3tm1a(KOMP)Wtsi gene (Figure 3C): Cnih3tm1a(KOMP)Wtsi homozygote males were bred
with Actin-FLPe females to excise the Splice Acceptor (SA) and pA sites, and the lacZ and
neomycin (neo) cassettes contained within the FRT sites (generation F1). Male F1 mice were bred
with Actin-Cre females to excise exon 4 contained with the loxP sites (generation F2). F2 mice
were backcrossed to wildtype C57/BL6j mice to remove Cre and Flpe alleles. Removal of exon 4
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resulted in a frameshift mutation across exons 5 and 6, encoding for a truncation of CNIH3
translation that would be predicted to undergo nonsense-mediated decay. Indeed, RT-qPCR
analysis found decreased Cnih3 expression between genotypes (F(2,22) = 264.1, p < 0.0001).
Cnih3+/- mice expressed ~50% of Cnih3 exon 4 compared to WT animals and Cnih3-/- had a total
elimination of Cnih3 exon 4 expression (p < 0.0001 each genotype) (Figure 3D). Cnih2 expression
remained unchanged in Cnih3+/- and Cnih3-/- mice compared to WT mice (F(2,22) = 1.097, p =
0.3513). No differences were observed in gene expression between male and female mice of any
genotype.
Spatial memory is impaired in Cnih3-/- female mice
To determine if CNIH3 is necessary for optimal spatial memory ability in female mice, we
tested Cnih3+/+, Cnih3+/-, and Cnih3-/- mice in the Barnes maze task (Figure 4A). Performance in
the Barnes maze during training trials are shown in Figure S4. One female Cnih3+/- animal was
excluded from the analysis due to freezing during the short-term probe trial. One outlier animal
was identified per group in all groups except for Cnih3-/- females.
In the short-term probe trial (Figures 4B – D), performance in the Barnes maze was strongly
affected by sex (Two-way ANOVA, Primary errors: F(1, 86) = 6.158, p = 0.015; Primary latency:
F(1, 86) = 7.338, p = 0.0081; Path efficiency: F(1, 86) = 11.71, p = 0.001), with a significant
interaction between sex and genotype (Primary errors: F(2, 86) = 4.493, p = 0.0139; Primary
latency: F(2, 86) = 7.249, p = 0.0012; Path efficiency: F(2, 86) = 5.704, p = 0.0047). We did not
observe an effect of genotype independent from animal sex (Primary errors: F(2, 86) = 2.479, p =
0.0898; Primary latency: F(2, 86) = 1.705, p = 0.1878; Path efficiency: F(2, 86) = 0.4759, p =
0.623). Compared to Cnih3+/+ and Cnih3+/- female mice, Cnih3-/- female mice made more primary
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Figure 4: Short-term spatial memory impaired in female Cnih3-/- mice during metestrus. (A) Time course
Barnes maze spatial memory paradigm. (B – D) Barnes Maze results of male and female Cnih3+/+ (male: n = 9;
female: n = 22), Cnih3+/- (male: n = 12; female: n = 21), and Cnih3-/- (male: n =10; female: n = 18) mice during
the short-term probe trials represented by (B) primary errors before location of the target hole, (C) primary latency
to entry into the target hole, and (D) path efficiency to the target hole. (E – G) Barnes Maze results of male and
female Cnih3+/+ (male: n = 9; female: n = 20), Cnih3+/- (male: n = 11, one animal froze during long-term probe
and was therefore excluded; female: n = 19), and Cnih3-/- (male: n =10; female: n = 14) mice which were also
tested in long-term probe trials represented by (E) primary errors, (F) primary latency, and (G) path efficiency
(some females were euthanized following the short-term trial for other experiments, thus were not tested in a longterm trial). (H – J) Female animals were subdivided into mice in the proestrus/estrus (P/E), metestrus (M), and
diestrus (D) phases of the estrous cycle during the short-term probe trial in the Barnes Maze. Data shown in these
figures from individual mice are shown in Figure S5. Estrous cycle stage was correlated to animal performance in
the short-term probe trial represented by (H) primary errors, (I) primary latency, and (J) path efficiency. Datasets
underwent two-way ANOVA for genotype and sex/estrous cycle stage and followed by post-hoc Sidak’s multiple
comparisons test (ns p > 0.05, ** p <0.01, *** p < 0.001, **** p < 0.0001).

errors (Sidak’s multiple comparisons test, p = 0.0006, p = 0.0156 respectively), had a higher
primary latency to reach the target (p = 0.0006, p = 0.0021), and displayed decreased path
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efficiency to the target compared to Cnih3+/+ females (p = 0.0043, p = 0.3927) (Figure 4B-D).
However, there were no changes in primary errors (p = 0.9987), primary latency (p > 0.999), nor
path efficiency (p = 0.7993) in Cnih3+/- female mice compared to Cnih3+/+ control female mice
(Figure 4B-D). During the short-term probe, compared to male Cnih3+/+ and Cnih3+/- male mice,
Cnih3-/- male mice displayed no differences in the number of primary errors committed (p >
0.9999, p > 0.9999 respectively), primary latency (p = 0.958, p = 0.9998), nor path efficiency (p
= 0.9188, p = 0.9907) (Figure 3B-D). No differences were observed between male and female
Cnih3+/+ animals in the Barnes maze (primary errors: p > 0.9999; primary latency: p > 0.9999;
path efficiency: p > 0.9999). Several groups within the short-term probe trial’s primary errors and
primary latency datasets did not pass the Shapiro-Wilk normality test, therefore these parameters
were also assessed by nonparametric Kruskal-Wallis tests. Comparison using the nonparametric
Kruskal-Wallis test identified pronounced differences between all groups for both primary errors
(H(5) = 12.24, p = 0.0317) and primary latency (H(5) = 24.51, p = 0.0002). Dunn’s multiple
comparisons tests confirmed that female Cnih3-/- mice made more primary errors compared to
female Cnih3+/+ mice (p = 0.0283), with no changes in primary errors committed between any
male groups nor between male and female Cnih3+/+ mice (all comparisons p > 0.9999). In
addition, nonparametric analysis confirmed that female Cnih3-/- mice had a longer latency to locate
the target compared to female Cnih3+/+ and Cnih3+/- mice (p = 0.0117 and p = 0.0378
respectively), with no changes in primary latency between any male groups (p = 0.1030 between
male Cnih3-/- and Cnih3+/+, p = 0.308 between male Cnih3-/- and Cnih3+/-), nor between male and
female Cnih3+/+ mice (p > 0.9999).
In the long-term probe on day 12 of the Barnes maze task (Figures 4E – G), no differences
in Barnes maze performance were observed across sex or genotype for most datasets. For primary
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latency and efficiency, two-way ANOVA found no effects of sex (Two-way ANOVA Primary
Latency: F(1, 77) = 0.6953, p = 0.4070; Path Efficiency: F(1, 77) = 0.0001843, p = 0.9892) or
genotype (Primary Latency: F(2, 77) = 2.097, p = 0.1298; Path Efficiency: F(2, 77) = 0.4683, p =
0.4683), with no interaction between sex and genotype (Primary Latency: F(2, 77) = 1.253, p =
0.2915; Path Efficiency: F(2, 77) = 2.194, p = 0.1184) (Figures 4F – G). For primary errors
committed in the long-term probe we did not observe an effect of sex (F(1, 77) = 0.3644, p = 0.5479)
nor an interaction between sex and genotype (F(2, 77) = 2.892, p = 0.0615), but we did identify a
small effect of genotype (F(2, 77) = 3.170, p = 0.0475) (Figure 4E). We further investigated the
potential effect of genotype on primary errors committed in the long-term probe trail with a posthoc Sidak’s multiple comparisons tests of primary errors, but did not identify differences between
any individual groups (p > 0.05 for all comparisons). However, there was a trending decrease in
primary errors committed in the long-term probe trial in Cnih3-/- mice compare to Cnih3+/+ male
controls (p = 0.0695) (Figures 4E). All datasets in the long-term probe contained groups which
did not pass the Shapiro-Wilk normality test, we therefore assessed each parameter using a
nonparametric Kruskal-Wallis test. No differences between groups were identified by the KruskalWallis test for the long-term probe (Primary Errors: H(5) = 8.745, p = 0.1197; Primary Latency:
H(5) = 6.327, p = 0.2757; Path Efficiency: H(5) = 3.984, p = 0.5517).
These experiments demonstrated that Cnih3 KO attenuated short-term spatial memory in
the Barnes maze task in female animals, an intriguing counterpoint to the enhanced short-term
memory seen specifically in Cnih3 overexpressing females (Figure 2). We did not observe sex
differences in spatial memory between WT control animals. Instead, we found pronounced deficits
in short-term memory retrieval only in female animals lacking CNIH3. This suggests that CNIH3
is either not involved in the neural mechanisms regulating spatial memory retrieval in male animals
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or that males can compensate for a lack of CNIH3 through functionally redundant mechanisms.
However, CNIH3 is a necessary component of normal memory retrieval mechanisms in females.
Spatial memory impairment in female Cnih3-/- mice occurs primarily during the metestrus stage
of the estrous cycle
Several studies previously reported on interactions between estrous cycling and
hippocampal AMPAR activity (99, 101), and due to the wide variability in Barnes maze
performance in Cnih3-/- females during the short-term probe (Figures 4B – D), we hypothesized
that the estrous cycle also modulated short-term spatial memory in naturally cycling Cnih3-/female mice. To test this hypothesis, we analyzed samples of vaginal smears collected from all
female animals which underwent training in the Barnes maze and correlated estrous cycle stage
during the short-term probe trial with performance in the task (Figure S1). For sufficient group
size, we combined data from mice in proestrus and estrus due to similarity in hormonal levels in
these stages (180). Data from individual animals during the short-term probe trial are shown in
Figure S5.
When female animals were subdivided by estrous cycle and genotype (Cnih3+/+ total n =
22: proestrus/estrus n = 10, metestrus n = 3, diestrus n = 9; Cnih3+/- total n = 21: proestrus/estrus
n = 7, metestrus n = 4, diestrus n = 10; Cnih3-/- total n = 18: proestrus/estrus n = 4, metestrus n
= 5, diestrus n = 9), we observed pronounced effects on primary errors and primary latency of
genotype (Two-way ANOVA, Primary errors: F(2, 52) = 9.206, p = 0.0004; Primary latency: F(2, 52)
= 13.14, p < 0.0001) and estrous cycle stage (Primary errors: F(2, 52) = 6.443, p = 0.0032; Primary
latency: F(2, 52) = 5.442, p = 0.0071), as well as a significant interaction between genotype and
estrous cycle stage (Primary errors: F(4, 52) = 5.628, p = 0.0008; Primary latency: F(4, 52) = 5.908,
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p = 0.0005) (Figures 4H – I). We also observed an effect of genotype on path efficiency (F(2, 52) =
5.820, p = 0.0052), but no effect of estrous cycle stage (F(2, 52) = 0.9325, p = 0.4000) nor an
interaction between these two factors (F(4, 52) = 2.060, p = 0.0995) (Figure 4J). Upon investigation
of the effects of estrous cycle stage and sex on spatial memory performance in the Barnes maze,
Cnih3-/- female animals in the metestrus stage of the estrous cycle committed more primary errors
(post-hoc Sidak’s multiple comparisons test, p = 0.0013 compared to Cnih3+/+ females, p < 0.0001
compared to compared to Cnih3+/- females), had a higher primary latency (p < 0.0001 compared
to compared to Cnih3+/+ and Cnih3+/- females), and displayed a lower path efficiency (p = 0.0045
compared to Cnih3+/+ females, p = 0.0122 compared to compared to Cnih3+/- females) compared
to other genotypes. Cnih3-/- female animals did not demonstrate any deficits in spatial memory
compared to other genotypes in estrus, diestrus, or proestrus stages (p > 0.05 across all
parameters). In addition, Cnih3-/- female animals in metestrus committed more errors compared
to Cnih3-/- female animals in both the proestrus/estrus and diestrus stages (p < 0.0001 and p <
0.0001 respectively), as well as presented a higher primary latency (p < 0.0001 and p < 0.0001)
and a lower path efficiency (p = 0.0224 and p = 0.0129). No differences were observed across
estrous cycle stages in Cnih3+/+ nor Cnih3+/- female animals (p > 0.05 across all parameters)
(Figure 4H – J). Several Cnih3+/+ and Cnih3+/- groups within the short-term probe trial’s primary
errors and primary latency datasets did not pass the Shapiro-Wilk normality test, therefore these
groups were also assessed by nonparametric Kruskal-Wallis tests comparing between estrous cycle
stages within each genotype. Nonparametric analysis confirmed no effect of estrous cycling in
Cnih3+/+ (Kruskal-Wallis test comparing estrous cycle stages, Primary Errors: H(2) = 1.872, p =
0.3922; Primary Latency: H(2) = 2.457, p = 0.3074) or Cnih3+/- female animals (H(2) = 3.387, p
= 0.1886; Primary Latency: H(2) = 0.4458, p = 0.4458) (Figures 4H – I). In addition, we also
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performed a one-way ANOVA on the primary errors and primary latency datasets for Cnih3-/female animals (all datasets of which did pass the Shapiro-Wilk normality test), which confirmed
a pronounced effect of estrous cycling on primary errors committed (One-way ANOVA, F(2, 15) =
9.19, p = 0.0025) and on primary latency (F(2, 15) = 6.645, p = 0.0086). Post-hoc analysis of Cnih3/-

female animals confirmed that Cnih3-/- females in metestrus committed more primary errors than

Cnih3-/- females in proestrus/estrus or in diestrus (post-hoc Sidak’s multiple comparisons test, p =
0.004 and p = 0.0089 respectively), as well as presented a higher primary latency (p = 0.0288 and
p = 0.0123) (Figures 4H – I).
No effects of the estrous cycle were observed during the long-term probe in any genotype
(p > 0.05 across all parameters) (Figure S6).
Overall, the results from these experiments demonstrated not only an important role for
CNIH3 in short-term spatial memory in female animals, but also found that natural estrous cycling
may affect the role of CNIH3 in these processes. In Cnih3-/- female animals, the mice which
displayed the most pronounced impairments in spatial memory were predominantly in the
metestrus phase of their estrous cycle at the time of the short-term probe test. In other genotypes
we did not observe any changes in spatial memory due to estrous cycling. This suggests that the
necessity of CNIH3 for memory-associated processes in females may be modulated by the
fluctuations of endogenous sex-specific hormones in the brain.
Gene expression of Cnih3 and related genes are unaffected by estrous cycle stage
Upon observation of the correlation between estrous cycle stage and spatial memory in
Cnih3-/- female mice, we utilized RT-qPCR to determine if natural estrous cycling affects gene
expression of Cnih3 and select genes closely associated with Cnih3 (Cnih2, Dlg4, Gria1, and
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Gria2) in the dHPC. Tissue samples from the dHPC were collected from male and naturally
cycling female mice. We observed no changes due to sex or estrous cycle in Cnih3, Cnih2, Gria1,
or Gria2 expression (Figure S7). However, we did observe sex-specific changes in the expression
of Dlg4, the gene which encodes for the post-synaptic scaffolding protein PSD-95, a critical for
anchoring receptors (including AMPARs) and ion channels at the synapse (192). Dlg4 expression
was increased in the dHPC of female compared to male mice (Two-tailed unpaired t test, p <
0.0001), but we did not observe differences in Dlg4 expression between estrous cycle stages in
females (Kruskal-Wallis test, H(3) = 2.358, p = 0.5014) (Figure S7). These data indicate that
neither animal sex nor the estrous cycle affected endogenous gene expression of Cnih3, Cnih2, or
AMPAR-encoding genes. However, animal sex did modulate the expression of Dlg4 independent
of estrous cycle stage. Therefore, changes in the function of CNIH3 in the dHPC are not due to
changes in the gene expression of Cnih3 or related genes.
The densities of pre- and post-synaptic markers and of synaptic loci in the dorsal hippocampus
are reduced in Cnih3-/- female animals
Changes in synaptic structural proteins can indicate altered synaptic structural dynamics
that underlie memory formation in the dHPC (53, 193, 194). Therefore, one possible explanation
for the impaired memory formation in the dHPC is a reduction in memory storing synapses in
Cnih3-/- females. To test this hypothesis, we examined expression levels of the postsynaptic marker
PSD-95 and the presynaptic marker synapsin-1 in whole-cell homogenate samples obtained from
the dHPC of male and female Cnih3+/+ and Cnih3-/- mice (Figure 5A). We also subdivided female
samples by estrous cycle, which were collected during the proestrus and metestrus phases. These
estrous cycle stages were selected based on the memory deficits we previously observed during
metestrus, but not proestrus, in Cnih3-/- female mice (Figure 4). One sample was removed from
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the analysis for both Cnih3+/+ and Cnih3-/- proestrus female datasets due incorrect estrous cycle
stage at the time of death.
PSD-95 expression in the dHPC did not differ between Cnih3+/+ (n = 8) and Cnih3-/- (n =
8) male mice (Two-tailed unpaired t test, p = 0.4011). No change in PSD-95 expression was
observed between Cnih3+/+ (n = 12) and Cnih3-/- (n = 12) female mice (p = 0.1222), nor were any
changes in PSD-95 expression observed due to estrous cycle when female mice were subdivided
into proestrus (Cnih3+/+ n = 6; Cnih3-/- n = 5) and metestrus (Cnih3+/+ n = 6, one statistical outlier
sample removed; Cnih3-/- n = 7) (Two-way ANOVA for Estrous Cycle: F(1, 20) = 0.001252, p =
0.9721; Genotype: F(1, 20) = 2.538, p = 0.1268; Interaction between Estrous Cycle and Genotype:
F(1, 20) = 0.4022, p = 0.5331) (Figure 5B). We also did not observe differences due to sex or estrous
cycle stage on PSD-95 expression in synaptosomal fractions of the dHPC (Figure S8). Synapsin1 expression in the dHPC did not change between Cnih3+/+ and Cnih3-/- male mice (Two-tailed
unpaired t test, p = 0.8086). However, reduced synapsin-1 expression in the dHPC was observed
in Cnih3-/- female mice (p = 0.0077). When female mice were subdivided by estrous cycle stage,
we observed a pronounced effect of genotype as well as a significant interaction between the
estrous cycle stage and genotype on synapsin-1 expression (Two-way ANOVA for Estrous Cycle:
F(1, 21) = 0.3485, p = 0.5613; Genotype: F(1, 21) = 8.801, p = 0.0097; Interaction between Estrous
Cycle and Genotype: F(1, 21) = 6.622, p = 0.0177), with reduced synapsin-1 expression in Cnih3-/female mice in metestrus compared to Cnih3+/+ female mice in metestrus (Post-hoc Sidak’s
multiple comparisons test, p = 0.0031) (Figure 5C). For both PSD-95 and synapsin-1, when
Cnih3+/+ females were normalized to Cnih3+/+ males, we did not observe any differences in
synaptic protein levels due to sex (Two-tailed t test, PSD-95: p = 0.2627; synapsin-1: p = 0.8598).
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Figure 5: Reduced synaptic density and weakened synaptic connectivity in the dHPC of Cnih3-/- female
mice.
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Figure 5: Reduced synaptic density and weakened synaptic connectivity in the dHPC of Cnih3-/- female mice
(A) Example western blot images from male and female Cnih3+/+ (male: n = 8; female: n = 13) and Cnih3-/- (male:
n = 8; female: n = 12) animals. Each lane represents dHPC whole-cell homogenate fractions obtained from a single
animal. Female samples were collected during proestrus and metestrus stages for both Cnih3+/+ (proestrus: n = 6;
metestrus: n = 7) and Cnih3-/- (proestrus: n = 5; metestrus: n = 7) genotypes. Blots were probed for PSD-95,
Synapsin-1, and HKPs β-actin (used for normalization) and β-tubulin. Datasets were normalized to within-sex and
within-blot Cnih3+/+ controls, data is shown as normalized percentages to the baseline average of Cnih3+/+ controls
(set at 100%). One Cnih3+/+ metestrus female was excluded as a statistical outlier in the PSD-95 dataset. (B)
Quantification of PSD-95 and (C) Synapsin-1 within males and within females. Female data is also subdivided by
estrous cycle stage. (D) SEQUIN multiscale imaging was utilized to quantify synaptic loci in the CA1 of the dorsal
hippocampus. Fixed brain slices were stained for the synapsin and PSD95, imaged by super-resolution ISM with
Airyscan, and images underwent 3D nearest neighbor analysis to identify synaptic loci (See Figure S8). (E)
Representative 3D images of the CA1 region of the dHPC from Cnih3+/+ (inset from panel D marked by *) and
Cnih3-/- female mice. (F) Average frequency distributions of male and female pre- and postsynaptic pairs, and (G)
corrected frequency distribution obtained by subtraction of randomized pairs to isolate the early peak used to
identify synaptic loci <400nm (dotted line). (H) Nearest neighbor (NN) separation distances of the synaptic peaks
in panel G. (I) Quantification of the top 20% of PSD-95 and (J) Synapsin puncta across images (n = 17 – 24 images
per group, from n = 3 – 4 animals per group). (K) Quantification of synaptic loci identified with SEQUIN. Datasets
underwent two-way ANOVA for genotype and sex, and post-hoc Sidak’s multiple comparisons test using total
images acquired (ns p > 0.05, * p < 0.05, ** p < 0.01, **** p < 0.0001).

While we did previously observe an overall increase in the expression of the PSD-95 encoding
gene Dlg4 in the dHPC of female WT mice compared to males (Figure S7), our data indicates that
PSD-95 protein levels in the dHPC does not change due to sex despite heightened gene
expression in the region. Altogether, these results indicated a reduction in hippocampal synaptic
structural proteins in Cnih3-/- female mice, with the strongest effect of CNIH3 on synapsin-1 in
Cnih3-/- female mice.
These alterations in structural synaptic proteins in female Cnih3-/- mice suggested there be
a disruption of synapses in the dHPC. Therefore we also investigated synaptic connectivity in the
dHPC using a newly developed high-resolution protocol for the quantification of synaptic loci:
SEQUIN (181). For these experiments we targeted the CA1 region of the dHPC for this experiment
due to its critical role in spatial memory and its strong expression of Cnih3 (Figure 1F). Due to the
limited resolution of western blotting for precise quantification of regionally specific changes in
protein levels, we also utilized SEQUIN imaging to assess the density of structural synaptic
76

proteins in the CA1 of the dHPC. Slices were stained for the presynaptic marker synapsin and the
postsynaptic marker PSD-95, and samples were imaged by super-resolution image scanning
microscopy (ISM) with Airyscan detection (Figure 5D) (Figure S9). To dissect potential sex
differences in synaptic loci, images were acquired from Cnih3+/+ and Cnih3-/- male and female
mice (n = 17 – 24 slices/group across n = 3 – 4 animals/group) (Figure 5E). A SEQUIN frequency
distribution of pre-to-postsynaptic pair separations (corrected to density as the nearest-neighbor
pair frequency/image volume) revealed a sharp early peak (<400 µm), representing paired puncta
at synaptic loci, in addition to a broader peak at higher separation distances, representing random
paired puncta associations (Figure 5F). In order to correct for random paired puncta associations
and isolate the early peak associated with paired puncta at synaptic loci, the analysis was repeated
with the PSD-95 image reflected on the y axis, thus eliminating the early peak (Figure S9). This
reflected frequency distribution was subtracted from the original distribution to quantify the paired
puncta associated with synaptic loci (Figure 5G).
Upon closer inspection of the frequency distributions for male and female Cnih3+/+ and
Cnih3-/- samples, we observed a rightward shift in the frequency distributions of pre-topostsynaptic separation distances of female Cnih3-/- samples compared to female Cnih3+/+ controls
(Figure 5F – G). The pre-to-postsynaptic separation distances with the highest frequency of paired
puncta were compared between Cnih3+/+ and Cnih3-/- samples within each sex. No difference in
separation distance was observed between male Cnih3+/+ and Cnih3-/- samples (Two-tailed MannWhitney test, p = 0.6892). However, we did observe an increase in the pre-to-postsynaptic
separation distances at the peak frequency of paired puncta within samples from female Cnih3-/samples (p = 0.0045) (Figure 5H). Comparing samples from male and female Cnih3+/+ controls
found a trend towards a decrease in the maximal frequency of pre-to-postsynaptic separation
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distances in Cnih3+/+ females (p = 0.0570). Overall, these analyses suggest that a lack of CNIH3
at excitatory synapses in the dorsal CA1 of female animals may lead to a larger separation between
pre- and postsynaptic matrices, or that a lack of CNIH3 may lead to a functional deficit at these
synapses which increases this separation. Another interpretation of this result is that since samples
obtained from Cnih3+/+ female mice showed a trend towards decreased pre- to postsynaptic
distances compared to males, CNIH3 in females may interact with synaptic mechanisms to tighten
the pre- to postsynaptic distance within synaptic loci. Therefore, a lack of CNIH3 in females would
result in synapses which more closely resemble the pre- to postsynaptic distances in males.
In addition to using SEQUIN to quantify synapses and pre-post synaptic densities, we can
also evaluate the images to quantify the total amount of PSD-95 and Synapsin at synapses. The
density (number of spots/image volume) of the top 20% of postsynaptic PSD-95 puncta and of
presynaptic synapsin puncta were compared across sex and genotype. A two-way ANOVA for sex
and genotype identified a pronounced effect of sex and genotype on PSD-95 puncta density in the
dorsal CA1, as well as a significant interaction between the two factors (One statistical outlier
value omitted from the female Cnih3-/- dataset, Sex: F(1, 75) = 11.35, p = 0.0012; Genotype: F(1, 75)
= 21.09, p < 0.0001; Interaction between sex and genotype: F(1, 75) = 9.623, p = 0.0027). Female
Cnih3-/- mice had a lower density of PSD-95 puncta compared to Female Cnih3+/+ mice (Post-hoc
Sidak’s multiple comparisons test, p < 0.0001). In addition, we also observed effects of both sex
and genotype on synapsin puncta density in the dorsal CA1, as well as a significant interaction
between the two factors (One statistical outlier value omitted from the male and female Cnih3-/datasets, Sex: F(1, 74) = 5.96, p = 0.0170; Genotype: F(1, 74) = 9.753, p = 0.0026; Interaction
between sex and genotype: F(1, 74) = 23.59, p < 0.0001). Female Cnih3-/- mice had a lower density
of synapsin compared to Female Cnih3+/+ mice (Post-hoc Sidak’s multiple comparisons test, p <
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0.0001). No differences were observed between male and female Cnih3+/+ controls for PSD-95 (p
> 0.9999), however we did observe a higher density of synapsin puncta in Cnih3+/+ female mice
compared to male controls (p < 0.0001). These analyses indicated that both pre- and postsynaptic
markers PSD-95 and synapsin were reduced in the dorsal CA1 in Cnih3-/- female mice.
To assess whether CNIH3 and animal sex affect not only individual synaptic markers, we
completed the SEQUIN workflow to quantify nearest neighbor (NN) pre- and postsynaptic
markers associated with synaptic loci. We observed a strong effect of sex and genotype, as well as
a significant interaction between these factors, on the density of synaptic loci in the dorsal CA1
(Two-way ANOVA, Sex: F(1, 76) = 7.023, p = 0.0098; Genotype: F(1, 76) = 5.891, p = 0.0176;
Interaction between sex and genotype: F(1, 76) = 4.057, p = 0.0475). In the dorsal CA1, samples
from Cnih3-/- females had a lower density of synaptic loci compared to samples from Cnih3+/+
females (post-hoc Sidak’s multiple comparisons test, p = 0.0197). No differences in the density of
synaptic loci were observed in the dorsal CA1 of male samples (p = 0.9998), nor between samples
from male and female Cnih3+/+ animals (p = 0.9987).
This sex-specific effect of CNIH3 on the density of excitatory synapses in the CA1 region
of the dHPC suggests that CNIH3-related processes play a key role in the maintenance of synaptic
connectivity in female mice. We observed a loss of synaptic loci in the CA1 in Cnih3-/- female
animals, which has been previously suggested to be an underlying factor for memory dysfunction
(195). Our data also revealed that pre- and postsynaptic paired puncta had expanded separation
distances within synaptic loci in the dorsal CA1 of Cnih3-/- females. This sex-specific increase in
the distance between PSD-95 and synapsin protein clusters within the synapse may indicate a shift
in the localization of these proteins within the synapse or reduced connectivity between pre- and
postsynaptic matrices, which could lead to defects in neurotransmission and synapse stability (196,
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197). Overall, these experiments demonstrated a sex-dependent role for CNIH3 in the separation
distances between pre- and postsynaptic puncta, the density of pre- and postsynaptic puncta, and
the density of synaptic loci in the dorsal CA1.
Synaptosomal AMPAR subunit composition is altered in the dHPC of Cnih3-/- female mice during
metestrus
Prior biochemical studies have dissected the interaction between CNIH proteins and
AMPAR subunits at length, but these studies either investigated only the role of CNIH2 (141,
145), did not distinguish between CNIH2/3 (126), or did not specifically investigate the individual
role of CNIH3 on AMPARs in the hippocampal region (146). None of these studies distinguished
samples by sex. Therefore, we investigated whether CNIH3 affected AMPAR subunit composition
in the dHPC in a sex-dependent manner. We collected samples from female animals in both the
proestrus and the metestrus phases to further dissect potential interactions between the estrous
cycle and CNIH3 on AMPAR subunits. In both the female Cnih3+/+ and Cnih3-/- proestrus datasets,
one sample was removed from the analysis due to incorrect estrous cycle stage.
First we investigated the role of CNIH3 on the expression of the GluA1 subunit in the
dHPC at the synaptosome (Figure 6A). We did not observe any changes in synaptosomal GluA1
expression in male animals (Male Cnih3+/+: n = 8; Male Cnih3-/-: n = 8) (Two-tailed unpaired t
test, p = 0.7734), nor in female animals (Female Cnih3+/+: n = 13; Female Cnih3-/-: n = 12) (p =
0.7579). When females were separated by estrous cycle stage (Cnih3+/+ Proestrus: n = 6; Cnih3+/+
Metestrus: n = 7; Female Cnih3-/- Proestrus n = 5; Female Cnih3-/- Metestrus n = 7), we did not
observe any effects of estrous cycle stage or genotype, nor did we observe a significant interaction
between the two factors on synaptosomal GluA1 expression (Two-way ANOVA, Estrous: F(1, 21) =
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Figure 6: Altered AMPAR subunit composition and attenuated synaptic plasticity were observed in the
Schaffer Collateral (SC) pathway of the dHPC in Cnih3-/- female mice during metestrus.
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Figure 6: Altered AMPAR subunit composition and attenuated synaptic plasticity were observed in the
Schaffer Collateral (SC) pathway of the dHPC in Cnih3-/- female mice during metestrus. (A) Example
western blot images from male and female Cnih3+/+ (male: n = 8; female: n = 13) and Cnih3-/- (male: n = 8; female:
n = 12) animals. Each lane represents dHPC synaptosomal fractions obtained from a single animal. Female samples
were collected during proestrus and metestrus stages for both Cnih3+/+ (proestrus: n = 6; metestrus: n = 7) and
Cnih3-/- (proestrus: n = 5; metestrus: n = 7) genotypes. Blots were probed for GluA1, P-GluA1 (Ser845), and HKPs
β-actin (used for normalization) and β-tubulin. Datasets were normalized to within-sex and within-blot Cnih3+/+
controls, data is shown as normalized percentages to the baseline average of Cnih3+/+ controls (set at 100%). (B)
Quantification of GluA1 and (C) P-GluA1 (Ser845) within males and within females. Female data also subdivided
by estrous cycle stage. (D) Example western blots from the same samples used in panels A – C, probed for GluA2,
P-GluA1 (Tyr876), and HKPs β-actin (used for normalization) and β-tubulin (used for normalization in one blot
due to inconsistent actin staining). (E) Quantification of GluA2 and (F) P-GluA2 (Tyr876) within males and within
females. Female data also subdivided by estrous cycle stage. (G) Schematic of field potential recording from the
SC pathway of the dHPC in slice. Female mice were chosen for LTP experiments during the metestrus phase.
Representative image of a stained vaginal lavage sample from a female animal in metestrus. (H) Time course of
LTP under standard conditions (2 mM Ca2+, 2 mM Mg2+ in ASCF) for Cnih3+/+ (n = 5) and Cnih3-/- female mice
(n = 5) in the metestrus stage of the estrous cycle Following 10 min of baseline fEPSPs , the SC pathway was
subjected to HFS to induce LTP. (I) Comparison of half-maximal fEPSP slope (presented as % baseline) 1 hr postHFS between Cnih3+/+ and Cnih3-/- metestrus females. (J) Time course of LTP under higher Ca2+ and lower Mg2+
conditions to enhance NMDAR activation during TBS (2.5 mM Ca 2+, 1.3 mM Mg2+ in ASCF) for Cnih3+/+ (n =
5) and Cnih3-/- female mice (n = 5) in the metestrus stage of the estrous cycle. TBS was applied after 10 min of
baseline recordings to induce LTP. (K) Comparison of half-maximal fEPSP slope 1 hr post-TBS under high Ca2+
conditions between Cnih3+/+ and Cnih3-/- metestrus female mice. Biochemical data underwent two-tailed t tests
within sex and two-way ANOVA comparing estrous cycle and genotype. LTP datasets underwent nonparametric
two-tailed unpaired Mann-Whitney tests for baseline comparisons (ns p > 0.05, ** p < 0.01).

2.395, p = 0.1367; Genotype: F(1, 21) = 0.07012, p = 0.7937; Interaction between estrous and
genotype: F(1, 21) = 0.03265, p = 0.8583) (Figure 6B). The phosphorylation of the GluA1 receptor
at the S845 residue results in increased receptor insertion in the membrane (43, 198), therefore we
also investigated whether CNIH3 affected the level GluA1 S845 phosphorylation. We did not
observe any changes in synaptosomal GluA1 S845 phosphorylation in males (p = 0.7284) nor in
females (Cnih3+/+ combined female dataset did not pass the Shapiro-Wilk normality test,
nonparametric two-tailed Mann-Whitney test, p = 0.9362). However, we did observe a pronounced
effect of estrous cycle stage on GluA1 S845 phosphorylation independent of genotype and no
interaction between estrous cycle stage and genotype (Two-way ANOVA, Estrous: F(1, 21) = 9.935,
p = 0.0048; Genotype: F(1, 21) = 0.1828, p = 0.6734; Interaction between estrous and genotype:
F(1, 21) = 6.723e-6, p = 0.9980). Subsequent post-hoc analysis of GluA1 S845 phosphorylation in
female animals revealed that female animals in the metestrus stage trended towards higher levels
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of GluA1 S845 phosphorylation in the synaptosome compared to females in proestrus (Post-hoc
Sidak’s multiple comparisons test between proestrus and metestrus, Cnih3+/+: p = 0.0639; Cnih3/-

: p = 0.0812) (Figure 6C). For both GluA1 and phospho-GluA1 Ser845, we observed no

differences between male and female Cnih3+/+ controls (female control values normalized to male
controls) (GluA1: Two-tailed unpaired t test, p = 0.8245; P-GluA1(Ser845): Cnih3+/+ combined
female dataset did not pass the Shapiro-Wilk normality test, nonparametric two-tailed MannWhitney test, p = 0.4558).
Next we investigated the role of CNIH3 on the levels of GluA2 subunits in the synaptosome
(Figure 6D). We did not observe any changes in dHPC GluA2 expression at the synaptosome in
male mice (Two-tailed unpaired t test, p = 0.1769), but we did observe a trending increase in
GluA2 expression in the dHPC of females (One statistical outlier removed from the Cnih3-/females proestrus dataset, two-tailed unpaired t test, p = 0.0618) (Figure 6E). When females were
subdivided by estrous cycle stage, we observed a strong effect of estrous cycle stage on GluA2
expression at the synaptosome in female animals, with trending effects of genotype and an
interaction between genotype and estrous cycle stage (Two-way ANOVA, Estrous: F(1, 20) = 13.45,
p = 0.0015; Genotype: F(1, 20) = 3.077, p = 0.0947; Interaction between estrous and genotype: F(1,
20)

= 3.768, p = 0.0665). Subsequent post-hoc analysis found an increase in synaptosomal GluA2

in Cnih3-/- females in metestrus compared to both Cnih3+/+ and Cnih3-/- females in proestrus, and
a slight increase in GluA2 in Cnih3-/- females compared to Cnih3+/+ females in metestrus (Posthoc Sidak’s multiple comparisons test, p = 0.0076 compared to Cnih3+/+ females in proestrus, p
= 0.0035 compared to Cnih3-/- females in proestrus, p = 0.0523 compared to Cnih3+/+ females in
metestrus) (Figure 6E). Next we examined the effect of CNIH3 and sex on Y876 phosphorylation
of the GluA2 subunit, which has been shown to trigger the removal of GluA2-containing AMPARs
83

from the synapse (199). We did not observe differences in synaptosomal Y876 phosphorylation of
the GluA2 subunit in the dHPC of males (Two-tailed unpaired t test, p = 0.9800) or in females (p
= 0.1243) (Figure 6F). When females were subdivided by estrous cycle stage, we did not observe
any effects of sex or genotype on Y876 phosphorylation, nor did we observe an interaction between
these two factors (Two-way ANOVA, Estrous: F(1, 20) = 2.698, p = 0.1161; Genotype: F(1, 20) =
1.630, p = 0.2163; Interaction between estrous and genotype: F(1, 20) = 0.9555, p = 0.3400).
Together these data reveal an increase in GluA2-containing AMPARs at the synapse in the
dHPC of Cnih3-/- female mice, particularly during the metestrus phase, with no change in the
overall expression of GluA1 subunits or in post-translational phosphorylation of either of these
subunits. The increase in GluA2-containing AMPARs in dHPC synaptosomes of Cnih3-/- in female
mice during metestrus suggests that the interaction between CNIH3 and AMPAR subunits may be
differentially modulated by fluctuations in endogenous hormones in the brain. Without CNIH3
available to assist in normal AMPAR trafficking and signaling during metestrus, AMPAR
composition skewed toward GluA2-containing receptors which are impermeable to calcium ions.
This shift in the delicate balance between receptor subunit composition in AMPARS may result in
disrupted AMPAR-reliant processes such as synaptic plasticity, where the exchange of GluA1 and
GluA2 AMPAR subunits is critical to the induction and maintenance of LTP.
LTP maintenance is disrupted in the Schaffer Collateral (SC) pathway of Cnih3-/- female mice
We examined the role of CNIH3 in LTP to investigate how these changes in AMPAR
subunit composition, observed only in Cnih3-/- female animals during metestrus, may affect
hippocampal mechanisms underlying memory. The SC pathway in the dorsal CA1 plays a critical
role in short-term spatial memory, making it an ideal target to monitor changes in
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electrophysiological function due to the loss of CNIH3 (200). For these experiments we utilized
field EPSP (fEPSP) recordings of the SC pathway in the CA1 of the dHPC to measure synaptic
responses (Figure 6G). Female mice in the metestrus stage were chosen for LTP studies due to
memory deficits (Figure 4H – J) and changes in AMPAR subunit composition (Figure 6E)
observed during this stage in Cnih3-/-, but not in Cnih3+/+, female mice (Figure 6G). During initial
experiments assessing the link between CNIH3 and excitatory signaling, we did not observe any
effects of CNIH3 on miniature excitatory postsynaptic currents (mEPSCs) in dHPC slices obtained
from juvenile, pre-cycling mice (P17-21) (Figure S10), which is consistent with our hypothesis
that differences in AMPAR function due to CNIH3 are unmasked during the metestrus stage in
naturally cycling female mice.
For the first experiment, we used a single 100 Hz x 1 s HFS to induce LTP in an ACSF
bath solution containing 2 mM Ca2+ and 2 mM Mg2+. We observed no change in the initial EPSP
potentiation following the induction of LTP by HFS in slices from Cnih3-/- females and Cnih3+/+
female controls (n = 5 mice/group, 1 min after HFS stimulation, Two-tailed unpaired t test, p =
0.8703) (Figure 6H). This aligned with our biochemical data which showed no difference in GluA1
expression or phosphorylation at the S845 site between genotypes during metestrus (Figure 6B –
C), as the rapid insertion of AMPARs containing the GluA1 subunit have been shown to mediate
early phase potentiation following LTP induction by HFS (46, 198). However, sixty min postHFS, the maintenance of LTP was disrupted in the dHPC of Cnih3-/- female mice in metestrus
compared to Cnih3+/+ females in metestrus (two-tailed Mann-Whitney test, p = 0.0079) (Figure
6H – I). This experiment demonstrated that CNIH3 plays a key role in the maintenance of LTP in
the dorsal hippocampus in female mice during metestrus.
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The attenuation of HFS-induced LTP in Cnih3-/- female mice indicated that CNIH3 is an
important component for excitatory plasticity, but left open the question whether SC synapses in
Cnih3-/- female mice can sustain LTP under more intense stimulation paradigms. Thus, we also
examined whether LTP can be induced under conditions that promoted greater degrees of NMDAR
activation to promote LTP maintenance. For these studies we induced LTP through TBS of slices
submerged in a bath solution of ACSF containing an elevated Ca2+/Mg2+ ratio to enhance Ca2+
influx via NMDARs (186, 187). 60 min following TBS of the SC pathway, no difference in
NMDAR-driven LTP was evident between metestrus Cnih3+/+ and Cnih3-/- females (n = 5/group,
unpaired two-tailed t test, p = 0.3711) (Figures 6J – K). This suggested that CNIH3 KO does not
completely eliminate the ability of SC synapses to exhibit LTP, but rather there is a shift in the
relative ease with which LTP can be induced.

3.5

Discussion
Learning and memory play a pivotal role in animal behavior, and dysregulation of the

mechanisms that underlie these processes are found in a wide array of psychiatric disorders. The
inclusion of sex as a biological variable (SABV) in neuroscientific studies is unearthing a
multitude of new findings in the field, shining a light on how many factors can modulate brain
function. This study identifies a sex-specific role for the AMPAR auxiliary protein CNIH3 on
spatial memory, hippocampal synaptic density, AMPAR subunit composition, and synaptic
plasticity in female mice (Figure 7). In addition, we also demonstrate that the role of CNIH3 in
females appears to be at least partially modulated by natural estrous cycling. First, upon observing
high levels of Cnih3 in the mouse dHPC, we overexpressed Cnih3 in the dHPC and found
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Figure 7: Summary of results. In this study we report altered spatial memory and hippocampal processes between
female WT and female Cnih3 KO mice, with no effect of CNIH3 in male animals. In summary, we observed: (1)
attenuated LTP in the SC pathway of the dHPC, (2) a reduction in synaptic markers and overall synaptic density
in the dorsal CA1, in addition to increased distance between PSD-95 (green) and Synapsin (magenta) puncta within
synaptic loci, and (3) increased GluA2-containing Ca2+-impermeable AMPARs in the dHPC synaptosome in
female Cnih3 KO mice (especially during metestrus). (4) We propose that these changes in the dHPC underlie the
short-term spatial memory deficits that we observed in female Cnih3 KO mice in the Barnes maze.

improved spatial memory only in female mice. We also generated a line of Cnih3-/- mice to isolate
the effects of CNIH3 and observed attenuated spatial memory in Cnih3-/- female mice.
Interestingly, we noticed the highest level of dysfunction in Cnih3-/- female mice was during
metestrus, a stage of the estrous cycle characterized by lower circulating levels of β-estradiol
(compared to stages such as proestrus and estrus), and lower levels of progesterone (compared to
diestrus) (180, 201). To further delve into the potential mechanisms underlying the role of CNIH3
on spatial memory in female mice, we utilized the newly developed SEQUIN imaging protocol to
quantify synapses in the CA1 of the dHPC. In these experiments we identified reduced levels of
pre- and postsynaptic markers, as well as an overall loss of synapses in female Cnih3-/- mice. In
the synaptosome of the dHPC in biochemical experiments, we did not observe changes in
synaptosomal levels of the GluA1 subunit, but we did see an increase in GluA2-containing, Ca2+87

impermeable AMPARs in the dHPC synaptosome of Cnih3-/- female mice, particularly during
metestrus. In synaptic plasticity studies conducted to assess how this shift in AMPAR subunit
composition may affect AMPAR-driven processes, we observed attenuated LTP maintenance in
the SC pathway in the CA1 in female Cnih3-/- mice. Overall, in this study we found a consistent
interaction between sex and the role of CNIH3 on memory and memory-related mechanisms in
the dHPC.
The body of literature exploring sex differences in memory, and especially spatial memory,
is rapidly growing, driven by the increased implementation of SABV. However, the observance of
sex differences in rodent behavior can be highly dependent upon animal species, age, strain, stress,
and memory task (78, 79). Due to the variability inherent to individual study designs, researchers
have reported a wide range of sex differences in rodent memory tasks. These include an overall
superior spatial memory in male rats (80), sex differences in search strategies but not end-of-task
performance (81), sex differences in spatial memory retention but not short-term memory
consolidation (82), or no overall observable sex differences (83, 84). Our study did not find any
differences in spatial memory in the Barnes maze between young adult WT male and female mice;
only female Cnih3-/- mice demonstrated observable deficits in spatial memory. Interestingly, we
did not observe any changes in long-term spatial memory across sex, genotype, or estrous cycle
stage. Prior studies demonstrated that long and short-term memory are regulated by distinct
mechanisms across multiple brain regions. Short-term memory is reported to be primarily
regulated by regions such as the hippocampus and the parietal and entorhinal cortices, while longterm memory is predominately mediated by the pre-frontal cortex and amygdala (202). Therefore,
we suggest that while CNIH3 plays a critical role for short-term memory retrieval in female
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animals, the storage and retrieval of long-term memory does not rely on CNIH3 but instead
engages a wider array of alternative mechanisms.
In addition to the study of the interaction between sex and memory, several reports have
provided key insights informing how sex-specific AMPAR mechanisms may underlie sex
differences in memory encoding and retrieval. Sex differences have been identified in evoked
AMPAR/NMDAR signaling in hippocampal synapses and in the magnitude of evoked LTP (80,
82). It is important to note that the sex-specific role of AMPARs in memory may also depend on
the memory task utilized (e.g. one study concluded that while the GluA1 subunit is necessary only
for male mice in fear conditioning memory, hippocampal GluA1 is necessary for spatial learning
in both sexes (84)). Differences in AMPAR expression have also been observed between male and
female rodents in other studies of fear memory and anxiety-related behaviors (203, 204). However,
little is known about how auxiliary proteins for AMPARs may interact with animal sex to modulate
receptor function. The post-synaptic protein SynGAP interacts differentially with TARPs by sex
(205), but the role of sex on the function of other AMPAR auxiliary proteins have not yet been
elucidated. These prior studies in conjunction with our own findings indicate that more
investigation is needed to determine how AMPARs and their auxiliary proteins mediate sexspecific spatial memory and glutamatergic mechanisms.
In female animals, multiple studies indicate the estrous cycle and sex hormones, such as
17β-estradiol and progesterone, play key roles in hippocampal molecular signaling, synaptic
structure, neuronal excitability, and synaptic plasticity (78, 90-95). However, prior studies
investigating the role of the estrous cycle on memory are mixed with some studies reporting
contributing effects of the estrous cycle (103-105) and others little to no effect of natural estrous
cycling on memory (106). Our study found no difference in spatial memory due to estrous cycling
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in WT females, we observed such changes only in Cnih3-/- female mice. Therefore, we hypothesize
that the combined effect of the hormonal fluctuations associated with the estrous cycle and the
molecular components of glutamatergic signaling mechanisms, such as CNIH3, may interact to
mediate spatial memory and plasticity in female mice. This suggests that CNIH3 plays a
compensatory role that masks an estrous-specific deficit in female memory, an effect that is only
revealed with an examination of changes across the estrous cycle in the absence of CNIH3.
Additional studies investigating the molecular interactions between CNIH3 and known hormonal
signaling pathways are needed to test this hypothesis, but it is supported by a growing body of
literature implicating glutamatergic changes during the estrous cycle. Multiple studies observed
changes in glutamatergic activity in the hippocampus during the estrous cycle and in the presence
of 17β-estradiol. 17β-estradiol has been shown to mediate LTP and dendritic spine density in the
hippocampus of female rodents through NMDAR-dependent mechanisms (96-98). In addition,
estrous cycling and 17β-estradiol modulate diffusion of AMPARs to the surface of the synaptic
membrane in female mice (99-101), alter AMPAR subunit stoichiometry (99), and increase the
expression of AMPAR subunits and associated scaffolding protein PSD-95 (102). Therefore, the
results obtained in our study add to this body of evidence that the estrous cycle and glutamatergic
mechanisms interact to facilitate synaptic plasticity and memory in female animals.
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Supplemental Materials

Primer sequences
All primers used for RT-qPCR were obtained from Integrated DNA Technologies. Primer
sequences are as follows: Viral Cnih3 gene variant 2: 5’-GCGCTGCGCTCATCTTTTTC-3’
(forward),

5’-CTTGAAATCCGTTCTTAGCTCGT-3’

TGGTGCTGCCCGAGTACTC-3’
(reverse).

Cnih2:

(forward),

5’-ATATTCCATCCACGGCCTCTTC-3’

AACCACGGAGGAAGGATACC-3’
Gria2:

Cnih3

(reverse).
(forward),

(forward),

5’-

5’-

5’-CGTTGAGGCGTTCTGATTCA-3’

(reverse).

(forward),

(reverse).

Rpl19:

5’5’-

Dlg4:

(forward),

ACCAGAAGAGTATAGCCGATTCG-3’
ACCAGAAGAGTATAGCCGATTCG-3’

4:

5’-

Gria1:

5’-CCGAGGCGAAACGAATGAAG-3’

CACTCTCGATGCCATATACGTTG-3’

exon

5’-GGAACATTGAGTCCCAGGGTG-3’

TCCAGAGGTGGTAGAAGAGGAG-3’

(reverse).

(reverse).

5’5’

–

CAGGAGATACCGGGAATCTAA -3’ (forward), 5’ – TGCCTTCAGTTTGTGGATGTG -3’
(reverse).
Generation of a Cnih3 expressing virus
A viral vector was constructed using mus musculus mRNA sequence of Cnih3, variant 2, PCR’d
from clone BC115640. This transcriptional variant was chosen based on expression level in the
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brain and hippocampus, as notated on the UCSC Genome browser(171). Using PCR stitching and
inFusion cloning into pENTR3x plasmid, the Cnih3 transcript was N-terminal Myc-tagged and a
t2A sequence followed by a GFP sequence was added at the C-terminus, and the entire construct
was confirmed by Sanger sequencing. The construct was then swapped into pAAV-EL1a using
Gateway cloning. Upon confirmation of cloning for this vector, the EF1A promoter was replaced
by a CamKIIa promoter via classical digestion enzyme cloning. The resulting plasmid, once fully
sequence verified using GENEWIZ, was packaged into an AAV5 viral vector at the Hope Center
Viral Core at Washington University in St. Louis.
Immunohistochemistry for validation of viral expression
40 µm free-floating brain slices from viral Cnih3 overexpressing mice were stained with rabbit
anti-myc primary antibody (1:1000, Cell Signaling Technology, #2272) and goat anti-rabbit 594
Alexa Fluor secondary antibody (Life Technologies, #A11037). Slices were mounted and imaged
via confocal microscopy (Leica) to visualize expression of the myc-tag adjacent to Cnih3 within
the viral construct (Figure 4A).
Whole cell patch-clamp recording
Female Cnih3+/+ and Cnih3-/- mice aged P17-21 were utilized for whole cell patch-clamp
slice recordings of miniature excitatory post-synaptic currents (mEPSCs) in the dHPC. This age is
common for whole cell patch clamp recordings to ensure optimal neuronal viability and visibility
of cells for targeting, and we previously used slices from similarly aged animals in prior studies to
measure dHPC glutamatergic signaling(206, 207). The brain was glued onto the specimen platform
of a Leica VT1200. Sagittal (300 μm) slices were cut in ice-cold modified artificial cerebrospinal
fluid (ACSF) (in mM: 87 NaCl, 75 sucrose, 25 glucose, 25 NaHCO3, 2.5 KCl, 1.25 NaH2PO4,
93

equilibrated with 95% O2-5% CO2 plus 0.5 CaCl2, 3 MgCl2; 320 mOsm). After incubation at 32–
34°C for 30 min in choline-based ACSF (in mM: 92 choline chloride, 25 glucose, 30 NaHCO3,
2.5 KCl, 1.2 NaH2PO4, 20 HEPES, 2 thiourea, 5 Na ascorbate, 3 Na pyruvate, equilibrated with
95% O2-5% CO2 plus 2 CaCl2, and 1 MgCl2, 300 mOsm), slices were stored for at least 1 h at
room temperature in regular ACSF (in mM: 125 NaCl, 25 glucose, 25 NaHCO3, 2.5 KCl, 1.25
NaH2PO4, equilibrated with 95% O2-5% CO2 plus 2.6 CaCl2, 1.2 MgCl2; 310 mOsm), before
recording. Somatic, whole-cell patch-clamp recordings were performed using standard differential
contrast interference microscopy under infrared illumination. CA1 pyramidal neurons were
identified on an upright Nikon Eclipse E600FN microscope and a QImaging camera controlled
with QCapture (QImaging). Somatic whole-cell recordings were made with borosilicate patch
pipettes (World Precision Instruments; Sutter Instruments), having open tip resistance of 3–6 MΩ.
After a whole-cell configuration was established, cells were allowed to fill with the intracellular
solution for ∼5 min. Recordings were obtained using a MultiClamp 700B amplifier (Molecular
Devices), Digidata1550 16-bit A/D converter, and pClamp 10.4 software (Molecular Devices).
Pipette capacitance was adjusted using MultiClamp 700B Commander software. Somatic access
resistance values were between 10 and 25 MΩ, and cells with unstable access resistance (>20%
change) were excluded from analysis. For measuring mEPSCs, cells were voltage-clamped at −70
mV, with the intracellular pipette solution containing the following (in mM): 120 cesium
methanesulfonate, 20 HEPES, 10 EGTA, 2 MgATP, 0.3 Na2GTP, and 5 QX-314; pH adjusted
with CsOH to pH 7.25; 290 mOsm. Data were acquired in gap-free mode in the presence of 1 μM
TTX and 10 μM gabazine. All mEPSC data were acquired at 5 kHz, and filtered at 2 kHz using an
8-pole Bessel filter. mEPSCs were detected using a template-matching algorithm in
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Clampfit(208); templates were created by averaging >20 events. Decay times were assigned based
on single or bi-exponential least-squares fits as appropriate.

Figure S1: Determination of estrous cycle stage in female mice. Estrous cycle stage was
monitored daily by vaginal lavage and staining with giemsa stain prior to sample collection and
during behavioral studies. For behavioral studies, estrous cycle samples were collected once all
testing was finished each day to avoid potential animal stress prior to testing. Estrous cycle samples
were blinded and assessed three separate times for correlative behavioral studies to reduce
potential experimenter bias. Estrus (E) was characterized by the presence of cornified epithelial
cells, metestrus (M) by a mix of leukocytes and both nucleated and cornified epithelial cells,
diestrus (D) by leukocytes, and proestrus (P) by nucleated epithelial cells.
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Figure S2: Barnes Maze performance during training for mice overexpressing Cnih3 in the
dHPC (A) Timeline for Barnes Maze training. (B – D) Barnes Maze results on the first trial of
each training day for male YFP control (n = 9) and Cnih3 overexpressing (n = 10) mice. Two-way
ANOVA identified no significant changes across trials due viral expression (Primary errors: F(1,
17)

= 0.8676, p = 0.3647, Primary latency: F(1, 17) = 0.3542, p = 0.5596, Path efficiency: F(1, 17) =

0.5533, p = 0.4671) and no significant changes between Cnih3 overexpressing and YFP control
male mice within any trial (post-hoc Sidak’s multiple comparisons test, p > 0.05). (E – G) Barnes
Maze results on the first trial of each training day for female YFP control (n = 8) and Cnih3
overexpressing (n = 10) mice. Two-way ANOVA identified no significant changes due to viral
expression across total trials for primary errors (F(1, 16) = 0.001337, p = 0.9713) and primary
latency (F(1, 16) = 0.4358, p = 0.5186), but did identify a significant effect of viral expression in
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path efficiency (F(1, 16) = 9.192, p = 0.0079). During the short-term probe trial, post-hoc Sidak’s
multiple comparisons tests with repeated measures across trials indicated significantly improved
path efficiency in female Cnih3 overexpressing females compared to YFP control females (p =
0.0023). However, when accounting for repeated measures across training, Cnih3 overexpressing
females did not significantly differ from YFP control females in primary errors or primary latency
(p > 0.05).

Figure S3: No significant correlation between estrous cycle stage and animal performance
in the Barnes maze in female animals overexpressing Cnih3 in the dHPC. Estrous cycle
correlations with female animal performance in the short-term probe trial in the Barnes Maze by
(A) primary errors, (B) primary latency, and (C) path efficiency. Estrous cycle correlations with
female animal performance in the long-term probe trial in the Barnes Maze by (D) primary
errors, (E) primary latency, and (F) path efficiency. No significant effects of estrous cycle stage
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or viral expression were observed during the long-term probe trial across any parameters (p >
0.05).

Figure S4: Barnes Maze performance during training for Cnih3+/+, Cnih3+/-, and Cnih3-/mice (A) Timeline for Barnes Maze training. Day 0 consists of 2 consecutive 180 s habituation
trials. Days 1-4 consist of 3X daily 180s training trials 15min apart. Days 5 and 12 consists of a

single 90 s probe trial where the escape box under the target hole is blocked. (B – D) Barnes Maze
results on the first trial of each training day for male Cnih3+/+ (n = 9), Cnih3+/- (n = 12), and Cnih3/-

(n =10) mice. Two-way ANOVA identifies no significant changes across trials due genotype

(Primary errors: F(2, 31) = 0.03752, p = 0.9632, Primary latency: F(2, 31) = 1.040, p = 0.3655, Path
efficiency: F(2, 31) = 1.654, p = 0.2077) and no significant changes between genotypes within any
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trial (post-hoc Sidak’s multiple comparisons test, p > 0.05). (E – G) Barnes Maze results on the
first trial of each training day for female Cnih3+/+ (n = 22), Cnih3+/- (n = 21), and Cnih3-/- (n = 18)
mice. Some female animals were used for other experiments immediately following the short-term
trial (Cnih3+/+ n = 2, Cnih3+/- n = 2, and Cnih3-/- n = 4), and therefore were not tested in the longterm probe. Mixed-effects analysis found no significant changes between genotypes across all
trials (Primary errors: F(2, 58) = 0.03266, p = 0.9679, Primary latency: F(2, 58) = 0.1084, p = 0.8974,

Path efficiency: F(2, 58) = 0.2590, p = 0.7727), but during the short-term probe trial there was a
significant difference observed between female Cnih3+/+ and Cnih3-/- mice (Primary errors: p =
0.0092, Primary latency: p = 0.0331, Path efficiency: p = 0.0222).
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Figure S5: Estrous cycle correlations to performance in the Barnes maze for each individual
animal. Individual datapoints and cycles for female animal performance in the short-term probe
trial in the Barnes Maze correlated to estrous cycle stage as shown in Figure 4H – J. (A) primary
errors, (B) primary latency, and (C) path efficiency. Datasets underwent two-way ANOVA for
genotype and estrous cycle stage and followed by post-hoc Sidak’s multiple comparisons test (ns
p > 0.05, ** p <0.01, **** p < 0.0001).
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Figure S6: No significant effects of estrous cycling or Cnih3-/- observed during the long-term

probe of the Barnes maze. Estrous cycle correlations with female animal performance in the
long-term probe trial in the Barnes Maze by (A) primary errors, (B) primary latency, and (C) path
efficiency. No significant effects of estrous cycle stage or genotype were observed during the longterm probe trial across any parameters (p > 0.05).
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Figure S7: Gene expression of Cnih3 and related genes unaffected by estrous cycle stage in
female animals. dHPC fresh tissue samples were collected from WT C57BL/6 male (n = 9) and
female mice at each stage of the estrous cycle (Female total: n = 38; Estrus (E): n = 9; Metestrus
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(M): n = 10; Diestrus (D): n = 9; Proestrus (P): n = 10), and mRNA was extracted from dHPC
tissue for conversion to cDNA for RT-qPCR analysis. Ct scores were normalized to an Rpl19
control gene and to the male average. (A-D) No significant differences were detected in Cnih3,
Cnih2, Gria1, or Gria2 expression between male and female mice (Two-tailed Mann-Whitney test,
Cnih3: p = 0.0619, one female outlier removed; Cnih2: p = 0.4781, one female outlier removed;
Gria1: p = 0.4971; Gria2: p = 0.3035), nor when females were subdivided by estrous cycle stage

(Kruskal-Wallis test, Cnih3: p = 0.3230, one diestrus female outlier removed; Cnih2: p = 0.3881,
one estrus female outlier removed; Gria1: p = 0.7570; Gria2: p = 0.7377). (E) Dlg4, which
encodes for the protein PSD-95, was significantly reduced in the dHPC of female mice compared
to males (Two-tailed unpaired t test, p < 0.0001), and Dlg4 was reduced in females in both estrus
and metestrus compared to males (Kruskal-Wallis test, p = 0.0241 across all groups; post-hoc
Dunn’s multiple comparisons test comparing each stage to male controls: Male vs. E, p = 0.0124;
Male vs. M, p = 0.0176; Male vs. D, p = 0.1632, Male vs. P, p = 0.2771). However, Dlg4
expression in females did not change between estrous stages (Kruskal-Wallis test, p = 0.5014
between estrous cycle stages).
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Figure S8: No change in PSD-95 expression in dHPC synaptosomal fractions from Cnih3-/mice. (A) Example western blot images from male and female Cnih3+/+ (male: n = 8; female: n =
13) and Cnih3-/- (male: n = 8; female: n = 12) animals. Each lane represents dHPC synaptosomal
fractions obtained from a single animal. Female samples were collected during proestrus and
metestrus stages for both Cnih3+/+ (proestrus: n = 6; metestrus: n = 7) and Cnih3-/- (proestrus: n =
5; metestrus: n = 7) genotypes. Blots were probed for PSD-95 and HKPs β-actin (used for
normalization) and β-tubulin. Datasets were normalized to within-sex and within-blot Cnih3+/+
controls, data shown as normalized percentages to the baseline average of Cnih3+/+ controls (set
at 100%). (B) Quantification of PSD-95 within males and within females (Two-tailed unpaired t
test within sex, Male: p = 0.2724; Female: p = 0.1964). Female data also subdivided by estrous
cycle stage (Two-way ANOVA, Estrous cycle stage: F(1, 21) = 0.1312, p = 0.7208; Genotype: F(1,
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21)

= 1.799, p = 0.1942; Interaction between estrous cycle stage and genotype: F(1, 21) = 0.2048, p

= 0.6555).

Figure S9: SEQUIN Multiscale Imaging Protocol. SEQUIN imaging is comprehensively
validated and described in detail in its original publication (5). For this study, SEQUIN imaging
was conducted as follows: (A) Brain slices underwent immunofluorescent labeling of synapsin
and PSD-95, proteins which are highly concentrated at the pre (synapsin) and post-synaptic (PSD105

95) membranes. (B) Brain slices were cleared to improve visibility for volumetric confocal
imaging. (C) Slices were acquired via super-resolution image-scanning microscopy (ISM) with an
Airyscan detector (Carl Zeiss Microscopy). Airyscan augments lateral and axial resolution by 1.7fold, significantly improving volumetric resolution compared to standard ISM capabilities (6).
Images underwent pre-processing with Airyscan deconvolution. (D) Synaptic loci were identified
from synapsin and PSD95 puncta using spot detection analysis with Imaris image processing

software (Bitplane) and synaptic loci were quantified using custom nearest neighbor analysis
software

(Matlab,

Mathworks;

Code

available

on

Github:

https://github.com/KummerLab/SEQUIN (5)). (E) This produced a bimodal frequency distribution
of the measured distances of NN pairs with an initial peak at ~150 nm with a wide secondary peak
of distantly associated puncta. (F) To remove random puncta associations from the analysis,
postsynaptic PSD95 coordinates were reflected 180º around the Y axis and merged with the
originally oriented synapsin puncta. (G) All NN pairs in this reflected distribution (gray line) were
therefore random associations and not indicative of biological synaptic loci, resulting in a removal
of the early peak seen in panel E. Subtraction of this random reflected NN pair distribution from
the original NN distribution isolated the early peak of synaptic loci consistent with synapses (red
line). The dotted line at 400 nm indicates the NN separation cutoff for quantification of true
synaptic loci, as 400 nm has previously been indicated as the upper limit for synaptic centroid
separation in electron microscopy studies (7).
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Figure S10: No change in whole-cell mEPSC recordings in the dHPC of juvenile female
Cnih3-/-. (A) mEPSCs were recorded at membrane potential of -70 mV from CA1 neurons in dHPC
of pre-estrous cycling, juvenile (P17-21) female mice. Sample traces show average waveforms
from representative cells of Cnih3+/+ (gray line) and Cnih3-/- (red line). Summary data showed no
difference between genotypes in (B) frequency, (C) decay time constant (τ) or (D) peak amplitude
of events (n = 13 cells from n = 5 animals/genotype). Two-tailed unpaired t tests between
genotypes were performed using total cells recorded.
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Chapter 4:
Establishment of cue-associated intravenous fentanyl
self-administration
for future studies in CNIH3 mouse models
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4.1

Abstract
Operant drug self-administration (SA) offers a direct measure of drug-seeking behavior. In

order to conduct future studies testing whether Cnih3 expression mediates opioid cue associative
learning and memory, we first needed to establish this protocol in a mouse model. We chose to
test this paradigm with a fentanyl, a potent and fast acting synthetic opioid which has recently led
to increased overdose deaths in the United States. In male and female wild-type C57 BL/6 mice,
we initially attempted to test oral liquid fentanyl SA which does not require invasive surgical
protocols. However, data obtained from operant cue-paired oral SA did not directly correlate
between cue responses and drug consumption, leading to uncertainty in data interpretation. We
therefore tested cue-paired intravenous SA (IVSA) through an implanted catheter in the mouse
jugular vein. We were able to successfully train mice to operantly self-administer fentanyl through
an IV implanted catheter, and we are currently testing dose response curves for the use of this
protocol in Cnih3 male and female KO animals.

4.2

Introduction
Following our findings presented in Chapter 3 which identified a consistent effect of animal

sex effect on synaptic function and spatial memory in Cnih3 KO mice, our collaborator Dr. Elliot
Nelson revisited the human GWAS data presented in Nelson et al., 2016 (123). In the study’s
Comorbidity and Trauma Study (CATS) data we found evidence of more robust protective effects
against opioid dependence in women for CNIH3 SNPs (Table 1). Therefore, we aim to explore
how sex and CNIH3 interact to mediate opioid-associated behaviors such as opioid selfadministration (SA).
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Table 1 Reexamination of human CNIH3 findings in CATS data – evaluating sex effects
CATS – Molec Psych
Women
Men
(N=1328)
(N=537)
(N=791)
CNIH3 SNP
OR
p value
OR
p value
OR
p value
(95%CI)
(95%CI)
(95%CI)
rs10799590
0.55
1.28E-6
0.44
1.60E-5
0.65
1.03E-2
(0.43 – 0.70)
(0.30 – 0.64)
(0.47 – 0.90)
rs12130499
0.54
9.59E-7
0.42
6.44E-6
0.66
1.32E-2
(0.42 – 0.69)
(0.29 – 0.61)
(0.48 – 0.92)
rs298733
0.55
1.27E-6
0.43
9.78E-6
0.66
1.27E-2
(0.43 – 0.70)
(0.29 – 0.62)
(0.48 – 0.92)
rs1436171
0.53
5.29E-7
0.40*
2.32E-6
0.67
1.53E-2
(0.42 – 0.68)
(0.27 – 0.58)
(0.48 – 0.93)
rs1369846
0.51
6.30E-8
0.38*
8.57E-7
0.65
6.55E-3
(0.40 – 0.65)
(0.26 – 0.56)
(0.47 – 0.88)
rs1436175
0.50
3.15E-8
0.36*
4.49E-7
0.63
3.92E-3
(0.39 – 0.64)
(0.24 – 0.53)
(0.46 – 0.86)
*p<0.05 indicating a significant interaction with greater protective effects in women

to operantly self-administer the opioid drug fentanyl. Overdose deaths due to synthetic opioids
such as fentanyl have increased dramatically since 2013, as these drugs are highly potent and
frequently mixed with additional illicit drugs for sale on the black market (112). Naturally-derived
opioids such as morphine are slower to pass
through the blood-brain-barrier (BBB) to
Fixed Ratio Self-Administration, Extinction, and Reinstatement
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the drug than more recently synthesized

rapidly pass through the BBB (210, 211).
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euphoric response, which is a crucial
component for the establishing operant SA
in mouse models.

Figure 1: Example of fixed ratio self-administration.
Our laboratory frequently performs self-administration in
rats and recently acquired equipment to begin selfadministration in mice. Animals are operantly trained to
press a lever/nose poke to access fentanyl. A cue-light
over the active inset indicates fentanyl availability. In a
fixed ratio (FR) schedule, the number of presses needed
to obtain the drug is increased from 1 to 2, then 5 presses
over several days. After 3 days of FR 5 training,
extinction of operant behavior is initiated where the cue
light is turned off and fentanyl is absent. The animal is
still free to nose poke. Following extinction, the active
lever cue light is turned on to induce reinstatement of
operant lever pressing despite an absence of drug.
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The operant chambers utilized for mouse self-administration contained two insets on the
right and left which could be lit to indicate the active inset. Nose poking by the animal in the active
inset triggered reward delivery. Animals were trained on a fixed ratio (FR) schedule for drug
administration (FR1, FR2, FR5) (Figure 1). Following FR training, animals were also tested in a
progressive ratio (PR) where each subsequent reward delivery required increased nose pokes in
the active inset. The PR test is used as a measurement of motivation to obtain the drug even with
rapidly increased effort required to obtain the reward. Following training, animals underwent
extinction, during which animals were placed back in the chamber with the cue light turned off
and drug absent to extinguish operant responses. Reinstatement of nose poking behavior in
response to the reintroduction of the cue light was measured following extinction, an indication of
drug seeking.
In this chapter I describe two routes of fentanyl self-administration tested in our laboratory.
First we tested oral fentanyl SA. This protocol required no surgical implantation of a catheter, a
strong advantage given the difficulty of surgical catheter insertion and catheter maintenance in
mice due to their small size and vulnerability to respiratory infection (212). Oral liquid SA is
commonly used for studies of natural rewards (such as sweet liquids) and for studies of substance
abuse such as ethanol drinking. Several prior studies have established protocols for oral fentanyl
consumption (such as two-bottle choice) and SA in mice (213, 214). Therefore, we sought to
replicate these protocols in our own lab to establish oral fentanyl SA in mice.
The second route of fentanyl SA that we tested in mice was intravenous SA (IVSA). IV
catheters were implanted in the mouse jugular vein and affixed to a vascular access port surgically
implanted on the back of the animal. Catheter patency was checked daily, and mice were tested
for fentanyl IVSA following surgical recovery.
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Several considerations taken into account when designing these experiments. Firstly, we
did not employ food or water-restriction paired with food SA training prior to fentanyl SA. This
decision was made to minimize potential confounds of animal stress, changes in body weight, or
residual food seeking from affecting oral or IV fentanyl SA. As we are especially interested in
assessing whether CNIH3 affects SA task acquisition for cue-paired fentanyl SA in future
experiments, prior food SA training may mask CNIH3-dependent deficits in cue-associated
fentanyl SA (212). Secondly, we also assessed the timing of animal testing during the light – dark
cycle on mouse operant conditioning. Rodents are nocturnal animals and reach their peak
locomotor activity during their dark cycle. Studies have demonstrated that animals consume
ethanol and drugs of abuse at higher levels during the dark cycle (215). Therefore, we tested both
oral and IV fentanyl SA in both their light and dark cycles to determine whether light – dark cycle
timing affected fentanyl SA.
Following establishment of fentanyl SA protocols in our laboratory, our goal is to utilize
our genetic mouse models to assess how Cnih3 KO and transgenic CNIH3 knock-in affect task
acquisition, maintenance, extinction, and cue-induced fentanyl reinstatement.

4.3

Materials and Methods

Animals
Procedures were approved by the Institutional Animal Care and Use Committee at
Washington University in St. Louis. Adult (8 – 16 weeks) male and female C57BL/6 WT mice
were kept in climate-controlled facilities with a 12-hour light/dark cycle (lights on: 7 AM, lights
off: 7 PM) and ad libitum access to food and water. Experiments conducted during the light cycle
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were conducted in the afternoon between 5 – 10 hours after lights turned on (variability depending
on number of rounds to be conducted and equipment scheduling with other experimenters), and
experiments conducted during the dark cycle were conducted 1 – 2 hours after lights off.
IV jugular catheter implantation surgeries
Surgeries were conducted as previously described and adapted for mouse surgical
procedures (216). Mice were anesthetized with 1-3% isofluorane and surgeries were performed
with aseptic conditions. Following incisions on the back and the right clavicle, a sterile
polyurethane catheter (Instech, 2Fr PU medical grade tubing) filled with sterile saline was guided
under this skin of the shoulder so that the end of the catheter connecting to the vascular access
button (Instech, 1 channel 25ga injector for mouse) extended from the back of the animal. The
jugular vein was isolated and sterile sutures were loosely tied under each end of the vein for
securing the catheter. With slight pressure applied to the vein to minimize bleeding, a guide needle
was used to puncture the vein and gently insert the tip of the catheter into the vein (~1 cm catheter
inserted into the vein). The catheter was tested for placement by drawing up a small amount of
blood, and the catheter was secured in the vein by tightening the sutures. The wound on the front
of the animal was sutured and the animal was flipped onto its stomach. The vascular access button
and excess tubing were tucked under the skin and skin was sutured around the button. Animals
were given 7 days to recover from surgery prior to behavioral testing and monitored daily for

health and post-operative pain.
Catheters were flushed daily with 0.03 mL of 100 Usp/mL of heparinized saline mixed
with 0.44 mg/mL gentamicin to ensure catheter patency and minimize bacterial infection at the
catheter insertion site. With daily flushing, ~80% of implanted animal catheters remained patent
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one month following surgery by ensuring that flushing solution could be flushed through the
catheter. Two or more months (up to three months) following surgery and at the end of behavioral
testing, 20 ug/kg of fentanyl solution was flushed through the catheter and animals were assessed
for behavioral responses (hyperlocomotion, tail lifting, freezing, etc.) to test for catheter patency.
50-60% catheters were still patent even after several months. Following institutional animal
protocol review and approval, we will be using 0.75 mg/mL of midazolam as the final test of

catheter patency.
Fentanyl Self-administration
Experimental details for setting up operant fentanyl SA protocols in mouse models are
given in the Results section of this chapter. SA experiments were conducted in mouse modular test
chambers housed in sound attenuating isolation boxes (MedAssociates). Two nose poke insets
with cue lights were located on the right and left sides at the front of the chamber. Responses on
the active and inactive lever were recorded with Med-PC V software (MedAssociates). Live video
cameras were installed in each box to allow live monitoring of animal behavior during the task.
For oral fentanyl SA, a lickometer spout (MedAssociates) was programmed to enter the
chamber following animal nose poking in the active inset (indicated by a cue light). The spout
would be available for 20 s in order for mice to have enough time to approach the spout for drug
consumption before the spout retracted outside of the chamber. Mice were tested in 1 hr sessions
once a day.
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Figure 2: Mouse IVSA Images (A) Image of a mouse after
successful implantation of the vascular access button which
allows protected access to the catheter inserted in the jugular
vein. (B) Image of a mouse connected via the vascular access
button to the tether in the IVSA chamber.

(Figure 2). The tether sheathed flexible tubing connected to a primed syringe to deliver drug into
the catheter implanted in the jugular. Syringe pumps were calibrated to deliver 0.018 mL fentanyl
per infusion following nose poke of the active inset. The infusion period was followed by an 8 s
timeout period where the cue light turned off and drug was unavailable. Mice were tested in 1 or
2 hr sessions once a day.

4.4

Results

Oral Fentanyl Self-administration
Based on prior experiments by Wade et al., 2008 & 2013 (213, 214), we chose doses of 2.5
and 10 µg/mL for oral fentanyl self-administration. Prior to each experiment, the lick spout was
inspected to ensure that the spout was not clogged or leaking. The lick spout was assembled to not
only administer the drug, but also to count the number of licks on the spout. In an initial test, we
attempted to habituate animals to the lickspout and to 2.5 µg/mL of fentanyl solution with 5 x 1 hr
habituation sessions prior to operant training. In each habituation session, the spout would be
available for 2 min and then retreat for 5 min. Mice were then tested for oral fentanyl SA on an
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FR1 schedule for 2.5 µg/mL of fentanyl solution diluted in water. A sweetener was not used to
avoid the confound of the animal drinking due to taste palatability (213). However, this habituation
session was not used in following experiments as we did not observe any seeking for the drug in
FR1 oral fentanyl SA trials over 8 days (Figure 3A). We hypothesized that this could be due to the
animal not acquiring the task after multiple trials where drug was available without the requirement
of operant responding during the habituation trials.
Mice were therefore tested for oral fentanyl SA over the course of 8 days at FR1 for 2.5
µg/mL fentanyl without prior habituation. We also installed a lickometer sensor program
connected to the spout to enable quantification of spout licks during each trial. At this dose of
fentanyl, we did not observe any preference for the active inset, nor did we observe consistent
consumption of the drug (Figure 3B). However, these experiments were optimistically started in
the beginning of March 2020. With the advent of the COVID-19 pandemic and resulting laboratory

shut-downs, these experiments were unable to be continued past 8 days and had to be postponed
until the laboratory reopened for experiments in the summer of 2020.
In the third round of oral fentanyl self-administration experiments, mice were separated
into testing during the light and dark cycles and the concentration of fentanyl was increased from
2.5 µg/mL to 10 µg/mL to encourage animal responding (n = 2/cycle due to limited animal and
equipment availability at the beginning of laboratory reopening following COVID-19-related

laboratory shut-downs). Oral fentanyl SA on an FR1 schedule once again did not result in animal
nose poke responses nor consistent drug consumption at 2.5 µg/mL. Increasing the dosage to 10
µg/mL did lead to a gradual preference for the active over the inactive nose poke insets. Animals
trained during their dark cycle began to prefer the active inset after approximately 6 days of FR1
at 10 µg/mL, whereas animals trained during the light cycle began to show discrimination between
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Figure 3: Oral fentanyl selfadministration resulted in cueassociated SA, but this did not
correlate
with
actual
drug
consumption (A) Following 5 days of
habituation to the apparatus and to 2.5
µg/mL oral fentanyl, WT mice (n = 2)
were placed in FR1 for 2.5 µg/mL oral
fentanyl for 8 trials. (B) WT mice (n =
2) were placed in FR1 for 2.5 µg/mL
oral fentanyl for 8 trials. These studies
could not be continued due to the
COVID-19 pandemic. Active and
inactive nose pokes were recorded as
well as the number of times the animal
licked the spout to consume liquid
fentanyl. (C) WT mice (n = 2/group)
were trained in either their light or
dark cycles in: FR1 for 2.5 µg/mL oral
fentanyl for 10 trials, FR1 for 10
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the active and inactive insets after 11 days of FR1 at 10 µg/mL (Figure 3C). Animals were
progressed to FR2 and FR5 10 µg/mL. However, despite a slight increase in fentanyl consumption
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after 7 days of FR1 10 µg/mL, drug consumption was sporadic during both the light and dark
cycles and did not correspond with active inset nose pokes (Figure 3C). Since actual drug
consumption did not correspond with cue responsive behavior, we opted to shift our efforts to
establish a protocol for fentanyl IVSA to ensure a direct correlation between cue response and
drug administration.
IV Fentanyl Self-administration
Due to the inconclusive results obtained from the oral fentanyl SA pilot studies, we
conducted pilot studies to establish a protocol for fentanyl IVSA in mice. Despite the difficulty to
implant catheters in the fragile mouse jugular vein compared to the larger and sturdier rat, we were
eventually able to obtain several survivors from these surgeries. Two members of our laboratory
have become highly proficient with these surgeries and I am improving with this technique as well.
We obtained enough mice from initial surgeries to begin testing fentanyl IVSA in mice.
We were surprised to find that there is not yet published work implementing fentanyl IVSA
in mice. However, multiple studies have utilized IVSA in mice for psychostimulants and even
remifentanil (217, 218). Multiple studies utilizing fentanyl IVSA in rat models are published, but
in order to determine a suitable starting dosage for mouse studies we consulted with researchers
who have also begun to implement mouse fentanyl IVSA protocols in their labs (Dr. Ryan Logan
lab Boston University School of Medicine and Dr. Catherine Cahill at University of California –
Los Angeles). Based on their input, we opted to start with a high dose (20 µg/kg) and move stepwise to a lower dose (10 µg/kg) for the remainder of testing to facilitate cue-association with the
rewarding effects of fentanyl (Figure 4A). In this pilot study, mice were tested in 1 hr sessions
once per day. During FR1 at 10 µg/kg, mice were trained at this stage until they met the following
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acquisition criteria: administration of over 5 doses per session, maintaining a discrimination index
(DI) between active and inactive nose pokes over 0.7 for 2 days, and maintain a variation between
active nose pokes of less than 0.3 for 2 days. Upon successful acquisition, mice were moved to
FR2, FR5, and PR testing schedules (Figure 4B – C). Following PR, mice underwent extinction
where the cue lights were turned off and no drug was available during the session (Figure 4D).
Mice were deemed to have met extinction criteria if they reduced their poking compared to their

extinction baseline (day 1 of extinction) and/or demonstrated a reduction in the DI compared to
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Figure 4: Fentanyl IVSA in a mouse model (A) Timeline for fentanyl IVSA. (B) Male and female mice (n = 8,
n = 4/sex) were trained in FR1 until mice met acquisition criteria before progressing to FR2 and FR5. Due to high
individual variability in mouse acquisition of the task, data is represented as the first day of FR1 training and then
the last 5 days of FR1 at 10 µg/kg fentanyl per infusion, followed by FR2 and FR5 trials. (C) Progressive ratio.
(D) Extinction. (E) Comparison of active nose pokes to the first day of extinction, the last day of extinction, and
cue-induced reinstatement. This data is also represented in (F) as the change in the discrimination index (DI)
between active and inactive nose pokes. (G) Data in this other panels of this figure are combined by sex as we did
not observe sex differences in this pilot study except for in the number of trials necessary to meet FR1 acquisition
criteria.
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Figure 5: Saline IVSA in a mouse model Saline IVSA results (n = 2) of
mice which underwent the same protocol as the fentanyl IVSA mice in
Figure 4, except for active nose pokes only resulted in an infusion of
saline.

published literature in operant
conditioning in C57BL/6 mice (219) and anecdotally from collaborating labs attempting mouse
extinction studies as well). However, even if mice did not fully extinguish, we still observed an
increase in active inset nose pokes upon cue-induced reinstatement and/or an increased preference
for the active inset (Figure 4E – F).

In this pilot study we did not observe sex differences between male and female animals,
except in the time to meet FR1 acquisition criteria (Figure 4G). While this effect was not
significant (n = 4 / sex, unpaired two-tailed Mann Whitney test p > 0.05), we are keeping this trend
in mind as we continue these pilot studies to establish fentanyl IVSA protocols.
In order to test whether the cue responses we observed were due to fentanyl seeking or due
to animal interest in the cue light, we conducted preliminary saline IVSA control experiments (n

= 2) where mice were placed through the same testing paradigm but only received an infusion of
saline upon active nose poke. We did not observe cue-associated saline IVSA in this small control
study (Figure 5).
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Figure 6: Fentanyl IVSA comparison between light
and dark cycle training 1 µg/kg fentanyl IVSA results
of previously trained mice (n = 6). Mice were tested
during their light and dark (shaded) cycles.

and the fentanyl dose was lowered to 1 µg/kg
to facilitate higher SA responses. Mice were

tested for two days during the light cycle to establish a baseline for responses. For 3 days, animals
were tested for fentanyl IVSA for one session in the light cycle, and a second session 6 hrs later in
their dark cycle. After allowing the animals to rest for several days, animals were reintroduced to
the chamber for fentanyl IVSA during their dark cycle on day 6. We observed an increase in
responses after dark cycle training for two days, with higher preference for the active versus the
inactive inset (Figure 6).
Finally, we needed to firmly establish a fentanyl dose for these studies which would result
in optimal responding while remaining potent enough to reinforce the association of the drug
effects with the presence of the light cue. Following training of additional members of the lab for

these surgeries, we were able to generate n = 21 new male and female mice with IV catheters
inserted in the jugular. These experiments are currently underway to test how a range of fentanyl
doses affect IVSA acquisition and maintenance.
4.5

Discussion
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Overall, we were able to successfully initiate pilot studies for the implementation of
fentanyl SA studies in C57BL/6 mouse models. At first we attempted to replicate studies of oral
fentanyl SA in mice as described in Wade et al. 2008 & 2013 (213, 214). While we did observe an
increase in active nose pokes and discrimination between active and inactive nose poking, we
found that cue responses did not correlate with actual drug consumption. One difference between
our study design and those described in the Wade et al. studies was in the design of our lick spout.
Their lick spouts were designed to distribute a specified volume of liquid, whereas our spouts
manually moved in and out of the chamber and we could only limit the time that drug was
available, not the volume of drug to be distributed. This led to several observable challenges. First
of all, while watching the live video feed during the tests I observed that the abrupt movement and
noise of the spout entering the chamber would frequently startle the mice, causing them to run to
the opposite side of the enclosure. The spout would then retract as the mouse returned to investigate
the spout. I attempted to adjust the timing of the spout insertion and retraction, but I did not want
the spout to be available for so long that they would binge on drug consumption within a single
exposure. Secondly, some mice would lick the spout upwards of twenty times during one infusion,
and it was impossible to control how much liquid was distributed at once with the equipment we
possessed. Third, I frequently observed the mice sitting directly in front of the spout entrance.
They could occasionally force a sufficient portion of their head through the spout entrance to reach
the retracted spout from within the chamber, compromising the motivation of the mice to engage
with the cues to obtain the drug. Finally, some mice would opt to engage with the active and
inactive cue insets while completely ignoring the drug when it became available. Overall, due to
the many technical and experimental confounds present in these oral fentanyl SA experiments, we
opted to conduct fentanyl IVSA experiments.
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The key challenge we confronted with initiating the fentanyl IVSA experiments was to
learn the IV catheter insertion surgeries. Even experienced surgeons in our lab with years of
experience in IV catheter insertion surgeries in rats found that insertion of the catheters in mice
was significantly more difficult to perform successfully. Mouse survival from these surgeries was
the critical rate limiting step for obtaining sufficient numbers of mice for fentanyl IVSA pilot
studies. We have improved significantly in our proficiency with these surgeries and we are now
able to generate sufficient numbers from these surgeries that we are confident that we will soon be
able to conduct these surgeries in our Cnih3 mouse models.
With some of the initial mice obtained from these surgeries, we were able to successfully
conduct fentanyl IVSA experiments in mice. We are currently conducting a dose response study
to confirm the optimal dose for us to continue with this protocol in our experimental genetic mouse
models. While we did not find strong effects of sex on fentanyl IVSA in WT mice, we did observe
a trend towards female mice acquiring the task faster than males. We are attempting to replicate
this finding, but this would be especially interesting for when we investigate the role of CNIH3 on
fentanyl IVSA acquisition given our previous findings of strong sex differences in our Cnih3 KO
studies on memory in mice. Since we found it especially challenging to fully extinguish fentanyl
seeking in this paradigm, we will focus our future studies on the acquisition and maintenance of
fentanyl IVSA. Finally, we also tested whether mice would increase responding to the fentanyl
IVSA task during their dark cycle. Given the heightened responses we observed after dark cycle
training and based on insight from other studies of drug consumption during the dark cycle in
rodents (215), we are considering holding animals in reverse light – dark cycle housing conditions
to ensure optimal behavioral responding.
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The pilot studies discussed in this chapter will lay the foundation for future experiments
in opioid SA in Cnih3 mouse models. With an established protocol for mouse fentanyl IVSA in
hand, we will be well-prepared to dissect how sex differences in CNIH3 function may mediate
mechanisms underlying opioid-associated memory and opioid seeking behavior.
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Chapter 5:
Conclusions and Future Directions
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In this dissertation I present the compilation of my thesis work to dissect sex differences in
the role of CNIH3 on spatial memory and synaptic plasticity, with the goal of utilizing the findings
from these studies for future experiments to determine the link between genetic factors such as
single nucleotide polymorphisms in CNIH3 and opioid use disorder (OUD) risk in human subjects.
I submit these findings to the honorable members of my thesis committee and to the Graduate
School at Washington University in St. Louis to meet the requirements for the Doctorate of
Philosophy in Biology and Biomedical Sciences – Neurosciences.

5.1

Significance
The biological processes underlying learning and memory share significant overlap with

the development of addictive behaviors. It is therefore critical for scientists to characterize how
drugs of abuse such as opioids commandeer these mechanisms in the brain to reinforce
maladaptive behavior. As genetic factors can shape an individual’s risk of developing drug
dependence following drug exposure, there has been significant efforts in the field to identify
genetic markers which are associated with opioid use disorder (OUD). A 2016 genome-wide
association study (GWAS) by Nelson et al. identified single nucleotide polymorphisms (SNPs) in
the gene CNIH3 to be protective against the progression to OUD in individuals with prior opioid
exposure (123). CNIH3 encodes for the protein cornichon homolog-3 (CNIH3), an AMPA receptor
(AMPAR) auxiliary protein highly expressed in the dorsal hippocampus (dHPC) (126). We
previously demonstrated a key role for AMPARs in the dHPC in modulating opioid-associated
learning and memory (69, 120-122), therefore we hypothesized that CNIH3 mediates learning and
memory processes underlying OUD risk through AMPAR-mediated mechanisms in the dHPC.
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To study the role of CNIH3 on memory and related mechanisms, we needed to generate
animal models with diverse Cnih3 expression profiles. Therefore, we bred and characterized three
new C57BL/6 mouse lines: a Cnih3 knockdown (KD), a functional Cnih3 global knockout (KO,
Cnih3-/-), and a humanized transgenic mouse line overexpressing human Cnih3 bearing the SNPs
identified in the Nelson et al., 2016 GWAS (123). In addition, we also created a viral vector
construct to induce localized overexpression of Cnih3.
We utilized these newly generated mouse lines to first study the role of Cnih3 in spatial
memory, synaptic plasticity, and AMPAR subunit configuration. We hypothesized that
modulation of Cnih3 expression would affect spatial memory and hippocampal synaptic
connectivity, AMPAR subunit composition, and synaptic plasticity. In pilot studies of Cnih3 KD
mice, we observed slight deficits in hippocampal synaptic proteins and spatial memory in female
mice. To address these potential sex differences in the role of CNIH3 in the dHPC, we utilized
several approaches to explore the interaction between sex and CNIH3 in the hippocampus. In mice
overexpressing Cnih3 in the dHPC, we observed marked improvement in short-term spatial
memory tested via a Barnes maze spatial memory task exclusively in female animals, with no
observable effect of dHPC Cnih3 overexpression in males. In Cnih3-/- mice, we observed
attenuated short-term spatial memory only in Cnih3-/- females. Within female mice, we also
observed the most robust effects of CNIH3 on spatial memory during the metestrus phase of the
female estrous cycle. In line with our behavioral data, we observed hippocampal deficits
exclusively in samples from Cnih3-/- female mice. In SEQUIN imaging studies quantifying
synaptic loci, we observed decreased levels of synaptic structural proteins and reduced synaptic
density in dHPC samples obtained from Cnih3-/- female mice. In biochemical studies, we detected
altered AMPAR subunit composition in synaptosomal samples obtained from the dHPC of Cnih3127
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female mice, particularly during the metestrus phase. In field recordings of the Schaffer

Collateral (SC) circuit in the dHPC, we observed attenuated maintenance of long-term potentiation
in Cnih3-/- female mice. These studies identified a previously unknown role for CNIH3, as
manipulation of this gene unmasked sexually dimorphic effects in spatial memory and
hippocampal synaptic plasticity.
Due to the role of AMPAR-mediated mechanisms underlying drug-associated learning and
memory, we next investigated how CNIH3 may interact with sex to mediate opioid-associated
behaviors. We revisited the original Comorbidity and Trauma Studies data from the 2016 Nelson
et al. GWAS to probe for correlations between CNIH3 SNPs and sex on OUD risk. Upon
separation of study participants by sex, we found that the genome-wide significance of the
protective CNIH3 SNPs was substantially stronger in women than in men. To investigate the role
of CNIH3 on sexual dimorphism in opioid-associated learning and opioid seeking in our mouse
models, we aimed to establish a protocol for operant self-administration (SA) of the fast-acting
synthetic opioid fentanyl. We first tested a protocol for oral fentanyl SA. Oral fentanyl SA resulted
in inconsistent and limited drug consumption during both the light and dark cycles of WT mice.
In pilot studies testing intravenous self-administration (IVSA) of fentanyl in male and female wildtype mice, we successfully trained mice to self-administer fentanyl and induced cue-associated
reinstatement following a period of extinction. Interestingly, female mice took slightly less time
to acquire the IVSA task compared male animals, but additional studies are required to confirm
these results. The next step of these studies will be to test the role of CNIH3 on cue-associated
IVSA in male and female Cnih3-/- mice. In addition, we will also investigate whether humanized
transgenic mice overexpressing the protective human CNIH3 SNPs display attenuation of cueassociated fentanyl IVSA acquisition and reinstatement.
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Taken together, these studies demonstrate a role for CNIH3 in mediating sexually
dimorphic hippocampal mechanisms underlying spatial memory. In addition, preliminary studies
also support an interaction between CNIH3 and sex on opioid use disorder risk. In future studies
we aim to further dissect how CNIH3 mediates opioid-associated learning and memory. The
findings presented in this thesis support a role of hippocampal CNIH3 in mediating AMPARdependent memory processes and illustrate the importance of considering sex as a biological factor
in biomedical research.

5.2

Future Studies

5.2.1 Investigation of the role of CNIH3 in opioid-use disorder and rodent models of drugassociated memory
Based on the long-term goals of this project to study CNIH3 in the context of OUD, the
logical next step for this project will be to expand on both our human and rodent studies
investigating the intersection between CNIH3, sex, and opioid addiction. I propose several key
areas of interest for these future studies: (1) Fentanyl IVSA behavioral studies in Cnih3 KO, Cnih3
conditional KO, and CNIH3 transgenic mouse lines, (2) in-vivo electrophysiological recordings of
the dHPC in Cnih3 KO during fentanyl operant IVSA, (3) dissection of the effect of CNIH3
activity in the dHPC on reward circuitry pathways in the brain, and (4) post-mortem tissue analysis
of CNIH3 expression in the hippocampus of human donors (with and without a history of OUD)
bearing the risk and protective haplotypes of the targeted CNIH3 SNPs.
As described in Chapter 4 of this thesis, we are currently conducting experiments to finalize
the establishment of fentanyl IVSA in mouse models. This paradigm will be utilized to test the
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role of CNIH3 on the acquisition and maintenance of cue-paired fentanyl IVSA in male and female
animals with daily estrous cycle tracking. We hypothesize that the acquisition of cue-paired
fentanyl IVSA will be attenuated in female, but not in male, Cnih3 KO mice compared to WT
controls. As a measure of CNIH3-mediated changes in hippocampal activity and their effects on
behavioral outcomes in fentanyl IVSA, we propose the use of in vivo electrophysiological
recordings in the hippocampus of Cnih3 KO and WT animals during operant fentanyl IVSA
testing. In the Moron-Concepcion laboratory, post-doctoral fellow Dr. Khairunisa Ibrahim is
already utilizing in vivo electrophysiology to record activity in the dHPC of mice during cueassociated food SA. Therefore, from these recordings we can obtain real-time measurements of
CNIH3-mediated changes in the dHPC during operant SA. To assess whether potential changes in
fentanyl IVSA behavior are due to deficits in in cue-associated learning or drug preference, we
will conduct control experiments to measure acquisition and maintenance of operant food SA and
non-operant drug preference in a fentanyl two-bottle choice experiment. Finally, we also propose
the use of three additional groups for testing in the cue-paired IVSA paradigm: (1) Cnih3
heterozygous KO mice as these animals did not display spatial memory deficits in either sex, but
may present attenuated cue association with drug rewards, (2) Cnih3 cre-induced conditional KO
mice bred from the Cnih3 KD mice as described in Chapter 2 to test the specificity of Cnih3 in the
dHPC for these behavioral studies, and (3) the humanized CNIH3 transgenic mice as both an
endogenous overexpression model, while also investigating whether the presence of the protective
haplotype in CNIH3 affects opioid-associated learning and drug seeking.
A second class of experiments which we aim to pursue are to investigate how CNIH3 in
the dHPC affects established reward circuitry in the brain. While we have previously reported in
multiple studies about the importance of glutamatergic mechanisms in the dHPC in mediating
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opioid-associated learning, sensitization, and extinction (69, 120, 122), the circuitry of the brain
mediating the reinforcing effects of opioids and other drugs is strongly regulated by activity in the
mesocorticolimbic dopaminergic system such as the ventral tegmental area (VTA) and the nucleus
accumbens (NAc) (220). Ventral hippocampal projections to the NAc play a key role in emotional
and reward-associated memory formation (221), and our lab has recently been investigating how
a projection from the dHPC to the NAc may also influence cue-associated memory. With our data
demonstrating a key role of CNIH3 in the dHPC for spatial memory and its links to addiction,
future experiments can probe whether manipulation of CNIH3 in the dHPC (such as with our
conditional KO mouse model or viral induction of Cnih3 overexpression) affects reward circuitry.
Finally, the identification of CNIH3 SNPs associated with progression to OUD after drug
exposure presents several key questions that have not yet been addressed in human studies. First
of all, we do not have data examining how these SNPs affect CNIH3 expression in the brain. We
propose the use of male and female human post-mortem tissue from donors bearing the protective
and risk-associated haplotypes to assess how these SNPs affect the gene expression profiles of
CNIH3 and associated genes. In addition, we can also probe whether prior opioid use with and
without a diagnosis of OUD leads to changes in CNIH3 function in the human brain. Secondly,
we do not know if these CNIH3 SNPs are associated with changes in memory, cognition, or
changes in behavior. The Nelson et al., 2016 GWAS did investigate how these SNPs affect
amygdala habituation to threatening facial associations in human imaging studies (123), but given
our findings linking CNIH3 to spatial memory in female mice there may be correlates between
CNIH3 expression and human cognition. As we also identified sex differences in the protective
effects of CNIH3 SNPs within the human GWAS data, it will be a key objective to include both
women and men in these future studies for detection of sexually dimorphic changes.
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5.2.2 Exploration of the link between CNIH3 and sexual dimorphism
Our discovery of sex differences in the role of CNIH3 was not a result that we anticipated
at the beginning of our investigation. Sex differences have never been previously reported in
studies of any CNIH proteins, nor any of the AMPAR auxiliary proteins. One prior study did
identify sexual dimorphism in the function of the PSD protein SynGAP (205), and several studies
have demonstrated sex differences in AMPAR function in the hippocampus (80, 84). To
investigate whether Cnih3 KO in males and in cycling females differentially modulates gene
expression of associated genes, we are currently conducting RNAseq studies of hippocampal tissue
from Cnih3 KO and WT mice across sex and estrous cycle stage. Results from this screen of RNA
expression will be useful to identify additional targets for future studies, especially in regards to
how sex and estrous cycling may differentially affect these processes. However, additional studies
would be required to explain how changes in Cnih3 expression affect spatial memory and
hippocampal synaptic proteins, structure, and plasticity only in females. Based on our observation
that CNIH3-mediated changes were strongest during the metestrus phase of the estrous cycle, we
hypothesize that CNIH3 function is influenced by circulating sex hormones such as 17β-estradiol.
To test this hypothesis, CNIH3-mediated changes in memory or hippocampal function can be
tested in ovariectomized female mice compared to intact females. We can also then test whether
injection of 17β-estradiol affects CNIH3-mediated changes in behavior and hippocampal activity.
This would be of key interest in understanding how sex and hormonal fluctuations affect learning
and memory processes in the brain.
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Science Policy & Advocacy
In addition to my training as an early career neuroscientist in the lab of Dr. Jose MoronConcepcion, I was also granted to opportunity to share my science with interested parties outside
of the lab environment. I completed coursework in science communication for broad audiences
and participated in multiple community science outreach initiatives such as the Young Scientist
Program & local Science on Tap seminars. While I found science communication opportunities to
be highly engaging, I became especially interested in applying these skills to a more specialized
field: regional and national science policy. I joined the Washington University student group
Promoting Science Policy, Education, and Research (ProSPER) where I served as the Science
Policy and Advocacy Chair. In ProSPER I coordinated career and advocacy events with national
and local organizations, co-authored a policy memo for the JSPG memo writing competition, and
attended national science policy meetings. In addition to my work with ProSPER, I was also
selected to serve in the 2020 cohort of the Society for Neuroscience (SfN) Early Career Policy
Ambassador (ECPA) program. As an ECPA, I contributed to monthly science advocacy activities
and participated in multiple biomedical research Capitol Hill Days in 2020 – 2021. These
experiences instilled in me a passion for civic engagement and an appreciation for the social
responsibility of scientists to present our findings to diverse audiences outside of the lab.
As an appendix to this thesis, I would like to include an example of some of the work I
conducted to develop as a science communicator and science advocator. Once such experience
was through the science policy memo writing competition, which is held annually by the Journal
for Science Policy & Governance in collaboration with the National Science Policy Network.
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Policy memos are short, informative writing pieces submitted to legislators to inform them on
topics related to public policy. In the professional realm of science policy, a policymaker may
request a member of their staff or a congressional research professional to draft a memo on a
subject which is relevant to a bill or other piece of upcoming legislation. The key challenge in
writing a memo is to provide evidence-based background, analysis, and recommendations in a
clear and concise format. Attached is the entry which was submitted by me and two WashU DBBS
students, Emilee Kotnik and Rachel Rahn, for the 2020 policy memo writing competition to voice
our concerns regarding the lack of genetic privacy consumer protections by third-party genetic
testing companies. While this entry was not a competition finalist, I am participating again this
year to draft a memo regarding gender and disability discrimination in safety equipment design
and testing.
Overall, these experiences gave me the opportunity to incorporate scientific data
into discussions of evidence-based policy and to improve my skills as a science communicator,
setting a strong foundation for me to grow as a civically engaged scientist.
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Executive summary
Direct-to-consumer genetic testing companies have become increasingly popular in the U.S. as
DNA sequencing technology has become more advanced and less expensive. But this growth in
the market comes with increased risks for consumers who have their unique and personal genetic
information shared with companies and public databases. Currently there are no federal protections
for consumers to protect their right to privacy regarding their genetic data when it is obtained by
private companies. This leaves consumers vulnerable to companies sharing their genetic
information with other entities and can have implications for consumers’ identity, family
members, and wellbeing. Federal regulations like the Genetic Information Nondiscrimination Act
(GINA) and the Health Insurance Portability and Accountability Act (HIPAA) provide regulations
for how genetic information can be used and shared, but these laws do not apply to commercial
direct-to-consumer genetic testing companies. We recommend that these already existing federal
laws be amended to include any company that obtains genetic sequencing information.

Statement of the issue
In the United States, commercial genetic tests have become more popular and widely available, as
the cost of testing has decreased and the number of companies offering direct-to-consumer (DTC)
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genetic

testing

has

increased.

Ancestry.com, just one company in
the DTC genetic testing market,
claims to have DNA-tested more
than 16 million people.1 Figure 1
demonstrates the estimated number
people that have used DTC testing
services and its expansion over
Figure 1: Growth of Direct-to-Consumer Customers 2013-2019.2

recent years. However, consumers’
personal genetic information, when shared with DTC genetic testing companies, is not protected
under federal law. This creates the potential for personal genetic information to be commercialized
and distributed without the informed consent of consumers.
There are only limited policies currently in place to protect individuals’ genetic information and
protect consumers from incorrect application of these testing results.5 Both the American Medical
Association (AMA) and Centers for Disease Control and Prevention (CDC) have expressed
concern about the risk of DTC genetic testing results being misinterpreted. The AMA claims that
results can be difficult to interpret without a physician’s or genetic counselor’s help, and the CDC
cautions that these are not diagnostic tests and do not guarantee the presence or absence of a
disease.3,4 The possibility that without oversight, individuals’ data could then be leveraged and
interpreted inappropriately for commercial purposes is a serious danger to individuals’ privacy.
Genetic data is different in nature from most personally identifiable health information, since it
cannot truly be de-identified as its code is unique to every individual.8 Genetic information can
also provide details about immediate or extended family member’s genetic makeup, which raises
163

questions regarding consent. While the individual undergoing a commercial genetic test may agree
to the testing company’s terms and conditions, their immediate relatives, whose genetic
information could be surmised from the customer’s details, have not provided consent. In 2018, a
research study found that 60 percent of Americans of European descent could have their DNA
matched to a third cousin or closer relative, using the 1.28 million samples available in a consumer
gene database.5 That number has only risen in recent years, but the exact number of individuals
represented in consumer gene databases is not known because of the lack of required
transparencies. Consumer companies dealing with genetic information are not required to disclose
the number of DNA samples they have collected or banked. Therefore, many Americans’ genetic
information may be available, in part, through their relatives and reasonable inferences about their
disease risk and other genetic factors can be made and distributed without their consent.

Political and Legal status
Currently there are no federal laws to specifically protect one’s genetic privacy, but there are some
laws that regulate how genetic data can be used. The Genetic Information Nondiscrimination Act
(GINA) protects individuals from discrimination based on their genetics by prohibiting employers
and health insurers from using genetic information in their decisions or asking for or buying
genetic information from individuals or their family members.7 However, GINA does not apply to
life, disability, or long-term care insurance and does not cover privacy concerns.7
The Health Insurance Portability and Accountability Act (HIPAA) passed by Congress in 1996
protects the privacy of individuals’ medical information in the U.S. healthcare system.6 Genetic
information does not fall under the HIPAA checklist safe harbor for de-identification, but it does
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qualify as Protected Health Information (PHI).7,8 This means there are limits on when and with
whom genetic information can be shared by health providers and insurance companies.
However, private DTC companies that collect genetic information, such as 23andMe, do not fall
under entities that must follow HIPAA regulations, which leaves customers of DTC genetic testing
agencies vulnerable.7,8
Federal genetic privacy laws have been proposed, the most recent of which was the Genetic
Information Privacy Act of 2019 (H.R.2155) introduced in the House of Representatives
Representative Bobby Rush (D-IL-1) in the 116th Congress session.9 The Act states that any
“genetic testing service”, defined as any entity that conducts a genetic test to consumers or analyzes
genetic information from genetic tests given directly to consumers, cannot disclose this genetic
information to third parties or conduct research without expressly informed consent. This bill was
referred to the Subcommittee of Consumer Protection and Commerce in April 2019, but was never
voted on in the House.9 Genetic privacy laws vary from state-to-state, and a total of 18 states have
laws with specific penalties for violating genetic privacy and 26 states require consent to disclose
genetic information.10

Policy Options
Option 1: Expand the definition of covered entities for HIPAA to include companies which
provide, analyze, and store data from DTC genetic testing services. This would mandate DTC
genetic testing companies to follow the HIPAA Privacy and Security Rules to protect consumer
genetic data as PHI. As genetic data obtained even for the purposes of investigating ancestry,
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ethnic background, or other consumer interests can contain medically relevant data, genetic testing
for these reasons would still necessitate HIPAA compliance.
i.i. Advantages: Genomic and genetic data obtained in a clinical setting is already covered by
HIPAA protections, therefore an expansion of the definition of covered entities to include DTC
genetic testing companies would further protect consumer genetic data using regulations already
integrated into the current healthcare system. In addition, the federal Health and Human Services
Office of Civil Rights would be granted enforcement authority over DTC genetic testing
companies to ensure compliance with the Privacy and Security Rules.
i.ii. Disadvantages: DTC genetic testing companies will likely be resistant to government
oversight over private sector business in the United States. This would require investment of
significant resources by these companies to ensure HIPAA compliance, which may be difficult for
smaller startup enterprises. In addition, this could severely limit the ability of researchers to access
large datasets of genetic information.
Option 2: Modify the Genetic Information Nondiscrimination Act (GINA) to include restrictions
on how genetic information can be shared with employers and insurance agencies. Currently,
GINA only protects individuals from genetic discrimination, it does not protect the privacy of this
information. GINA can be amended to further limit the sharing of genetic information with
employers and insurers and require explicit consumer consent in order for genetic testing
companies to share genetic data.
ii.i. Advantages: This would provide some protections for consumers using DTC genetic testing
services over how their genetic information is shared and with whom their genetic data is shared.
In addition, this would strengthen consumer control over their distribution of their genetic data.
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ii.ii. Disadvantages: GINA is already quite limited in scope, as it only applies to genetic
discrimination in health insurance and employment prior to the onset of symptoms. Therefore,
amending GINA to improve genetic privacy would still leave many gaps in how this data is
protected and under what circumstances these protections will apply to consumers.
Option 3: Pass the Genetic Information Privacy Act of 2019 H. R. 2155. In the spring of 2019,
Congressman Bobby L. Rush proposed this bill to the House Committee on Energy and
Commerce. This bill seeks to require consumer consent for 3rd party distribution of personally
identifiable genetic information, ensure notification to both new and existing customers about
consumer genetic privacy rights, and grants enforcement authority for the protection of consumer
genetic information to the Federal Trade Commission and State attorneys general.
iii.i. Advantages: H.R. 2155 would require DTC genetic testing services to obtain explicit consent
for sharing genetic information with third parties. In addition, H.R. 2155 specifies that companies
cannot require that consumers must consent to share genetic information in order to for the
company to provide genetic testing services. Finally, this bill would enable consumers with the
ability to consent to share genetic data for research purposes, which is critical for many populationwide genetic studies.
iii.ii. Disadvantages: Following the proposal of H.R. 2155 to Congress in April of 2019, no
publicly available action has been taken to bring this bill to a vote in the House of Representatives.
Regarding the content of the bill, data security requirements for the storage and distribution of
genetic information are only vaguely specified.
Option 4: Inaction. Multiple states have already set up state-level genetic privacy laws with
varying levels of protections for consumers of DTC genetic testing services.
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iv.i. Advantages: Private businesses and individual states will be allowed to set in place policies
which grant them greater flexibility in how they collect and secure genetic health information, and
states will be able to tailor policies to the interests of their constituents. In addition, this information
would be more accessible for researchers looking to study large amounts of genomic and genetic
data.
iv.ii. Disadvantages: Leaving genetic privacy policies to the states or the courts will result in
inconsistent, if any, protections for the genetic privacy of individuals. In addition, genetic
information on individuals also contain significant familial information, and family ties often
stretch across state borders, leading to inconsistencies in how family genetic privacy is handled
across states with different policies for genetic privacy.

Policy Recommendation
We recommend that the definition of “covered entities” for HIPAA compliance be expanded to
include DTC genetic testing companies. Patients’ genetic information is already protected under
HIPAA when genetic testing is conducted in a healthcare setting, and HIPAA has comprehensive
systems in place to ensure the privacy and security of PHI. Therefore, amending the definition of
HIPAA covered entities to include DTC genetic testing companies will provide improved
protections for consumers through the utilization of pre-existing regulatory systems.
DTC genetic testing services can provide valuable information on ancestral origin, familial
heritage, and personal identity, but without adequate privacy protections this information can come
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at great risk to consumers. Therefore, DTC genetic testing companies must be held to a higher
standard to protect consumers’ genetic information.
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